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Abstract 
Humans spend one third of their life sleeping, then we could raise the basic question: Why do we 
sleep? Despite the fact that we still don’t fully understand its function, we made much progress in 
understanding at different levels how sleep is regulated. One model suggests that sleep is regulated 
by two processes: a homeostatic process that tracks the need for sleep and by a circadian rhythm 
that determines the preferred time-of-day sleep occurs.  
At the molecular level circadian rhythms are a property of interlocking transcriptional regula-
tors referred to as clock genes. The heterodimeric transcription factors BMAL1::CLOCK/NPAS2 drive 
the transcription of many target genes including the clock genes Cryptochome1 (Cry1), Cry2, Period1 
(Per1), and Per2. The encoded CRY/PER proteins are transcriptional inhibitors of 
BMAL1::CLOCK/NPAS2 thereby providing negative feedback to their own transcription. These genes 
seem, however, also involved in sleep homeostasis because the brain expression of clock genes, es-
pecially that of Per2, increase as a function of time-spent-awake and because mice lacking clock 
genes display altered sleep homeostasis. 
 The aim of first part of my doctoral work has been to advance our understanding the link 
that exists between sleep homeostasis and circadian rhythms investigating a possible mechanism by 
which sleep deprivation could alter clock gene expression by quantifying DNA-binding of the core-
clock genes BMAL1, CLOCK and NPAS2 to their target chromatin loci including the E-box enhancers of 
the Per2 promoter. We made use of chromatin immunoprecipitation (ChIP) and quantitative poly-
merase chain reaction (qPCR) to show that DNA-binding of CLOCK and BMAL1 to their target genes 
changes as a function of time-of-day in both liver and cerebral cortex. We then performed a 6h sleep 
deprivation (SD) and observed a significant decrease in DNA-binding of CLOCK and BMAL1 to Dbp. 
This is consistent with a decrease in Dbp mRNA levels after SD. The DNA-binding of NPAS2 and 
BMAL1 to Per2 was similarly decreased following SD. However, SD has been previously shown to in-
crease Per2 expression in the cortex which seems paradoxical. Our results demonstrate that sleep-
wake history can affect the molecular clock machinery directly at the level of the chromatin thereby 
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altering the cortical expression of Dbp and Per2, and likely other targets. However, the precise dy-
namic relationship between DNA-binding and mRNA expression, especially for Per2, remains elusive.  
The second aim of my doctoral work has been to perform an in depth characterization of cir-
cadian rhythmicity, sleep architecture, analyze the response to SD in full null-Per2 knock-out (Per2-/-) 
mice, and Per1-/- mice, as well as their double knock-out offspring (Per1,2-/-) and littermate wildtype 
(Wt) mice. The techniques used include locomotor activity recording by passive infrared (PIR) sen-
sors, EEG/EMG surgery, recording, and analysis, and cerebral cortex extraction and quantification of 
mRNA levels by qPCR. Under standard LD12:12 conditions, we found that wakefulness onset, as well 
as the time courses of clock gene expression in the brain and corticosterone plasma levels were ad-
vanced by about 2h in Per2-/- mice compared to Wt mice.  When released under constant dark condi-
tions almost all Per2-/- mice (97%) became arrhythmic immediately. From these observations, we 
conclude that while Per2-/- mice seem to be able to anticipate dark onset, this does not result from a 
self-sustained circadian clock. Our results suggest instead that the earlier onset of activity results 
from a labile, not-self sustained 22h rhythm linked to light onset suggesting the existence of a light-
driven rhythm. Analyses of sleep under LD12:12 conditions revealed that in both Per2-/- and Per1,2-/- 
mice the same sleep phenotypes are observed compared to Wt mice: increased NREM sleep frag-
mentation and inability to adequately compensate the loss of NREM sleep. That suggests a possible 
role of PER2 in sleep consolidation and recovery. 
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Résumé 
L’homme passe près un tiers de sa vie à dormir. Ainsi nous pouvons nous poser la question fonda-
mentale : Pourquoi dormons-nous ? Malgré le fait que nous ne saisissons pas encore la fonction du 
sommeil, beaucoup de progrès ont été faits dans l’étude de sa régulation. Un modèle suggère que le 
sommeil est régulé par deux processus : un processus homéostatique qui suit le besoin de sommeil 
et un processus circadien qui détermine à quels moments auront lieu les différents processus biolo-
giques, physiologiques et comportementaux des êtres vivants durant le nycthémère.  
Au niveau moléculaire, le rythme circadien est composé de deux boucles principales inter-
connectées. La première est constituée des hétérodimères BMAL1::CLOCK/NPAS2 qui va entraîner la 
transcription de nombreux gènes cibles en se fixant à leurs promoteurs E-box. Parmi ces gènes cibles 
se trouvent, entre autres, les gènes de l'horloge Cryptochromes (Cry1 et -2) et Periodes (Per1 et -2). 
Les protéines résultantes vont former les complexes PER/CRY qui vont opérer comme boucle de ré-
trocontrôle négative en inhibant leur propre transcription. Il a été préalablement démontré qu’une 
privation de sommeil chez la souris entraîne une altération de l’expression des gènes de l’horloge (en 
particulier Per2) dans le cerveau, suggérant que ces gènes ne sont pas uniquement impliqués dans 
les rythmes circadiens, mais également dans l’homéostasie du sommeil. Il a également été observé 
que certaines souris mutées pour un gène de l’horloge possèdent des altérations de leurs marqueurs 
de l’homéostasie du sommeil.  
Le premier objectif de mon travail de thèse a consisté à approfondir le lien existant entre 
l’homéostasie du sommeil et les rythmes circadiens au niveau même de l’ADN. Nous avons voulu tes-
ter l’hypothèse selon laquelle une privation de sommeil (PdS) modifierait l’expression des gènes hor-
loges en altérant la liaison spécifique de trois facteurs de transcriptions clés, à savoir BMAL1, CLOCK 
et NPAS2, aux séquences promotrices E-box des gènes cibles de l’horloges: Per1, Per2, Cry1 et Dbp. 
Pour ce faire, nous avons utilisé comme technique l’immunoprécipitation de la chromatine (ChIP), 
ainsi que la réaction en chaîne par polymérase quantitative (qPCR). Pour la première fois, nous avons 
démontré que la liaison de CLOCK et BMAL1 aux gènes cibles variait de manière circadienne dans le 
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cortex cérébral, comme cela avait préalablement été établi dans le foie. Puis en effectuant 6h de PdS, 
nous avons observé une diminution significative des liaisons de CLOCK et BMAL1 au promoteur E-box 
de Dbp ; ce qui est cohérent étant donné que l’on observe une baisse de l’ARN de Dbp après la PdS. 
Cependant, nous obtenons également une baisse de la liaison au promoteur de Per2 de la part de 
NPAS2 et BMAL1, alors qu’il est connu que l’ARN de Per2 augmente après PdS, ce qui peut sembler 
paradoxal de prime abord. Nos résultats démontrent qu’une PdS affecte directement le mécanisme 
moléculaire de l’horloge lors de la liaison à l’ADN, au niveau cortical. Bien que la relation entre la liai-
son à l’ADN et l’expression de l’ARN semble comprise pour Dbp, la dynamique pour Per2 reste bien 
plus compliquée à saisir. 
Le second objectif de mon doctorat fut de caractériser de manière approfondie le rythme cir-
cadien et l'architecture du sommeil des souris mutantes pour les gènes Per1, Per2, Per1,2, ainsi que 
leurs réponses homéostatiques à une PdS. Les techniques employées ont été : enregistrements de 
l’activité locomotrice par capteurs infrarouges, enregistrement électroencéphalographique et la 
quantification des niveaux d'ARNm par qPCR du cortex cérébral. Nous avons découvert que sous des 
conditions standard 12h lumière/12h nuit (LD12:12), l’enclenchement de l’activité, l’expression des 
gènes de l’horloge dans le cortex, ainsi que les taux plasmatiques de corticostérone sont avancés 
d’environ 2h chez la souris Per2-/- comparé aux sauvages (Wt). Dans des conditions d’obscurité cons-
tante, 94% des Per2-/- deviennent immédiatement arythmiques. Les résultats obtenus ont démontré 
que bien que les souris Per2-/- semblent capables d'anticiper l’obscurité, cela n’est pas le résultat 
d'une horloge circadienne autonome et fonctionnelle, mais plutôt la conséquence d’un rythme court 
de 22h induit par l’apparition de la lumière. Les analyses du sommeil en LD12:12 ont, en outre, révé-
lées que les souris Per2-/- et Per1,2-/- comparées aux Wt avaient un sommeil profond plus fragmenté 
et étaient incapables de compenser adéquatement la perte de sommeil suite à une PdS. Ceci suggère 
fortement que PER2 possède un rôle dans la consolidation et la récupération du sommeil. 
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 Introduction 
Humans spend one third of their life sleeping. The 
basic question “Why do we sleep?” is a conundrum. 
For many centuries, sleep was associated to death. 
For example, in the Greek mythology the act of 
sleeping was personified by the god Hypnos who was 
the twin brother of Thanatos, the god of death, both 
children of Nyx the primordial goddess of the night 
(Fig.1)[1].This allegory perfectly summarizes the idea 
that women and men had of sleep: a mysterious state homologous to death in its stillness, uncon-
sciousness and loss of muscular tone. This similarity between death and sleep has appeared many 
times in the literature until present day, like the citation of Arthur Schopenhauer: ”Each day is a little 
life: every waking and rising a little birth, every fresh morning a little youth, every going to rest and 
sleep a little death.”[2]. However, this “little death” was considered useless and a waste of time but 
nevertheless essential to life, especially to the recovery that it provides. The nature of that what re-
covered is, however, still not understood. 
 The first important step forward in the description of sleep was made possible by the discov-
ery of the electro-encephalogram (EEG) in 1924 by the neurologist Hans Berger with the initial objec-
tive to demonstrate his theory on mental telepathy [3]. This technic permitted in 1937 to Alfred Lee 
Loomins et al. to demonstrate that sleep is not a unitary state and they defined the first classification 
and description of the vigilance states [4]. In 1953, rapid eye movement were discovered by Eugene 
Aserinsky and Nathaniel Kleitman [5]. However Michel Jouvet discovered in 1959 that specific brain 
activity and muscle atonia were associated to rapid eye moment and thus he identified a new inde-
pendent state of alertness called “paradoxical sleep” that could be also named rapid eye movement 
Figure 1  "Sleep and his half-brother Death" by John William 
Waterhouse, 1874 (Oil on canvas) 
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(REM) sleep [6]. From 2007 the American academy of sleep medicine (AASM) proposed technical 
specification and precise terminology to distinguish five sleep-wake states in human [7].  
To understand the function of sleep, Allan Rechtschaffen et al. proved in 1989 its necessity 
showing that a long period of constant sleep deprivation in rats had an enormous impact on metabo-
lism, food intake, immune response, body temperature and provoked the death of the animal [8]. In 
human long constant sleep deprivation or daily small sleep deprivation decreased the cognitive skills 
(memories task, reaction time, etc.), increased the hallucination risk and modified the mood and 
judgment [9]. Unfortunately these observations didn’t explain why we sleep. However, based on 
many observations, many hypotheses were put forward. For example, sleep could be important to 
restore the balance of energy and metabolites (adenosine and glycogen), altered during wakefulness 
[10, 11]; to equilibrate the synaptic potentiation accumulated during the wakefulness [12]; to reverse 
damage caused by oxidative stress in wakefulness [13]; to consolidate learning and memory [14] or 
on contrary to forget useless information [15]. 
 Despite the fact that we still do not fully understand its function, we made much progress in 
understanding at different levels how sleep is regulated such as the neurophysiological basis of non-
rapid eye movement (NREM) and REM sleep and its molecular components and neurotransmitters 
[16, 17]; and many conceptual models of sleep regulation were proposed as the reciprocal-
interaction model of NREM–REM sleep alternation [18], the flip-flop switch model [19], and the two 
process model [20]. This latter proposes that two main processes contribute to determine the 
sleep/wake cycle and the sleep structure [21]. The first one is the circadian rhythm (process C) that 
determines when it is the better moment for wakefulness and sleepiness to occur across a 24h day. 
The second is the homeostatic process (process S) that tracked the need for sleep that increased dur-
ing wakefulness and decreased during the sleep. This model assumes that both process S and C are 
independent and their interaction predicts the sleep/wake distribution. These two processes are 
considerate as separate at the neuroanatomical and physiological level. In fact, forced desynchrony 
studies where human were scheduled to a 28h day shown that marker of the process S was inde-
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pendent of the process C [21]. Similar conclusion was done in lesion of the suprachiasmatic nuclei 
(SCN, the masterclock of the mammals) studies in several animals [22-25]. In fact, the suppression of 
circadian rhythm did not affect the dynamic of the process S. However, it was show that these two 
processes are interconnected by a molecular link. This idea is based on two types of observations. 
The first one is that mice with disrupted clock genes have changes in the dynamics of the sleep ho-
meostatic process. The second type of observation was that an increase in homeostatic sleep pres-
sure by doing a sleep deprivation increases the expression of certain clock genes [26]. 
 To better understand at which level this link is regulated, the first project of this thesis inves-
tigated a possible mechanism by which sleep deprivation could alter clock gene expression at DNA-
binding level. To further investigate how this link operated, the second project aimed to characterize 
scrupulously the circadian and homeostasis aspects of sleep regulation in mice lacking the central 
clock genes named Period.  
 Before to show my experimental work, some general concepts on sleep and its regulation 
will be introduced in the next pages, followed by a section dedicated to the role of circadian rhythms 
at the physiological and molecular level. Moreover, I will specially focus on those aspects that are 
pertinent to my experiments as circadian and sleep phenotype in clock mutant mice, and finally I will 
provide a description of the Period genes, their function and interactions. 
I. Sleep 
1. Definition of sleep 
Sleep is a basic behavior present in almost all animals studied thus far. However depending on the 
species, the proprieties of sleep differ. For example, REM sleep is only present in mammals and birds. 
However, in invertebrates and reptiles the sleep state could not been defined as REM and NREM 
sleep state, and the term sleep-like state was preferred as in turtles, in drosophila or in honey bee 
[27, 28]. Unihemispheric NREM sleep has been observed in in cetaceans , seals , and birds [29]. 
 In absence of EEG, the behavioral definition of sleep becomes an immobile state in a species 
specific body posture with a notable decreased response to various external stimuli. Moreover, this 
25 
 
state has to be quickly reversible, it has to follow a homeostatic regulation, and it as to be required 
for survival. Indeed, if sleep is prevented death might occur [30]. Although sleep as a behavior can be 
readably recognized, all previous criteria are need to distinguish this state from torpor, hibernation 
and coma.  
2. Description of sleep 
The standard procedure to analyze sleep in mammals and birds is to use the EEG to measure the 
electrical activity of the forebrain (more specially the cortex). To gather more information, electro-
myogram (EMG) and electro-oculogram (EOG) are often recorded in parallel to detect the muscle 
tone and eye movements, respectively. Together these signals permits to identify the two sleep 
states NREM sleep (also called slow-wave sleep, SWS) and REM sleep (also called paradoxical sleep). 
Note that REM sleep is not detected in cetaceans and only observed in the brainstem of the mono-
tremata family [29]. An alternative and non-invasive technic to collect data on vigilance states in 
mice is the piezoelectric system that detects animal’s movements with high sensitivity permitting to 
automatically distinguish sleep from wakefulness [31]. In the context of this thesis, I will focus on 
human and mice studies for the detailed description of different vigilant states. 
 One protocol currently used in human was standardized by the AASM [7]. It proposes to 
place non-invasive electrodes in a detailed location on the human scalp and recommended specific 
EEG derivations between the electrodes to collect the EEG. For the minimal montage in mice, two 
EEG electrodes were fixed in parietal and frontal bones in the right hemisphere. This placement was 
chosen to ensure an optimal distinction between the different behavioral states [32]. In fact, the 
frontal electrode was sited over the frontal cerebral cortex to detect the slow waves oscillations 
(<5Hz) characteristic of the NREM sleep. The parietal electrode was placed just over the hippocampal 
structure to capture at best the theta oscillation (5-7Hz) characteristic of the REM sleep. This bipolar 
acquirement permits to measure the potential difference between the electrodes [33].These elec-
trodes detect a complex electric signal resulting mainly from summed synaptic currents from the api-
cal dendrites of pyramidal cortical neurons. Synchronized electrical activity in large numbers of these 
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neurons provides the basis for the changes in extracellular field potentials that underlie the EEG that 
can be described by amplitudes and frequencies variations [34].  
The EEG during wakefulness is 
composed of irregular signal of small 
amplitude (mainly alpha rhythm 8–
12Hz) often associated with a high and 
variable muscle tone (EMG) and eye 
movements (EOG) in both human and 
mice illustrated in figure 2 [7, 35]. 
NREM sleep in humans is segregated 
in 3 distinct stages corresponding to 
increasing depth of NREM sleep. The 
first one, N1, represent a transition 
stage with low amplitude and mixed frequency activity (mainly 4-7Hz). Usually the first N1 epoch is 
considered as the sleep onset.  The second stage, N2, is characterized by spindles (a train of distinct 
waves of 12-14Hz with a maximal duration of 0.5s) and K-complexes (a negative sharp deflection fol-
lowed by a slower positive component with a maximal duration of 0.5s). The last stage, N3, is charac-
terized by the largest EEG amplitude and prominent slow-wave. For this reason this stage is also 
called SWS (Fig.3) [7, 34, 35]. Usually NREM sleep is not further subdivided in stages in mice, alt-
hough similar changes occur between the beginning and the end of the state, such as spindles. NREM 
sleep has the highest amplitude with predominantly delta activity. Note that no distinction is done 
between the terms NREM sleep and slow-wave sleep (SWS) in mice. Both in man and mouse, NREM 
sleep is characterized by reduced muscle tone [34, 36]. REM sleep is composed of EEG pattern similar 
to wakefulness, with low amplitude and high frequency activity. Muscle tone is at the lowest levels of 
the entire recording (muscle atonia), despite occasional twitches shorter than 0.25s. Irregular and 
sharply peaked eye movements with an initial deflection usually lasting less than 500ms are present 
Figure 2  Typical polygraphic appearance of wakefulness (left column), slow-wave 
sleep (middle column), and REM sleep (right column) in the adult mouse and hu-
man. Wakefulness presents low-amplitude and high-frequency EEG waves (sign of 
activated cortex) and muscles tone. Slow-wave sleep (SWS, part of NREM sleep) have 
high-amplitude, low-frequency EEG waves with slightly reduced muscle tone. During 
REM sleep, cortical EEG is as activated (low-amplitude, high-frequency waves) as 
during wakefulness, but with reduction or absence of muscle tone (atonia) and pres-
ence of rapid eye movements. Time bar (for all species and states) = 5s. EEG = elec-
troencephalogram; EMG = electromyogram; EOG = electrooculogram. Modified from 
Datta S. et al. (2007) [35]. 
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in human. Due to its smaller size, the EOG recordings are normally not utilized to identify sleep-wake   
states   in   mice (Fig.2) [34-36]. 
In human, the different sleep stages mentioned 
above are structured in a precise sequence in a regular 
night. For example, in a normal young adult following a 
conventional sleep/wake schedule without sleep com-
plaints, the sleep state sequence looks like in figure 3 up-
per panel [37]. Indeed, sleep was composed by 4 or 5 cy-
cles of approximate length of ca. 90-100min. Each cycle 
begins with NREM sleep stage N1, followed by stage N2 
and, especially in the first half of the night, by stage N3. 
Thereafter a small moment of stage N2 appear, followed 
by REM sleep.  After REM sleep’s end, a new cycle starts with sometimes a short arousal between. A 
regular night is structured by 4 to 5 cycles. The first cycles are composed principally by NREM sleep, 
while the last cycles are composed mainly by REM sleep [37]. Aging affects the sleep architecture and 
the EEG in humans. In fact, sleep becomes more fragmented, the prevalence of EEG slow waves dur-
ing NREM sleep decreases and the time spent in NREM sleep stage N3 decreases accordingly as we 
get older [38].  
 In C57BL6/J mice the NREM and REM sleep follow a distribution over the day as illustrated in 
figure 3 lower panel. Note that mice are a nocturnal species and that they sleep mostly during the 
day, although considerable amounts of sleep are usually present also in the dark period. The usual 
sequence during sleep in mice is first NREM sleep that is followed sometimes by a REM sleep episode 
and ends by an arousal. Nevertheless, this order is not strictly respected. In opposition to human 
whose sleep is monophasic, mice have a polyphasic sleep. In the first part of light period, the sleep is 
composed by long episode of NREM sleep followed by regular REM sleep episode. It is the most con-
solidate sleep period. In the second half of this light period, the NREM sleep became more fragment-
Figure 3  Human hypnogram and sleep distribution in mice. 
Upper panel Vigilance state distribution in a precise se-
quence in a normal young adult human night Lower panel 
Vigilance states distribution over one day in inbred 
C57BL6/J mice  
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ed and less NREM sleep was reported. Some strains of mice are known to take a ‘nap’ in the second 
half of the dark period. [32, 36]. The effect of aging is similar in mice compared with human. In fact, 
the time spent in sleep is smaller in inbred stain mice older than 15 months compared with young of 
4 months. Moreover, older mice have less consolidation of sleep and appear to make up this lost 
sleep over longer time periods [39, 40]. 
Besides using the EEG to differentiate between different sleep-wake states, the EEG signal 
contains a lot of information that can be extracted and quantified mathematically. The EEG recorded 
signal is transformed by a Fast Fourier transformation algorithm to obtain EEG power spectra [41].  
This spectrum is divided into the following frequency bands: delta (1–4Hz), theta (5–9Hz), alpha (8–
12Hz), sigma (12–15Hz), beta (16–30Hz), low gamma (30-70Hz), and high gamma (70-120Hz) [34, 42]. 
The reader is reminded that 1 Hertz (Hz) is a SI unit defined as the number of cycles per second to 
calculate a periodic phenomenon. [43, 44].  
During wakefulness, the EEG spectrum is characterized by theta when the animals moving or 
exploring and with attention and memory task in human (in humans often slower in frequency 2.5-
4.0 Hz). The spectrum is also composed of beta and gamma range frequencies (15-120Hz), especially 
during quiet waking. During relaxed wakefulness, alpha (8-12Hz) rhythms can be observed in humans 
[34]. SWS is characterized by the largest EEG amplitude and prominent delta (1-4Hz) activity both in 
human and mice. [7, 34]. Delta activity is typical of the deeper stages of NREM sleep [45-48]. The to-
tal power of the EEG signal that occurs within the delta band is called EEG delta power and it is a 
widely-used marker of the homeostatic sleep need representing the sleep intensity [26]. Changes in 
delta power can be calculated in mammals based on the sleep/wake distribution especially under 
sleep deprivation condition. In fact, sleep deprivation increases the delta power [46, 48]. On the oth-
er hand, an excess of sleep by nap preceding nighttime sleep prolongs sleep latency and reduces EEG 
delta power [49]. Unusual higher beta activity in SWS appears in human suffering of primary insom-
nia resulting from cortical arousal [50]. REM sleep is composed principally by strongly synchronized 
activity in the theta (5-9Hz) range in rodents that is very similar to wakefulness [34]. However a ge-
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netic study suggests that theta generated from hippocampus during REM sleep differ from wakeful-
ness. In fact mice with deficiency in short-chain acylcoenzyme A dehydrogenase causes a marked 
slowing in theta frequency during sleep only. This [51].  In contrast to rodents, theta rhythm is not 
observed continuously in human, but rather is limited to 1s bouts [34]. 
3. Neurochemistry of sleep and wakefulness 
a. Wakefulness 
Wakefulness is one term that encompasses many different behaviors each with their specific brain 
activity. This following is a very simplified rendition of the complexity that accompanies the initiation 
and maintenance of wakefulness which only the main players are mentioned. At the neuronal level, 
it involves multiple redundant structures. Most structures, described below, are dispensable for the 
maintenance of cortical activation, even though they all contribute. Studies indicated that each struc-
ture could be responsible for the waking induction by a specific arousal. For example, new and unex-
pected external stimulus activate noradrenergic neurons that induce wakefulness and play an im-
portant role in alertness; a very lower glucose cerebral level mediate the activation of 
hypocretin/orexin neurons promoting also waking [52-54]. As illustrated in figure 4, wakefulness is 
mainly regulated by particular cells groups in the hypothalamus, basal forebrain and brainstem that 
arouse the thalamus and cerebral cortex in the same way in human and mice. Shortly, histaminergic 
neurons of the tuberomammillary nucleus (TMN) of the posterior hypothalamus project in all central 
nervous system producing a constant slow activity. 
30 
 
         
Hypocretin/orexin neurons located in lateral hypothalamus (LH) project throughout the brain and 
especially to other wake-promoting centers [16, 55-57]. These neurons have a key role to stabilize 
the waking state. In fact, deficits in neuropeptides hypocretin/orexin or in their receptors cause the 
sleep disorder narcolepsy [58-61]. People suffering of this pathology were not able to sustain contin-
ually wakefulness and have spontaneous attacks of irresistible sleepiness especially during emotional 
situations [62]. The basal forebrain (BF) is essentially composed by cholinergic, glutamatergic and 
GABAergic neurons that during wakefulness project to the cortex and thalamus. Cholinergic and glu-
tamatergic neurons directly rouse cortical neurons through nicotinic and glutamatergic receptors as 
well as indirectly by inhibiting specific thalamic neurons. GABAeric neurons activate the cortical neu-
rons indirectly by inhibiting cortical interneurons. Most of these neurons are responsible of cortical 
Figure 4  A schematic sagittal view of rodent 
brain showing the major structures and 
neurotransmitters involved in the regulation of 
the vigilance states. Wakefulness is maintained 
by cholinergic (in blue) ascending inputs from the 
brainstem (PFP, LDT, PPT) to the thalamus, which 
in turn activates the cortex, and from the BF. 
Additionally, monoaminergic (in red) such as 5HT 
from DRN, NA from LC, DA from vPAG, and His 
from TMN; as well as Hcrt (in green) inputs, con-
tribute to the waking cortical activation. NREM 
sleep may be initiated and maintained by GABA 
and galanin inhibitory inputs (in orange) from the 
VLPO to all wakefulness-promoting brain sites. 
REM sleep cortical activation is under the control 
of cholinergic and non-cholinergic structures 
arising from SLD in the brainstem, while REM 
sleep atonia is under the control of the glutama-
tergic and glycinergic projections to the spinal 
cord (in purple). Andretic R. et al. (2008) [55] 
Neurotransmitters: Ach: acetylcholine; 5HT: sero-
tonin; NA: noradrenaline; DA: dopamine; His: 
histamin; Hcrt: hypocretin/orexin; GABA: γ-
aminobutyric acid; Gal: Galanin; Glu: glutamate; 
Gly: glycine. 
Brain region: PFP: pontine reticular formation; 
LDT: laterodorsal tegmentum; PPT: pendoncu-
lopontine tegmentum; BF: basal forebrain; DRN: 
dorsal raphe nucleus; LC: locus coeruleus; vPAG: 
ventral periaqueductal; TMN: tuberomammillary 
nucleus; VLPO: ventrolateral preoptic nucleus; 
SLD: sublaterodorsal tegmental nucleus. 
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activation during wake and also REM sleep. [54, 63]. In the brainstem, the pendonculopontine teg-
mentum (PPT) and laterodorsal tegmentum (LDT) nuclei, which are also composed of cholinergic 
neurons, project to the reticular nucleus and to the thalamic-relay nuclei both in the thalamus. These 
latter nuclei facilitate the activation of the cerebral cortex during wake and REM sleep [54, 57, 64]. 
Serotonergic neurons from dorsal raphe nucleus (DRN or raphe), noradrenergic neurons from locus 
coeruleus (LC), and dopaminergic neurons from ventral periaqueductal gray matter (vPAG) project to 
the cortical region of the brain [55, 57, 65]. 
b. NREM sleep 
During NREM sleep, the wakefulness-promoting brain sites (TMN, PPT, LDT, DRN, LC, vPAG) and 
hypocretin/orexin neurons in perifornical hypothalamus (PeF) are inhibited by GABAergic and gal-
aninergic neurons from the ventrolateral preoptic nucleus (VLPO) in the hypothalamus [57, 66, 67]. 
VLPO cells show their first signs of inhibition activity during drowsiness and continue to discharge 
throughout NREM sleep and are able to initiate and maintain NREM sleep. While the wake-
promoting structures are less active during NREM sleep, they are not completely repressed [55, 57]. 
Note that VLPO is inhibited by the arousal systems that it inhibits during sleep. In fact, serotonergic 
neurons from DRN, noradrenergic neurons from LC and GABAergic neurons from TMN inhibit VLPO 
neurons [57, 68, 69]. Hypocretin/orexin plays a role in the maintenance of the sleep as well. Actually, 
narcoleptic people do not sleep more than normal individuals but waking more often from sleep at 
night [56]. The complex circuit containing both inhibitor and activator elements modulate the wake-
fulness/sleep mechanism seems to follow an electronic flip-flop model, where the production of 
states are discrete with sharp transitions. In fact, this model tend to avoid transitional states, be-
cause when either side begins to overcome the other, the switch ‘flips’ immediately into the alterna-
tive state (Fig.5) [57].  
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Adenosine is also an important player in sleep 
regulation [70]. Adenosine is the molecular basis 
component of adenosine-5'-triphosphate (ATP) 
synthesis. To produce the energy that neurons 
require, ATP is consumed and degraded in the 
secondary by-product adenosine which concen-
tration increases in the brain in activity-
dependent manner. Thereby adenosine increas-
es with time spent awake [71]. Adenosine binds 
several receptors which A1 and A2A are probably 
promoting sleep. In fact, adenosine inhibits ex-
citatory neurotransmission of neurons in all 
nervous system by A1 receptor binding. Moreo-
ver, adenosine binds also the A2A receptor pre-
sent in the VLPO area that contribute to pro-
mote sleep as explain above [72]. The most 
commonly used substance to avoid sleepiness is 
the caffeine that is an adenosine antagonist in-
creasing wakefulness and sleep latency [73]. 
c. REM sleep 
Brainstem structures are sufficient and necessary to trigger and maintain the REM sleep state [74]. 
More precisely the REM sleep onset is triggered by neurons in the dorsal part of the pontis oralis 
(PnO) and caudalis (PnC) nuclei in cats [74-76]. In rodents, glutamatergic neurons from a specific 
brainstem region called sublaterodorsal tegmental nucleus (SLD) trigger REM sleep and also cause 
muscle atonia [77, 78]. The inhibition from the VLPO observed in NREM sleep is even more pro-
nounced in REM sleep [55].   
Figure 5  A schematic diagram of the flip-flop switch model. A During 
wakefulness, the monoaminergic nuclei (LC, TMN, Raphe; red) inhibit 
the VLPO (purple), thereby relieving the inhibition of the monoamin-
ergic cells, and that of the hypocretin/orexin neurons (ORX; green), 
and the cholinergic PPT and LDT. Because the VLPO neurons do not 
have hypocretin/orexin receptors, the hypocretin/orexin neurons 
serve primarily to reinforce the monoaminergic tone, rather than 
directly inhibiting the VLPO on their own. B During sleep, the firing of 
the VLPO neurons inhibits the monoaminergic cell groups, thereby 
relieving their own inhibition. This also allows it to inhibit the 
hypocretin/orexin neurons, further preventing monoaminergic activa-
tion that might interrupt sleep. The direct mutual inhibition between 
the VLPO and the monoaminergic cell groups forms a classic flip-flop 
switch, which produces sharp transitions in state, but is relatively 
unstable. The addition of the hypocretin/orexin neurons stabilizes the 
switch. VLPO: ventrolateral preoptic nucleus;  eVLPO: extended ven-
trolateral preoptic nucleus; LC: locus coeruleus; TMN: tuberomammil-
lary nucleus; PPT: pedunculopontine tegmentum; LDT; laterodorsal 
tegmentum. Saper CB et al. (2005) [57] 
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A network model of REM sleep onset and maintenance has been proposed. It suggests that during 
wake and NREM sleep, specific GABAergic neurons localized in the ventrolateral periaqueductal gray 
(vlPAG) and  dorsal deep mesencephalic reticular nuclei (dDpMe) inhibits the glutamatergic neurons 
in the SLD. REM sleep onset would be due to an activation of other GABAergic neurons in an intrinsic 
manner both the in dorsal paragigantocellular reticular nucleus (DPGi) and vlPAG. These latter acti-
vate indirectly the SLD by inhibiting both dDpMe and vlPAG neurons. Descending SLD neurons would 
induce muscle atonia and sensory inhibition, while ascending SLD neurons induce cortical activation 
via thalamic relay neurons in collaboration with cholinergic and glutamatergic neurons from maintly 
PPT, LDT and basal forebrain  BF [79]. This cortical activation is responsible for the EEG during REM 
sleep that closely resembles wakefulness [16]. The exit from REM sleep would be due to the activa-
tion of waking systems that inhibits once again GABAtergic neurons in DPGi and vlPAG [79]. 
4. Regulation of sleep 
As I mentioned in the beginning of this introduction, the distribution and quality of sleep are princi-
pally regulated by two processes, one homeostatic and one circadian that can be illustrated by a 
model (i.e. “two-process model”) which will been explained in more detail below. One way to distin-
guish between these two processes is to imagine the oscillation generated by the homeostatic pro-
cess as an hourglass, every time the sleep/wake state is changed, the hourglass is turned; while the 
oscillation generated by the circadian process as a self-sustained clock [26]. These two processes 
work together allowing an optimal adaptation of living organisms to the environment while satisfying 
their daily need for sleep.   
a. Homeostatic process 
This process tracks the need for sleep and determines the propensity of an individual to fall asleep 
during the nychthemeron. During wakefulness the homeostatic process increases exponentially until 
reaching a maximum (i.e. asymptote). Sleep has the opposite effect; homeostasis sleep decreases 
until reaching the minimum. Despite the observation that homeostatic process appeared to oscillate 
with a period of 24h, it is important to realize that this oscillation in propensity is driven by the sleep-
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wake distribution which in turn strongly depends on circadian factors [26]. Thus although under 
normal conditions the sleep homeostatic process follows a circadian time course, the homeostatic 
process per se is completely independent of the circadian process.  
 Dijk and Czeisler made use of a forced desynchrony protocol in humans to differentiate be-
tween circadian and sleep-wake dependent contributions to different aspects of sleep and the EEG 
[21]. This protocol consisted of scheduling sleep in voluntary subjects in an environment free of time 
cues for several weeks according to a 28h rest-activity cycle so that sleep episodes of 9.33h occurred 
at all phases of the endogenous circadian cycle and variations in wakefulness preceding sleep were 
minimized. They observed that the time course of EEG delta power was mainly sleep/wake driven 
and varied with very small amplitude to its circadian time suggesting that circadian factors has no or 
only a small impact on this homeostatic process [21]. Studies in others species such as squirrel mon-
keys, Siberian hamsters, rats and mice underscored this conclusion. For instance, when the circadian 
rhythm was abolished by a lesion of the suprachiasmatic nuclei (SCN, the central clock pacemaker), 
these animals became completely arrhythmic. However, their homeostatic process remained un-
changed [22-25]. In conclusion, it is now established that circadian rhythm and sleep homeostasis 
processes are functionally and physiologically separate. 
 Markers of the sleep homeostatic process are: the total sleep time (or more specifically the 
duration of NREM and REM sleep), the sleep fragmentation, the EEG theta (4-8Hz) power during 
wakefulness and, of course, the EEG delta (1-4Hz) power collected during NREM sleep. This latter 
EEG power represents the sleep intensity [46-48]. Both theta and delta power are so predictable that 
their time courses can be calculated in mammals based solely on the sleep/wake distribution. [46, 
48, 49]. 
  The molecular aspect of the sleep homeostat is also relevant. For instance, the genetic back-
ground in mice has a strong impact on the NREM sleep need. In fact, the dynamic of the EEG delta 
power and NREM sleep duration after a sleep deprivation is specific to the strain [46]. Moreover, it 
was shown that both NREM sleep intensity (delta power) and NREM sleep duration are regulated 
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differently between human too [80, 81]. Homer1a is the best candidate transcript because its expres-
sion follows the sleep/wake distribution in the forebrain. Its expression increase in a very precise way 
in response to sleep loss and it is also specific of the strain mice. Thus, Homer1a is considered a relia-
ble molecular marker of the sleep need as the EEG delta power [45]. 
b. Circadian process 
The circadian process determines when wakefulness and sleep occur across the 24h day. It promotes 
sleep by decreasing the body temperature and increasing the level of the hormone melatonin to its 
maximum at a specific time. In contrast, it prevents sleep in other moment of the day by increasing 
sleep latency. Moreover, it consolidates the vigilance states [21].  There are a several markers that 
allow the tracing of the circadian process, for instance cortisol and melatonin levels in the blood, the 
fluctuation of the body temperature and the expression of many clock gene [21, 48]. An entire and 
complete section will be dedicated below to the circadian rhythm topic.  
c. Two-process model 
In 1982 Borbély A.A. imagined a model that conceptualizes the 
wake/sleep cycle named two-process model [20]. The latter has 
been improved and revisited through the years. [82, 83]. 
Nowdays, there are many models derived from this model ad-
dressing the regulation of fatigue [84], alertness [85, 86] and 
performance [87]. The original model postulated that both cir-
cadian and homeostatic processes were independent as illus-
trated in figure 6 (upper panel). The process C in blue represents 
the circadian process that oscillates in a sinusoidal manner 
across the nychthemeron of 24h. Its H (high) and L (low) thresh-
olds demarcate the boundaries of the process S marked in red. 
This Process S is based on the dynamics of the EEG delta power 
and represents the homeostatic process and follows the in-
Figure 6  Two-process model of sleep regulation. 
Upper panel Illustration of original two-process 
model showing the additive effects of circadian 
(C) and homeostatis (S) processes. Achermann P. 
(2004) [83] Lower panel Prediction of the two-
process model of an augmentation of both delta 
power and total sleep time after sleep derpiva-
tion. Borbély A. and Achermann P. (2011) [88] 
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creased need for sleep during wakefulness which decreases during sleep. Process S increases and 
decreases in an exponential manner reaching its asymptote. When the process S reaches a blue 
threshold, the model predicts a change in vigilance state. The EEG delta power is the widely used 
marker of this process S [83]. Moreover, based on observations, this model was improved to predict 
the effect of a sleep deprivation (Fig. 6 lower panel), suggesting that a sleep deprivation for 40h 
would accumulate additional sleep pressure (Process S), resulting in a bigger sleep intensity (EEG del-
ta power) during the recovery night as well an increased total sleep time [88].  
 The two-process model was successful in predicting alertness and sleepiness for experi-
mental manipulations in a physiological range. However, a challenging task is the modeling of cumu-
lative effects of chronic sleep restriction [83]. In fact, the level of EEG delta power (and Process S) 
quickly saturated during sleep restriction in accordance with delta power while vigilance and cogni-
tive performance continue to decrease. These data raise the question whether an additional process 
has to be assumed [89]. Furthermore, additional neurobehavioral measures (such as performance, 
subjective alertness) , within- and between-subject variability, and cumulative effects need to be ad-
dressed to facilitate the development of accurate models [90]. 
II. Circadian Rhythm 
The earth revolves around the sun in one year, creating the seasons. Moreover, it spins on its axis 
with an angle of 23° creating the nychthemeron (i.e. day/night cycle within 24h). When life emerged, 
roughly 3.5 billion years ago, it adapted to this predictable variation of temperature, light, humidity, 
as this was crucial for survival.  Indeed, the ability to anticipate these daily changes give an undenia-
ble adaptive advantage because it allows organisms to be more competitive and survive natural se-
lection. For this reason, this internal endogenous timing mechanism is present today in almost all 
species, from the simplest organisms such as bacteria to more complex ones such as humans, passing 
through plants and fungi. However, there are exceptions, such as creatures living in ocean trenches 
or in totally obscure caves [91]. In mammals, most physiological and behavioral processes depend on 
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this circadian timing. Examples are the body temperature fluctuation [21, 92], metabolism variation 
[93], cardiovascular activity [94], cognitive performance [92] and of course the sleep/wake cycle [21]. 
 The first scientific observation of the circadian rhythm was made in 1729 by the French sci-
entist Dortous de Mairan, which became the first chronobiologist. He noticed that the daily leaf 
movements of mimosa pudica persisted during several days even in constant obscurity [95]. This 
simple experiment provided the first evidence that a daily rhythm could be generated by an organ-
ism itself. Since then, this biological timekeeper is called circadian clock (from Latin words circa and 
diem meaning respectively about and day). Nevertheless, we had to wait the middle of the twentieth 
century for the first description of this endogenous clock in an animal and the year 1972 to precisely 
localize the master-clock in mammals, named SCN, in the anterior part of the hypothalamus above 
the optic chiasm on either side of the third ventricle [96].  
1. Definition of circadian rhythm 
A biological rhythm can be called “circadian” if it respects the following properties that were stated 
by Pittendrigh in 1960 at the XXV Cold Spring Harbor Symposium dedicated to biological clocks [97]: 
 Has a period length corresponding to the earth’s rotation with a small variance 
 Is endogenous and innate 
 Is self-sustained  
 Is near-independent of the external temperature (temperature compensation) 
 Is light-intensity dependent (period in nocturnal animal was greater in constant light condi-
tion (LL)  than in constant dark condition (DD); period in diurnal animal was smaller in LL than 
in DD) 
 Can be entrained by environmental stimuli (called Zeitgeber)  
The term Zeitgeber (ZT) was first used in 1954 by Jürgen Aschoff (from German words zeit and geber 
meaning respectively time and giver) [98]. This term represents any circadian external or environ-
mental cue (such as light, temperature, social interaction, feeding, and pharmaceutical manipulation) 
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that can entrain the circadian oscillator of an organism or synchronize circadian oscillators in cultures 
cells [98, 99]. 
2. Circadian rhythm in animals 
The easiest way to study the circadian rhythm in animals is to record its locomotor activity. In hu-
mans, the actiwatch is the most used technique to record activity and light exposure at the same 
time [100]. In rodents, the running wheel or the passive infrared sensor (PIR) are the easiest methods 
to record locomotor activity [101].  
Locomotor activity patterns 
are commonly represented as a so-
called actogram, where each day is 
represented by a horizontal line on 
which the activity is plotted with 
vertical black ticks with heights pro-
portional to the activity at a given 
time. Consecutive days are plotted 
beneath each other. For clarity, such 
a graph is often double-plotted so 
that on each horizontal line two 
consecutive days are plotted. In figure 7A, an actogram is illustrated for one mouse that was main-
tained in a light-dark (LD) cycle of 12h on 12h (LD 12:12) for 10 days followed by a DD [101]. This ex-
ample illustrates the main proprieties of a circadian rhythm mentioned above. The animal’s activity 
was stably entrained by the LD cycle and then when released in DD, the activity patterns started to 
‘free-run’ with a period slightly less than 24h for the remaining days under DD, demonstrating the 
endogenous and self-sustained properties of the circadian clock. Note that “free-run” activity is 
called when the sleep/wake cycle is no longer period entrained by ZT; without temporal cues the ac-
tivity follow its own internal intrinsic circadian clock.  
Figure 7  Real acrograms and phase re-
sponse curve in mice. A-C Typical actograms 
of wild-type mice subjected to an Aschoff 
type II protocol. Mice were entrained to an 
LD 12:12 cycle (10 days) before releasing 
them into DD. The line above “DD” indicates 
the transition from LD to DD. The grey back-
ground represents darkness. A Upon release 
into DD, no light pulse was administered to 
the mouse, B whereas light pulses of 15min 
were applied to the mouse at ZT14 and C at 
ZT 22.  Regression lines (in red) are drawn 
through the onsets of wheel-running activity 
in order to calculate the phase shift. D Typi-
cal light phase response curve (PRC) for 
nocturnal rodents. The grey and black bars 
below the PRC indicate subjective day and 
night, respectively. The X-axis shows the 
circadian time (CT) at which the light pulse 
was applied whereas the Y-axis displays the 
observed phase shift (φ) [h]. Light pulses 
administered between CT11 and CT18 pro-
voke a phase   delay (negative values). Light 
pulses between CT19 and CT3, on the other 
hand, generate phase advances (positive 
values). Between CT4 and CT10, no phase 
shift can be observed (dead zone). Jud C. et 
al. (2005) [101] 
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 Furthermore, during DD, the phase of this mouse could be shifted by light exposure. The di-
rection of the phase shift in subsequent locomotor activity onset induced by the light pulse, depend-
ed on the circadian time light was given (Fig.7B-C) [101]. The relation between the timing of the light 
signal and its effect is summarized in a so-called phase response curve (PRC) whose shape varies de-
pending on species and stimulus. However, this relationship is stereotypic for all organisms (whether 
diurnal or nocturnal) and characterized by a delay of the phase of activity onset when light is experi-
enced in the evening and early night, an advance in late night and early morning, and a “dead zone”, 
in which no phase change occurs, corresponding to the midportion of the ‘subjective’ day, i.e. when 
the animal suppose that this is the light period (Fig.7D) [101, 102]. 
 The response of the circadian clock to these Zeitgeber is a consequence of the plasticity of 
this mechanism. This can be explained by the fact that day length varies enormously during the year 
depending on the location of the earth compared to the sun and also depends of the location on the 
earth. Therefore, it is primordial to have an adaptive mechanism that can be entrained according 
with the photoperiod or with the food viability [103]. 
The ability to reset the inner master-clock in a new environment is an opportunity that al-
lows human to resynchronize promptly our physiological functions after a rapid long-distance trans-
meridian travel, in spite of some inconveniences called jet-lag [104]. Interestingly, if this circadian 
regulation is not respected due to jet-lag and more so during shift-work, individuals can develop 
sleep disorders, a decrease in the quality of life, performance, vigilance, negatively affect the mood 
and even cause irreversible health damage [105, 106].  
Circadian clocks play a role in other things as well: changes in the photoperiod of the day 
supported by the circadian clock enables animals also to anticipate and prepare for seasonal changes 
in their environment [107]. In fact studies shown that circadian clock are involved to sense changes 
in day length and to mediate a diverse number of photoperiodic responses in plants [108] as in 
mammals [109, 110], however this molecular link is controversial topic in insects [107, 111, 112].  
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 The circadian clock is also involved in the navigation. A nice example is the monarch butter-
flie (Danaus plexippus) that undertake a long distance migration from eastern north America to Mex-
ico (about 3600km) maintaining a southwesterly flight as the sun moves across the sky each day us-
ing a time-compensated sun compass [113]. Birds (Columbia livia L.) have also to compensate their 
sun compass for the apparent movement of the sun with the help of their internal clock during hom-
ing [114]. 
It was observed that aberrant expression of circadian clock genes could have important con-
sequences on expression of downstream targets gene that control the cell cycle and on the ability of 
cells to undergo apoptosis. This may lead to genomic instability and accelerated cellular proliferation 
potentially promoting carcinogenesis [115]. For instance, tumors grew two to three times faster in 
mice with SCN lesions than in sham-operated mice [116]. Moreover, it was reported that arrhythmic 
Bmal1−/− mice have reduced lifespans and display various symptoms of premature aging including 
sarcopenia, cataracts, less subcutaneous fat and organ shrinkage [117]. Conversely, Cry1,2-/- mice had 
no predisposition to cancer due to γ-radiation induction and were indistinguishable from wild-type 
(Wt) mice [118]. More surprisingly, it was shown that Cry1,2-/-p53-/- mice had a reduced cancer risk 
compared to p53-/- mice [119]. The Per2 knock-out mice that a used in unspecified 129/C57BL6 mixed 
background develop lymphomas at a higher rate than Wt mice after γ-radiation exposure due to par-
tial impairment of p53-mediated apoptosis. For this reason, it has been proposed that PER2 functions 
as a tumor suppressor [120]. To resume, the effect of circadian clock disruption on cellular response 
to DNA damage and cancer predisposition may depend on the mechanism by which the clock is dis-
rupted, and elucidation of this mechanism warrants further investigation [115]. 
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Figure 8  Schematic diagram of synchronized SCN by sunlight during 
daytime that projected to different brain area to activate in proper timing 
diverse physiological functions. Here for instance light synchronized the 
SCN that project to PVN neurons that activated preganglianic sympathetic 
neurons of the spinal cord, which in turn modulated the activity of the 
superior cervical ganglia that finally projected to the pineal gland to regu-
late the melatonin secretion. Braintreatmentcenter.com 
3. Organization of circadian rhythms 
As mentioned above, in mammals the master-
clock of our circadian rhythm is in the SCN, 
located in the anterior part of the hypothala-
mus (Fig.8C). The SCN is composed of two nu-
clei containing circa 10’000 neurons each, and 
subdivided in two parts: the core and the shell 
[121, 122]. The SCN has several input and 
output mechanisms. The principal input is vis-
ible light especially around 460-500nm 
(Fig.8A). These wavelengths pass through the 
eye lens to hit the retina where photopig-
ments transform this electromagnetic signal 
into bioelectrical signal. The photopigments in 
humans are three cone opsins in cone cells, rhodopsin in rod cells and, of particular importance, 
melanopsin in the retinal ganglion cells (fig.8B) [123]. Melanopsin is not used for image forming but 
importantly contributes to circadian physiology and pupillary reflex. All five opsins must be disrupted 
to completely prevent the synchronization of the SCN by light [124]. These melanopsin-containing 
retinal ganglion cells project monosynaptically via the retinohypothalamic tract (RHT) to the SCN by 
glutamate and pituitary adenylate cyclase-activating polypeptide (PACAP) release (Fig.8C)[125]. This 
release leads to membrane depolarization, elevated calcium and cAMP levels, phosphorylation of 
cyclic-AMP response element binding protein (pCREB) and its binding to cyclic-AMP response ele-
ments (CRE) on the DNA, finally allowing the transcription of the Period genes. Given that Per1 is al-
ready induced after 5–15min of a light pulse and is involved directly in the core clock feedback loop, 
its induction is thought to be largely responsible for resetting the clock [126-128]. 
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In a second step, the SCN output pathways are 
responsible for proper timing of diverse physio-
logical functions, such as thermoregulation, 
sleep/wake cycle, corticosteroid and melatonin 
release, and feeding at the neuronal level, as 
schematized in figure 9. The SCN projects to the 
ventral and dorsal subparaventricular zone 
(vSPZ, dSPZ). dSPZ neurons are crucial for 
rhythms of body temperature via the medial 
preoptic area (MPO), whereas vSPZ relay the 
information to the dorsomedial nucleus of the 
hypothalamus (DMH) that drives circadian sleep 
cycles via GABAergic neurons in the VLPO to 
promote sleep and via hypocretin/orexins neurons in lateral hypothalamic (LH) to promote wakeful-
ness. The LH also contains melanin-concentrating neurons that are involved in feeding behavior. Fi-
nally, the DMH projects to the paraventricular nucleus (PVN) which is responsible for the cyclic re-
lease of corticosteroid and melatonin [57, 121]. In the case of melatonin, PVN activates preganglianic 
sympathetic neurons of the spinal cord, which in turn modulated the activity of the superior cervical 
ganglia that finally projected to the pineal gland to regulate the melatonin secretion (Fig. 8).  
Not only in the SCN circadian rhythms are generated, but in all cells, tissues and organs of 
our body, that are considerate as peripheral clocks (including brain). The SCN set the phase directly 
the rhythm of theses peripheral clocks as well as many physiological functions as discussed above 
(temperature, feeding, sleep/wake cycle, etc.). However, some behavioral changes such as food and 
medication intakes or changes in sleep/wake distribution act as Zeitgebers for specific peripheral 
clock, and then can shift their oscillations [122]. At the cellular level, individual cells of peripheral tis-
sues, like NIH3T3 fibroblast maintained in culture, are not synchronized among themselves. Their 
Figure 9  A schematic diagram to illustrate the several-stage inte-
grator for circadian rhythms. The suprachiasmatic nucleus (SCN) 
serves as a biological master-clock to regulate other systems (e.g. 
thermoregulation, sleep, corticosteroid release). Most of SCN 
output  goes into the region in light brown, which includes the  
ventral (vSPZ) and dorsal (dSPZ) subparaventricular  zone, and the 
dorsomedial nucleus of the hypothalamus  (DMH). Neurons in the 
vSPZ relay information necessary for organizing daily cycles of 
wake–sleep, whereas dSPZ neurons are crucial for rhythms of body 
temperature. Outputs from the SPZ are integrated in the DMH 
with other inputs, and DMH neurons drive circadian cycles of 
sleep, activity, feeding and corticosteroid secretion. Cycles of body 
temperature are maintained by dSPZ projections  back to the me-
dial preoptic area (MPO), whereas the  DMN is the origin of projec-
tions to the VLPO for sleep  cycles, to the corticotropin-releasing 
hormone neurons of the paraventricular nucleus (PVH) for cortico-
steroid cycles, and to the lateral hypothalamic (LH) 
hypocretin/orexin and melanin-concentrating hormone  neurons 
for wakefulness and feeding cycles. Saper CB et al. (2005) [57] 
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circadian rhythm could be synchronized for few days with a serum shock of dexamethasone, howev-
er after several days, each cell continues to oscillate with its own period and the culture lost its syn-
chrony [99]. However, if these fibroblasts were in co-culture with SCN neurons, their synchrony was 
constantly maintained [129]. How the SCN exactly synchronizes peripheral clocks is still poorly under-
stood. Nevertheless, neuronal and humoral pathways, such as glucocorticoids, are the best candi-
date. Indeed, Period genes contains glucocorticoid response element (GRE) sequences which allow 
their transcription in presence of glucocorticoid [99]. The synchronization by temperature fluctuation 
is also another possibility. In fact Per2 also contains heat-shock element (HSE) in its promoter that 
were activated by heat-shock factors (HSF), mediated themselves my temperature fluctuation [130]. 
 The hierarchic organization in non-mammalian vertebrates such as birds, fish, reptiles and 
amphibians, is significantly different, in that they have multiple photic inputs other than the eyes, 
such as the pineal gland and deep-brain photoreceptors [131]. Most of these species, in addition to 
the SCN [131-133], also use the pineal organ (which in mammals has only a secretory role) and the 
retina as circadian pacemakers. All these structures communicate together to provide a single syn-
chronized output. Significant variation occurs among these species in the relative roles that SCN, pin-
eal gland and eyes in respect to the regulation of the circadian system [131]. 
4. Chronotype 
The phase of rhythms generated by the SCN needs to be synchronized to the external light-dark cycle 
every day, mainly through the eye exposure to the light. In the absence of such entrainment, the os-
cillation of the inner clock would follow its own rhythm depending of the endogenous period of the 
species and the strain [134]. For instance, most laboratory mice have a period somewhat shorter 
than 24h, while humans have a period of 24.2h [135, 136]. Despite the fact that light is the main syn-
chronizer of our master-clock, other nonphotic Zeitgebers are also important, such as social and envi-
ronmental factors, work-related constraints and food restriction. It has been shown that mice that 
had access to food only between ZT3-7 (light period when mice usually do not eat), were able to an-
ticipate it and were awake before this access period. This held true in a normal light/dark cycle or in 
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constant dark condition. It was shown that in response to this feeding restriction, the expression of 
circadian genes in the forebrain was affected [137]. However, these nonphotic entrainments are not 
sufficient to regulate the master-clock. In fact, rhythms in the SCN are ‘immune’ to feeding cycles and 
completely dissociate from rhythms elsewhere in the body, thus this food-anticipatory behavior is 
not organized in the SCN. Consistently, most totally blind people suffer from a “non-24h sleep/wake 
disorder” (subjects with ‘free-running’ circadian rhythms) can be treated with melatonin to adjust 
the phase of its circadian clock, as regular meals and other environmental constrains are not suffi-
cient [138-140]. The usual treatment used for people suffering of circadian rhythm sleep disorders is 
the chronotherapy which take into account the body’s natural rhythms, along with bright light thera-
py. As example, familial advanced sleep-phase syndrome (FASPS) in human is circadian disorder char-
acterized by a very short circadian period with early sleep and early morning awakening time as a 
result. Strategy attempts to cause the body of these patients is to use bright light tables to delaz the 
sleep phase backwards [141]. FASPS is a human circadian disorder characterized by a very short cir-
cadian period with early sleep and early morning awakening time as a result [142]. In two families 
FASPS was found to be caused by two auto-
somal dominant mutations:  a single amino-
acid missense mutation (S662G) in the period 
2 (per2) gene that decreases PER2 phosphory-
lation preventing the proteolysis of PER2 
[143], and a mutation (T44A) within the casein 
kinase Iδ (CKIδ), normally responsible for 
PER2 phosphorylation [144], which therefore 
reduces PER2 phosphorylation that decreases 
substantially its enzymatic activity preventing 
an effective rate of PER2 proteolysis. In con-
trast, delayed sleep-phase syndrome (DSPS) is 
Figure 10  Illustration of chronotype. Upper panel Activity rhythms to 
individuals affected by FASPS, DSPS or normal people. “Morning-type” 
people tend to wake up early the morning (like larks) and “evening-type” 
people tend to sleep late in the evening (like owls). Gallego M. and 
Virshup D.M. (2007) [147] Lower panel Graphic representing a popula-
tion (100’000 people) distribution on Munich chronotype questionnaire 
(MCTQ) based on their sleep habits. Roenneberg T. (2003) [149] 
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characterized by a late sleep and awaking onset. The cause has not been precisely identified, but 
mainly two polymorphisms were associated with this disease. The first one is a variant of the human 
CKIε (S408N) that is significantly more present in normal population rather than in DSPS patients 
[145]. While the second polymorphism is in the human PER3 gene (V647G) has been linked to the 
pathogenesis of DSPS patient [146]. Note that this residue 647 locates in a region similar to the CKIε-
binding region of PER1 and PER2, close to the serine residue in PER2 that is disrupted in FASPS pa-
tient. Therefore, this polymorphism might alter the CKIε-dependent phosphorylation of human PER3 
[147].  
 The chronotype reflects the moment of the day when our physical functions, such as cogni-
tive faculties, eating and sleeping, are most active specific to each individual. FASPS and DSPS people 
are greatly delayed in these physical functions and belong to the extremes shown in figure 10. Be-
tween the extremes formed by FASPS and DSPS subjects lie “morning-type” people who tend to 
wake up early the morning (like larks) and “evening-type” people who tend to sleep late in the even-
ing (like owls) [147]. This scale could be correlated with the Munich chronotype questionnaire 
(MCTQ) used already to calculate the chronotype of 100’000 people using the midpoint of sleep on 
working days (MSF) which was corrected for “oversleep” on free days (MSFsc). The distribution of 
the population seemed a Gaussian distribution with the maximum at MSFsc=4.5 [148, 149].  
5. Circadian rhythm at molecular level 
The first genetic discovery of the circadian loop at molecular level was made in the fruit fly drosophi-
la melanogaster. In 1971, three mutants fly have been isolated according to short, long or no (ar-
rhythmic) period, in both pupal eclosion and locomotor activity, led to the discovery of a crucial gene 
named Period (Per) for the circadian rhythmicity [150]. It was sequenced and characterized ten years 
after [151, 152], and in 1990 the rhythmic expression in both transcript and protein was measured 
[153]. This discovery led the suggestion that Period gene is involved in a negative auto-regulatory 
feedback loop. In parallel, this forward genetic and also mutagenesis approach to identify genes re-
sponsible for particular circadian behavioral phenotypes was applied to other species like fungi (e.g. 
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neurospora crassa) [154], plants (e.g. arabidopsis thaliana) [155], and, of course, mammals (e.g. mus 
musculus) [156]. All species were found to have similar circadian machineries at the molecular level. 
In short, the circadian rhythm is composed of a positive limb allowing the transcription of many tar-
get genes. More importantly, some of these targets form a negative limb that inhibits their own tran-
scription, as well as some targeted genes by the positive limb. The co-existence of such positive and 
negative limbs is thought to be the key for the formation of an endogenous biological cycle. Indeed, 
this positive limb in association with the negative feedback loop (described below) are essentially 
responsible for the oscillation of all downstream genes involved behavioral and metabolic pathway 
[157]. Given the scope of this thesis, only the mammalian clock will be detailed further. 
a. Core clock loops 
The molecular mechanism involved in the circadian rhythms in mammals is well understood. The 
principal positive limb is composed by the hetero-dimerization of brain and muscle ARNT-like 1 
(BMAL1 also called ARNTL or MOP3) with circadian locomotor output cycles kaput protein (CLOCK) or 
neuronal PAS domain protein 2 protein (NPAS2 also called MOP4) (Fig.11A). All three contain both a 
basic helix-loop-helix (bHLH) and Per-Arnt-Single-minded (PAS) domains [158]. NPAS2 is a homologue 
to CLOCK but intriguingly it is only expressed in neuronal tissue, such as brain and spinal cord [159]. 
This hetero-dimerization allow the transcription of many clock controlled genes (CCG) by binding the 
promoter elements E-boxes (5’-CACGTG-3’) and E’-boxes (5’-CACGTT-3’) [160, 161]. Among the mul-
titude of activated genes, specific targets such as Cry1 & -2 and Per1 & -2 genes provides a subse-
quent negative limb. The resulting PER and CRY proteins bind together and translocate into the nu-
cleus to inhibit their own transcription by interfering with the complexes BMAL1:CLOCK/NPAS2 
[162]. This is the main core feedback loop of the circadian rhythm. If all homologues of these genes 
are removed, the mutants became completely arrhythmic (e.g. Bmal1-/- [163], Clock-/-Npas2-/- [136], 
Cry1-/-Cry2-/-  [164], and Per1-/-Per2m/m [165]). This negative feedback loop is essential for the endoge-
nous oscillation of all downstream CCG [26].  
47 
 
 
 
b. Secondary clock loop 
In parallel, an additional regulatory loop involves Bmal1 through its retinoic acid-related orphan re-
ceptor response element (RORE) promoter (Fig.11B). In fact, the two orphan nuclear receptors 
RORα/β/γ and Rev-Erbα/β, induced by the dimer BMAL1:CLOCK/NPAS2, act, respectively, as an acti-
vator and an inhibitor [166]. ROR and REV-ERB proteins were in part responsible of the cyclic expres-
sion of Bmal1 [167, 168]. Mutation of RORα was shown to reduce Bmal1 amplitude both in SCN and 
fibroblasts [169, 170] and a deletion of all RORα/β/γ did not abolish the Bmal1 rhythmicity in fibro-
blasts [168], while Rev-Erbα deletion resulted in a higher Bmal1 transcription levels [171] and both 
Rev-Erbα/β depletion abolish the Bmal1 oscillation in fibroblast [168]. However even Bmal1 did not 
cycle anymore, that seems not to affect the oscillation of other clock genes such as Per2 [168]. 
Moreover, deficiencies in ROR/REV/Bmal1 loop only produces modest clock phenotypes [167, 169, 
Figure 11  Mammal circadian 
clock is composed of a tran-
scriptional-translational feed-
back network. A Main loop 
composed by the positive limp 
BMAL1:CLOCK/NPAS2 and its 
negative feedback by PER:CRY B 
Auxiliary loop reinforcing the 
main loop via Bmal1 expression 
controlled by the positive fac-
tors RORα/β/γ and by the nega-
tive factors Rev-erbα/β C PER 
and CRY regulation by kinase 
phosphorylation that have an 
important role for the period 
length of the rhythm. This 
phosphorylation contribute to 
the PER and CRY degradation 
and also to contribute to their 
nucleus translocation. Note 
that PPAR, DBP and LDHA were 
only three proteins example of 
the clock controlled gene (CCG) 
expression tuned by the clock 
machinery 
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171], suggesting that secondary loop provides a ‘‘stabilizing’’ function. An recent study shown that 
despite the severe activity and metabolism defects observed in Rev-erbαlox/loxRev-erbβlox/lox mice, this 
mutant still maintained a short circadian rhythm in constant dark, confirming the accessory nature of 
this loop [167].  
 Even though the basic mechanism of the circadian rhythms at molecular level is now well 
understood, it remains a very simplified rendition. A lot of the crucial regulation is post-
transcriptional and post-translation and involves chromatin remodeling, protein phosphorylation and 
degradation; and oxidation/reduction (redox) potential. Although a lot is known about clock genes 
and circadian rhythms, very basic question on how it encodes a period length close to 24h, or how 
temperature compensation is achieved is largely unknown. Some of these hypotheses will be dis-
cussed. 
c. Chromatin remodeling 
Chromatin remodeling is also an essential mech-
anism for transcriptional regulation of circadian 
genes (Fig.12). In fact, histones (H3 and H4) from 
specific target genes (as Per and Cry) are acety-
lated and deacetylated in a circadian fashion with 
the recruitment of multiprotein complexes [172, 
173]. For instance, when the dimer BMAL1:CLOCK 
binds the E-boxes, CLOCK acquired histone acetyl-
transferase (HAT) activity specifically on histone 
H3, and this contributes to opening of the chro-
matin fiber which stimulates the rhythmic tran-
scription of the target genes. Other HATs, such as 
p300 and CREB binding protein (CBP), seems to 
bind this complex on CLOCK as well and contrib-
Figure 12  Chromatin remodeling in the circadian clock. Chromatin 
modifying enzymes act in synchrony for fine-tuning clock-controlled 
gene expression. Transcriptional activators coordinate rhythmic 
histone hyperacetylation and H3K4 trimethylation at circadian gene 
promoters, thereby inducing transcription. Conversely, repressors 
remove acetylation marks and promote a closed state of the chro-
matin fiber at the clock controlled gene promoters to inhibit tran-
scription. Thus, activator and repressor enzymes act in a very precise 
synchrony leading to the circadian transcription. Aguilar-Arnal L. and 
Sassone-Corsi P. (2013) [173] 
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utes to histone acetylation [173]. Methyltransferase mixed lineage leukemia 1 (MLL1) also interacts 
with this complex to trimethylate the actual methylation residue to promote the transcriptional acti-
vation [174]. In contrast, in association with the inhibition brought by the complex PER:CRY, re-
pressors such as the histone deacetylase 3 (HDAC3) and the NAD+-dependent enzyme sirtuin 1 
(SIRT1) promote histone deacetylation, while the enhancer of zest 2 (EZH2) methylates histones and 
ultimately promotes a closed chromatin state [175-177]. Together, these observations highlight the 
crucial role of the clock in maintaining tissue homeostasis by epigenetic control of gene expression 
[173]. 
d. Regulation by protein phosphorylation  
Another key point of this clock mechanism is protein phosphorylation. This post-transcriptional regu-
lation of PER2 and CRY is important for the period length of the rhythm that modifies the delay in the 
negative-feedback loop. If after the synthesis of the both repressor proteins, PER and CRY, would di-
rectly translocated to the nucleus to repress BMAL1:CLOCK/NPAS2, the whole cycle would take just a 
few hours rather than one day. To maintain the daily oscillations of clock proteins, a significant delay 
between the activation and repression of transcription is required. One way to ensure precisely this 
regulation is through post-translational modifications. Reversible phosphorylation regulates im-
portant processes such as nuclear entry, formation of protein complexes and protein degradation. 
Each of these can individually contribute to introduce the delay that keeps the period at about 24h 
(Fig.11C) [147]. These post-translational modifications seem to be more important that Bmal1 clock 
core gene oscillation. As shown previously, a constitutive BMAL1 expression did not affect Per2 oscil-
lation in fibroblast [168]. In mammals, the phosphorylation of PER and CRY is mediated by Casein 
kinase Iδ and ε (CKIδ and CKIε) (Fig.11C), that ensure many roles in the circadian clock. One main 
function of PER and CRY phosphorylation is to control its protein stability. In fact, when one or two 
distinct sites on PER1 are PER2 were phosphorylated by CKIδ/ε, these latter PER proteins are prote-
olysed in a second step by the proteasome [178-180]. CRY1 and CRY2 are respectively phosphory-
lated by AMP-activated protein kinase catalytic subunit alpha-1 (AMPK1) and by a sequential dual 
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specificity tyrosine-phosphorylation-regulated kinase 1A/glycogen synthase kinase 3 (DYRK1A/GSK3β) 
cascade [158]. Subsequently, phosphorylated-PER and -CRY are polyubiquitinated respectively by f-
box/wd repeat-containing protein 1A (FBXW1A also called β-TrCP1) and f-box/llr-repeat protein 3 
(FBXL3), and are finally degraded by the 26S proteasome [181]. These PER and CRY degradations can 
reset the clock, allowing the BMAL1:CLOCK/NPAS2 complex to become active. A second central func-
tion of protein phosphorylation by kinases is the subcellular localization. In fact, when PER1,-2,-3 are 
phosphorylated, theirs nuclear localization signals (NLS) become unmasked allowing the nucleus 
translocation [180, 182, 183].  
e. Temperature compensation 
As mentioned above, one property of the circadian rhythm is to generate a stable oscillation regard-
less of the body or ambient temperature [158]. This is very important given that most enzymatic re-
actions are directly dependent on the temperature. The phosphorylation rates by CKIδ/ε of the clock 
proteins remain stable at different ambient temperature [184]. While the mechanism for tempera-
ture compensation is still under investigation, it has been suggested that heat-shock factors (HSF) 
play a role in this process, as well in the cells synchronization by temperature rhythm [130]. It was 
shown that SCN is resistant to temperature resetting, that is not the case for peripheral tissues [130, 
185]. This differential sensitivity to temperature allows the SCN to drive circadian rhythms in body 
temperature which can then act as a universal cue for the entrainment of others oscillators through-
out the body [130, 186]. However, Per2 that contains a heat-shock element (HSE) in its promoter, 
shown an impairment in temperature compensation both in SCN and in pituitary cells in mice when 
HSF was pharmacologically blocked [130]. This suggests that HSF is also implicated in this tempera-
ture compensation in mammals. Another candidate for temperature compensation might be the 
cold-inducible RNA-binding protein (CIRBP) that is essential to sustain high amplitude in the circadian 
gene expression in fibroblasts. CIRBP binds several RNA encoding circadian protein such as CLOCK, 
and is thought to confer robustness to circadian oscillators through regulation of CLOCK expression 
[187]. 
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f. Effect of the redox potential 
The redox state in the cell is mainly represented by the ratio 
of oxided and reduced forms of nicotinamide adenine dinu-
cleotide (NAD(P)+/NAD(P)H) and is thought to play a role in 
the circadian circuitry as well. Indeed, binding of the dimers 
BMAL1:CLOCK/NPAS2 to DNA is regulated by the redox state 
in vitro. The reduced form of NAD enhanced DNA-binding, 
while the oxided form prevents it [188]. Moreover, the activi-
ty of the NAD-dependent histone deacetylase SIRT1 is modu-
lated by the redox state and, as mentioned above, is im-
portant for PER2 regulation [177]. Therefore SIRT1 links the 
redox state of the cell and NAD availability to regulation of 
circadian rhythms. 
To summarize, the different mechanisms described above 
are orchestrated in synergy. The resulting effect is the expression of target genes (clock gene per se 
but also CCG) in a stable oscillatory manner with near-24h period (Fig.13). Surprisingly, circadian reg-
ulation can affect both gene transcription and mRNA translation taking place at different phases. In 
fact, all Per and Cry did not reach at the exact same time. For instance, Per1 maximum was reached 
3h before the Cry1 in SCN mouse. However Per and Cry oscillation could be considerate in the same 
phase and in anti-phase with Bmal1. All resulting PER, CRY and BMAL1 protein were translated about 
6h after the RNA expression [189]. 
III. Sleep studies in clock mutant mice 
As previously discussed, sleep is regulated by both homeostatic and circadian components. Although 
these two processes were considerate as separate at neuroanatomical and physiological level, it was 
observed that the circadian and homeostatic somehow share the same molecular components. This 
notion is based on clock gene knock-out studies and also mRNA changes after sleep deprivation (SD). 
Figure 13  Circadian rhythms of clock gene expression 
and clock protein levels in the mouse suprachiasmatic 
nuclus. Top Rhythmic abundance of Per1, -2, -3, and 
Cry1 RNAs; Middle PER1, -2, and CRY1, -2 proteins; 
Bottom Bmal1 RNA (solid line) and hypothetical data 
(dashed line) represent the expected rhythmic varia-
tions in BMAL1 protein. Gray bar represent the subjec-
tive day rather than black bar is the subjective night. 
Reppert S.M. and Weaver D.R. (2001) [189] 
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If the circadian rhythm was perturbed via the mutation or deletion of an important component of 
the clock machinery, such as the double Cryptochrome (Cry)-1-2 Ko or the brain and muscle ARNT-
like 1 (Bmal1) Ko, the delta power was affected [190, 191]. A significant modification on the homeo-
static process, such as SD, can impact the expression of some clock genes (Per2, increased) or clock 
controlled gene expression (D-site albumin-promoter binding protein (Dbp), decreased) [192]. How-
ever, this molecular link remains poorly understood. The reader is reminded that if circadian rhythm 
was disrupted by e.g. lesion of the SCN, the delta power was not affected [22-25]. 
In order to better understand this molecular link, it is interesting to record sleep in mice with differ-
ent disrupted clock genes. In this chapter, I will therefore review sleep and locomotor phenotypes of 
several mice mutant for a given circadian gene.  
1. Bmal1 
As mentioned above, Bmal1-/- mice are completely arrhythmic in DD. In addition, its activity distribu-
tion was also severely altered under LD [163]. The sleep pattern of Bmal1-/- in C57Bl/6J background is 
also greatly perturbed. First, sleep distribution was affected in that this mutant mice showed more 
NREM and REM sleep across the 24h day but was also more fragmented compared with Wt mice 
[190]. Moreover, the daily amplitude distribution of sleep and body temperature is null in DD [190]. 
When sleep intensity was monitored by the EEG delta power, these mice had flat EEG delta power 
amplitude under baseline condition, and this is in accordance with the NREM sleep distribution [190]. 
Inspecting the sleep recovery after 6h SD revealed that the EEG delta power in Bmal1-/- was lower 
than the Wt mice suggesting an altered homeostatic regulation of sleep [190]. 
 In summary, the deleting of the central clock component Bmal1 of the positive limp of the circa-
dian machinery, abolish circadian rhythms and leads to profound differences in time spent asleep, 
the sleep-wake distribution, and also in the sleep homeostasis. 
2. Clock & Npas2 
The knock-out Clock-/- and Npas2-/- mice in C57BL/6J background had statistically no changes in the 
period of locomotor activity in DD compared with the Wt mice. However, the double knock-out 
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Clock-/-Npas2-/- mice become directly arrhythmic in DD. Moreover, double knock-out mice were en-
trained under LD with in irregular manner  [136]. Intriguingly, in the same C57BL/6J background, 
Npas2-/- mice displayed a shorter period [103], while, the hypomorphic mutant Clockm/m mice had a 
longer period [193]. Given that no sleep studies were done in Clock-/-Npas2-/- mice, only Clockm/mand 
Npas2-/- single mutant mice were investigated.  
 In baseline, Npas2-/- mice slept less at the end of the second half dark period, while Wt mice 
typically take a “nap” at this time of the day (i.e. significant decrease of wakefulness from ZT18-22) 
[103, 194]. After 6h of SD, Npas2-/- mice regained less NREM and REM sleep in the following recovery 
dark period. Moreover, just after the SD, the EEG delta power was smaller in the knock-out mice. 
Simulation analysis estimating the rate at which EEG delta power increases during wakefulness, 
showed that delta power in Npas2-/- mice increases at a slower rate than in Wt mice, implying that 
homeostatic regulation was affected [194]. 
 On the other hand, Clockm/m mice under baseline condition are characterized by higher wake-
fulness amount than Wt mice, and a decrease of NREM sleep amount which was also more frag-
mented. The sleep architecture and the amount of sleep were thus affected by the mutation. EEG 
delta power and NREM sleep quantity of the Clockm/m mice responded in the exact same way after a 
SD than Wt mice, suggesting that in this case homeostatic regulation of the NREM sleep and sleep 
intensity was not affected. Nevertheless, the REM sleep homeostasis is affected by the mutation, 
being smaller after a SD in mutant mice compared with Wt [193]. 
 To summarize, NPAS2 affects the homeostatic regulation of NREM sleep but not the homeo-
static regulation of REM sleep, while in Clockm/m mice the opposite effect was observed. 
3. Cry 
In the C57BL/6J background, the Cry1-/- mice had a shorter period than Wt mice while Cry2-/- mice 
had a longer period [195]. The double Cry1,2-/- knock-out mice become directly arrhythmic in DD 
[196]. 
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Despite this opposite effect on period duration, both single Cry1-/- and Cry2-/- knock-out mice 
had no phenotype in the EEG delta power in baseline and after a SD. This suggests that these genes 
have redundant roles at both sleep and circadian level [195].  
 In baseline, double Cry1,2-/- knock-out mice had more NREM sleep than Wt, and the NREM 
sleep episodes were longer suggesting a more consolidated sleep. However, their EEG delta power 
was constantly higher in comparison with Wt. Based on simulation analysis estimating the rate at 
which EEG delta power increases during wakefulness; the dynamic of delta power in Cry1,2-/- mice 
increased faster than Wt, suggesting that homeostatic regulation was inversely affected compared to 
Npas2-/- mice (see above) [191]. 
4. Per 
To assess the role of Period genes, several constructs have been made to generate mice with a non-
functional Per1, -2 and -3 gene in various genetic backgrounds. For instance, three Per1-/- mouse lines 
were considered as full knock-out mice because PER1 protein was not detected:  Per1tm1Drw (some-
times also called Per1Ldc) [197], Per1tm1Brd [165] and Per1tm1Saco [198]. Surprisingly, these lines did not 
display the exact same locomotor activity profile. The majority of the Per1tm1Drw mice in 129S4/SvJae 
maintained labile rhythmicity for about 10-14 days, followed with a severe and gradual loss of ampli-
tude in Per1tm1Drw mice to finally became arrhythmic [197]. Per1tm1Saco in mixed C57BL/6-129S2/SvPas 
background (94% and 6%, respectively) had a shorter period (23.2h±0.2) than Wt mice 
(23.7h±0.1)[198]. Finally, Per1tm1Brd had a period of 22.6h±0.2 in 129S7/SvEvBrd shorter than Wt 
(23.7h±0.1) [165]. 
 Concerning Per2 mutant mice, two constructs can be found in the literature:  Per2tm1Drw 
(sometimes called Per2Ldc) and Per2tm1Brd. Despite the mutation, these mice still express a mutant 
transcript that could be translated [197, 199]. Under DD conditions, Per2tm1Drw on a 129S4/SvJae 
background, initially displayed a shorter period (23.0h±0.3) than Wt mice (23.1±0.1) and then be-
came arrhythmic. The duration and extent of rhythm persistence in DD was variable [197]. However, 
when backcrossed onto a C57BL6/J genetic background, these mice remained rhythmic throughout 
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DD with a normal period (data not shown) demonstrating the dramatic effect that genetic back-
ground has on the circadian phenotype [200]. On the other hand, Per2tm1Brd mice of 129S7/SvEvBrd x 
C57BL6 mixed background displayed a period of 22.1h±0.1; i.e., shorter than Wt mice (23.7h±0.1). 
Moreover some mutant mice became arrhythmic between 2-18 days in a under DD conditions [199]. 
Double mutant Per1,2tm1Drw mice were arrhythmic under DD, demonstrating their redundancy and its 
importance within circadian machinery [197, 201]. 
A full null-Per2 mutant mouse was generated: Per2tm1Clc. This latter was never characterized 
and only one paper mentioned that this construct had the same circadian phenotype that Per2tm1Brd 
in mixed 129(not precisely specified)/C57BL6 background, despite the fact that PER2 protein could 
not be detected in these mice [120]. One part of this thesis is then based on circadian characteriza-
tion in Per2tm1Clc mice. 
 A Per3 mutant mice (Per3tm1Drw) was constructed in 129S4/SvJae background. No PER3 pro-
tein was detected in Per3tm1Drw, while Per3 transcript was still present and rhythmically expressed but 
larger than Wt mice.  Per3tm1Drw had a shorter period (23.3h±0.2) compared with Wt mice (23.8h±0.1) 
[202]. In spite of this difference, it was concluded that Per3tm1Drw only shown a subtle circadian phe-
notype contrasting with previous Per1tm1Drw and Per2tm1Drw. In fact these latter had important changes 
in circadian clock gene expression, that was not the case pour Per3tm1Drw [202]. Moreover, the double 
mutant mice Per1,3tm1Drw and Per2,3tm1Drw had not a stronger circadian phenotype [197]. Therefore it 
was concluded that Per3 does not play an important role in the circadian clock mechanism [197, 
202]. 
Two studies investigated sleep in Period mutant mice. The first one done by Kopp et al. using 
Per1tm1Brd and Per2tm1Brd mice backcrossed to a C57BL6/J background [203], and the second by Shi-
romani et al. using Per1tm1Drw, Per2tm1Drw , Per3tm1Drw and double mutant Per1,2tm1Drw mice under an 
unspecified 129/Sv background (probably 129S4/SvJae background as it was used by the strain crea-
tors) [201].  
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Kopp et al. demonstrated that although daily amount of sleep did not differ in mutant mice, 
the distribution of sleep was affected: Per1tm1Brd mice slept less than Wt in the second haft of the 
dark period while Per2tm1Brd mice slept less before the dark onset. After a 6h SD, an increase of the 
amount of sleep was noted in the Per2tm1Brd mice recovery in comparison with Wt mice. Both mutant 
mice lines had also higher amount of REM sleep in the light period of the recovery. Furthermore, 
lower levels of EEG delta power were reached during recovery sleep immediately following the SD. 
Despite these changes in sleep distribution and recovery, it was concluded that Per1tm1Brd and 
Per2tm1Brd mice have intact sleep homeostasis [203].  
The study done by Shiromani et al. confirmed that Per1tm1Drw and Per2tm1Drw had an altered 
sleep-wake distribution. Concerning the EEG delta power after 6h SD, the rebound was lasting longer 
in Per1tm1Drw and in double mutant Per1,2tm1Drw mice. On the other hand, EEG delta power seem to be 
higher in the Per1tm1Drw and in Per1,2tm1Drw mice than Wt mice [201]. This ascertainment was in per-
fect opposition with the previous study done by Kopp et al. [203]. Nevertheless, the authors argued 
that deletion of the Per genes do not affect sleep homeostasis [201].  
In this thesis, I will show that even that the sleep intensity does not change; the sleep dura-
tion is affected differently between the Per1-/- , Per2-/- , Per1,2-/-  and Wt mice after 6h SD. I would 
like to remember also that both sleep intensity and sleep duration were involved in sleep homeosta-
sis. 
 Shiromani et al. showed that Per3tm1Brd had no differences in both sleep distribution and EEG 
delta power during recovery after 6h SD [201]. In contrast, a subsequent study done in C57BL6/J 
background did find differences in the relative REM sleep rebound during the recovery from 6h SD; 
due to REM sleep difference under baseline. However, EEG delta power after SD was the same in 
Per3-/- and Wt mice. Given that under baseline the EEG delta power was higher in Per3-/- mice, de-
spite the same amount of vigilance state, a homeostatic sleep phenotype was suggested [204]. 
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5. Rev-erb 
In C57BL6/J background Rev-erbα-/- had a shorter period than Rev-erbaβ-/- and Wt mice. Given that 
the double mutant mice were not viable, a conditional system had to be used. As mentioned above, 
Rev-Erbαlox/loxRevErbaβlox/lox showed severe activity defects but maintained a short circadian rhythm 
under DD condition [167]. Sleep studies were not already published on these mice, however Rev-
erbα-/- in mix 129/C57BL6 background showed altered sleep/wake distribution. Moreover, EEG delta 
power levels were lower at sleep onset under baseline and after 6h SD compared to Wt mice, estab-
lishing that sleep homeostasis was affected in the Rev-erbα-/- mutant mice [205]. 
 
In conclusion, it is important to keep in mind that the genetic background can have a huge impact on 
the activity profile, as well as on sleep patterns [206]. However, it is clear that knock-out of a clock 
gene belonging to the master-clock generates completely arrhythmic mice, which can also display 
perturbation of the homeostatic sleep regulation. Some single mutation were enough to modify the 
homeostatic process such as Npas2-/-, Rev-erbα-/-, rather others had not effect such as Clock-/-, Cry1-/-, 
Cry2-/-, Per1-/-. For the single knock-out Per2-/- or Per3-/- the results were not so clear and the exact 
readout could depend from the way the studies were designed and analyzed. All phenotype in clock 
mutant mice were summarized in table 1. 
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IV. Period 1 and Period 2 
To understand better the phenotype of mice lacking Per1 and/or Per2 genes, it is important to know 
the possible interactions of these proteins, but also their role in functions other than the circadian 
machinery. Moreover, by which other way than circadian pathway these genes could be regulated is 
another important topic of further investigation. Afterward, in this chapter, I will describe the Per1 
and Per2 genes in further details, as well as their respective proteins and their functions. 
1. Genes 
In mice Per1 is located on the chromosome 11 (69’095’217 - 69’109’960b). It has 6 splice variants 
with 5 having an open reading frame (ORF) permitting protein translation (table 2). In mice Per2 is 
located on chromosome 1 (91’415’984 - 91’459’330b), it only has one transcript which is translated 
in a single protein.  
Sleep/wake 
distribution
Sleep 
consolidation
EEG delta 
power
NREM/REM 
sleep duration
Bmal1 tm1Bra arrhythmic altered less altered n.a. C57BL/6J 163, 190
Clock
tm1Rep normal - n.a. n.a. n.a. C57BL/6J 136
Clock
m1Jt longer altered yes - less REM C57BL/6J 193
Npas2 tm1Slm shorter - - altered less NREM/REM C57BL/6J 103, 194
Clock tm1Rep Npas2 tm1Slm arrhythmic altered n.a. n.a. n.a. C57BL/6J 136
Cry1
tm1Asn shorter altered - - n.a. C57BL/6J 195
Cry2
tm1Asn longer altered - - n.a. C57BL/6J 195
Cry1 tm1Asn  Cry2 tm1Asn arrhythmic altered more altered less REM C57BL/6J 191, 196
Per1
tm1Drw progressively arr. affected - affected - 129S4/SvJve 197, 201
Per1
tm1Saco shorter - - - - C57BL/6-129S2/SvPas 198
shorter - - - - 129S7/SvEvBrd 165
- affected - affected - C57BL/6J 203
shorter, prog. arr. altered n.a. altered n.a. 129S4/SvJve 197. 201
- - n.a. n.a. n.a. C57BL/6J 200
shorter, prog. arr. n.a. n.a. n.a. n.a. 129S7/SvEvBrd- C57BL/6 199
n.a. altered n.a. altered n.a. C57BL/6J 203
Per1,2 tm1Drw arrhythmic altered n.a. altered n.a. 129S4/SvJve 197, 201
shorter - n.a. - - 129S4/SvJve 202
n.a. altered more - - C57BL/6J 204
Per1
tm1Ccl shorter affected - - - C57BL/6J present study
Per2
tm1Ccl arrhythmic affected less - less NREM/REM C57BL/6J present study
Per1,2
tm1Ccl arrhythmic affected less - less NREM C57BL/6J present study
Per3 tm1Drw
periodClock mutant mice
Per1 tm1Brd
Per2
tm1Drw
Per2
tm1Brd
Baseline SD condition
Background References
Table 1  Summary of all phenotype in clock mutant mice n.a: not available data; - : as the Wt mice 
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Per genes have several promoter regions. The most important are the E-box and E’-box that allow 
the binding of proteins having a basic helix-loop-helix (bHLH) such as BMAL1, CLOCK and NPAS2 but 
also many other such as neurogenin, which are involved in neuronal differentiation [207]. The gluco-
corticoid response element (GRE) is also present in the Per promoter region and is induced by the 
glucocorticoids (GC). The principal endogenous GC in rodents is corticosterone which is associated 
with stress during sleep deprivation [208]. Corticosterone is thought to be important for synchroniza-
tion of peripheral rhythms [209]. Another interesting GC in rodents is the primary female sex hor-
mone estrogen. In the SCN, estrogen advanced the acrophase of Per2 only, while not effect was ob-
served in the cortex. On the other hand, only Per1 expression is changed by estrogen in liver and kid-
ney, whereas acrophase in both genes were advanced in the reproductive tissues uterus. This sug-
gested that the effects of estrogen are tissues specific [210]. In culture cells, the most widely used GC 
is dexamethasone, a synthetic drug, had similar effect on cells synchronization and Pers expression 
that corticosterone [99]. However, gene induction via GC did not work in the exactly same way for 
Per1 and Per2. In fact, only GC combined with glucocorticoid receptor (GR) is enough to induce the 
Per1 expression, this is not the case for Per2. This latter requires the transcription factor BMAL1 for 
binding the GRE propably due to an overlapping of GRE and E-box that is specific of the Per2 promot-
er [211].  
The cAMP response element (CRE) is another Per1 and -2 promoter element, and is activated by 
phosphorylated CRE binding protein (pCREB) [212]. pCREB was found to be particularly highly ex-
pressed in the cerebral cortex and hippocampus after staying awake for a few hours or after sleep 
deprivation [213]. Light exposure induced via RHT a release of glutamate and PACAP in the SCN, 
which produced high level of cAMP and pCREB, ultimately allowing the expression of Per1 and Per2 
Table 2  All transcripts and protein variants for Per1 and Per2 
Name Transcript ID Length (bp) Exon Coding exon Protein ID Length (aa) Biotype
Per1-001 ENSMUST00000021271 4671 23 22 ENSMUSP00000021271 1291 Protein coding
Per1-201 ENSMUST00000166748 4636 23 22 ENSMUSP00000132635 1291 Protein coding
Per1-002 ENSMUST00000102605 4537 22 22 ENSMUSP00000099665 1271 Protein coding
Per1-003 ENSMUST00000101004 3507 18 17 ENSMUSP00000098566 827 Protein coding
Per1-005 ENSMUST00000132462 496 3 2 ENSMUSP00000122164 106 Protein coding
Per1-004 ENSMUST00000142392 2972 15 13 ENSMUSP00000121713 572 Nonsense mediated decay
Per2-201 ENSMUST00000069620 5837 23 22 ENSMUSP00000066620 1257 Protein coding
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(but not Per3) in the SCN [125, 214, 215]. D-box is another element present in the promoter of Per1 
and-2 genes, it allows induction by the clock controlled gene Dbp and inhibition by nuclear factor, 
interleukin 3 regulated (NFIL3 also called E4BP4) which both plays an important role in determining 
the period length [216]. As explained above, the Per2 promoter contains a HSE that responds to 
warm exposure via HSF permitting cells synchronization in vitro [130, 186] but also to have a purpose 
role in the temperature compensation process [130]. Pers genes also have a TATA-box (5'-TATAAA-3') 
in their promoters that is targeted by the TATA binding protein (TBP) -like POU domain, class 2, tran-
scription factor protein (POU2F) [217]. Of course the TATA-box is a very common element present at 
the promoters of about 24% of human genes and therefore has many roles outside the circadian 
regulation [218].  
2. Proteins 
The Per1 gene produces 5 functional translated proteins (table 2). However, PER1-001 and PER1-201 
are exactly the same protein composed by 1291 amino-acid (aa). The other 3 proteins are trunca-
tions, but could still be functional. PER2 is 1257aa long. PER1 and PER2 are very similar in their main 
domain composition as shown in the comparison view in figure 14 (upper panel) suggesting that the 
more precisely view of the PER2 domains (Fig.14 lower panel [219, 220]) it is also in part true for 
PER1. 
 The first domain found in PER2 from the N-terminal is the helix-loop-helix (HLH) motif; how-
ever this probably does not have the ability to bind the E-boxes due to the non-basic aa preceding it 
[219]. Within this HLH, the first nuclear export signal (NES1) is located. The second,NES2, is located 
just after the proline-rich (pro-rich) sequence, and the third (NES3) follows the cytoplasmic localiza-
tion domain (CLD). These latter two domains (NES and CLD) are responsible for protein exportation 
into the cytosol [221]. PER1 and -2 have NES motifs enabling their exit from the nucleus as well as a 
nuclear export site (NLS) that can be masked by binding of CKIε, thus controlling the rate at which 
PER1 enters the nucleus [178, 222]. 
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 Both PER1 and PER2 contain 
two distinct Per-Arnt-Sim (PAS) domains 
in the N-terminal region. PAS domains 
are conserved in all life kingdoms and 
are composed of 275aa containing two 
∼70aa repeat sections called PAS A (or 
1) and PAS B (or 2). Members of this 
family are often found in pathways that 
regulate responses to environmental 
change. In mammals these include the 
hypoxia, circadian (Per gene), and dioxin 
response pathways (Arnt gene). PAS 
domains are also found in proteins in-
volved in the development of the central 
nervous system (Sim gene) [223]. Most 
relevant mammalian proteins with PAS 
domain are reported in table 3. Phylogenetic analysis of the PAS domain in mice showed that PAS A 
& B are highly conserved with an identity ratio of 35% and 31%, respectively. Based on this data, 
mouse PAS domains were grouped into distinct clades: basic helix-loop-helix (bHLH) transcriptional 
regulators involved in neuronal and vascular development; circadian transactivators Clock and 
Npas2; Arnt, Bmal1, and their paralogs; and finally homologs of Per which act as transcriptional re-
pressors. Given their ability to bind and sense small molecules, PAS domain–containing proteins are 
important to mediate environmental adaptation. Small molecules can be used as cofactors, but can 
also mediate protein-protein interactions [223]. The PAC motif is present at the C-terminal of all 
known PAS motifs and contributes to the folding of PAS [224]. Thus PAS domains in PERIOD protein 
allow its dimerization (with BMAL1, CLOCK and NPAS2 for example), but also protein-protein interac-
Figure 14 Comparison between mains domains of PER1 and PER2 proteins 
(Upper panel). From Uniprot.org and ensemblr.org Detailed domains and 
protein interation region for PER2 protein (Lower panel). NES: nuclear export 
site; HLH: helix-loop-helix; PAS: Per-Arnt-Sim domain; NLS: nuclear localization 
site; CLD: cytoplasm localization domain; CKI: casein kinase 1; pro-rich: proline 
rich region. Ripperger J.A. and Albrecht U. (2012) [220] 
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tions with other PER proteins [220]. It was also reported that the kinase GSK3β interact with the PAS 
domains of PER2 (but not PER1) [183]. It is interesting to note that the PAS A domain of NPAS2 is able 
to bind heme and a point mutation this PAS A domain that disrupts this heme binding and then inhib-
its its partnering with BMAL1 [225]. The PAS A domain of PER2 likewise binds heme and can ex-
change this heme with NPAS2, suggesting similar mechanism of interactions [226]. Moreover, it was 
proposed that the PAS domain enables PER2 to sense the redox state by this heme interaction [227]. 
It was also shown that mice lacking the PAS B/PAC domain in PER2 had an altered response to light 
[228].  
PER2 possess some elements also found in coactivators and corepressors proteins as LXXLL 
motifs (also called NR boxes; L=leucine, X= any aa) and consensus sequence named CoRNR boxes. It 
let us postulate that PER2 is able to interact with different nuclear receptors as other protein con-
taining the same boxes (such as progesterone, estrogen and peroxisome proliferator-activated re-
ceptors) [219]. In fact, a study showed that PER2 interacts with some nuclear receptors such as 
PPARα and REV-ERBα, serving as a coregulator of nuclear receptor-mediated transcription and thus 
Table 3  Main murine Per-Arnt-Sim (PAS) domain superfamily members with associated domains and features. From McIntosh B.E., 
Hogenesch J.B. &. Brad C.A. (2010) [223] 
Gene 
symbol
Aliases Chrm.
Peptide 
length (aa)
bHLH 
(cd00083, 
cl00081)
PAS
PAS A 
(cd00130, 
cl02459)
PAS B 
(cd00130, 
cl02459)
PAC 
(smart00086)
Hif1a Mop1, Aip 12 836 17–71 80–345 80–155 228–298 302–345
Epas1 Hif2a, Mop2, Hlf 17 874 15–68 84–357 84–154 230–300 304–347
Hif3a Mop7, Ipas, Nepas 7 662 12–66 80–340 80–150 225–295 299–340
Ahr Dioxin receptor 12 805 12–80 116–359 116–179 269–336 342–380
Ahrr 13 701 13–79 106–176 106–176 na na
Arnt Drnt, Hif1b 3 776 75–128 147–451 147–223 334–405 409–451
Arnt2 Hif-2β 7 712 64–117 134–441 134–209 323–393 398–441
Arntl Arnt3, Mop3, Bmal1 7 626 80–133 150–451 150–222 333–403 408–451
Arntl2 Bmal2, Clif, Mop9 6 579 49–102 119–414 119–190 296–366 371–414
Clock 5 855 35–85 107–379 107–177 262–332 336–379
Npas2 Mop4 1 816 10–60 82–354 82–152 237–301 311–354
Per1 Per, m-rigui 11 1291 na 208–465 208–275 348–414 422–465
Per2 1 1257 na 179–436 179–246 319–385 393–436
Per3 4 1113 na 120–376 120–187 250–324 333–376
Sim1 10 765 1–54 77–335 77–147 218–288 292–335
Sim2 16 657 1–54 77–335 77–147 218–288 292–335
Npas1 Mop5 7 594 46–99 135–409 135–205 289–360 366–409
Npas3 Mop6 12 925 59–116 152–441 152–222 324–394 398–441
Npas4 Nxf 19 802 1–52 70–319 70–144 203–275 280–319
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modulating the expression of nuclear receptor target genes such as Bmal1, Hnf1a, and Glucose-6-
phosphatase. Thereby PER2 propagates clock information to metabolic pathways [229]. 
PER1,-2 also contain a pro-rich sequence. This sequence is responsible for a less structured 
aa chain, preventing helice α structures, and so dividing PER protein into two separate structural en-
tities that could interact with two different protein. Therefore, PER protein could serve as a scaffold. 
These two structural entities could also fold back on themself and interact with only one other pro-
tein [219]. 
At its carboxy-terminal, the PER2 protein contains a coiled-coil (a small helix form) that al-
lows the dimerization with other protein in possession of this helix structure [219]. In addition, it was 
reported that this surrounding area of PER1 and -2, able to bind CRY1 and -2 [230]. It was shown that 
NFIL3 binds PER2 in the same region [231]. In the figure 14, the yellow-shaded areas represent these 
potential protein-binding domains [219]. 
Several kinases can bind PER, as GSK3β stated above (specifically PER2)[183] and also CKIε 
(and probably also CKIδ) which as an important role in PER1 and -2 phosphorylation by the binding of 
CSNK1E domain (see chapter II.5.d) [178-180]. In the figure 14, the orange-shaded areas represent 
these potential phosphorylation sites [219]. 
It was shown that FBXW1A (also called β-TrCP1) binds PER protein to leads its polyubiquitina-
tion permitting its proteolysis [181].  
Given the remarkable size of the PER proteins, it is possible that additional domains and 
function remain to be discovered. In fact, a cistrome analysis in the mice liver identified about 4600 
and 7300 genomic-binding sites for PER1 and PER2, respectively. Motif analysis showed that these 
factors are specially enriched for E-box sites as well as nuclear receptor binding sites [232].  
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Science never solves a problem without creating ten more 
George Bernard Shaw 
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Thesis Project 
V. Research outline 
During my doctoral work I had two main projects both related to circadian rhythm and sleep re-
search, with a particular focus on the Per2 gene. Given that these two projects address fundamental-
ly different questions, I separated them in two distinct sections. 
The aim of my first project has been to advance our understanding of the link between sleep 
homeostasis and circadian rhythms. In particular, I investigated a possible mechanism by which sleep 
deprivation could alter clock gene expression by quantifying DNA-binding of the core-clock genes 
BMAL1, CLOCK and NPAS2 to their target chromatin loci including the E-box enhancers of the Per2 
promoter. To further investigate the nature of this link, my second project aimed at studying locomo-
tor activity and sleep architecture of mice lacking Period1 and -2. I characterized the recovery period 
after sleep deprivation, and finally assessed the repercussion on the expression of other clock genes.  
1. DNA-binding of clock transcription factors as a function of sleep loss  
Increasing evidence suggest that clock genes contribute to the homeostatic aspect of sleep regula-
tion [233]. Increasing homeostatic sleep pressure by means of a SD affects the expression of some 
clock genes in the brain. On the other hand, mutation of some clock genes alters the markers of 
sleep homeostasis. The goal of my first project was to investigate a possible mechanism by which SD 
could alter clock gene expression focusing on the DNA-binding of the transcription factors involved in 
the positive limb of the circadian machinery (i.e. BMAL1, CLOCK and NPAS2). The hypothesis is that 
changing in sleep/wake behavior preforming a SD might contribute to driven transcription through 
clock machinery (Fig.15). 
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I made use of chromatin immunoprecipitation (ChIP) and quantitative polymerase chain reaction 
(qPCR). To validate these methodologies, the experiments were first performed on liver tissue, and 
we showed that DNA-binding of CLOCK and BMAL1 to their target genes changes as a function of 
time-of-day as published earlier [234-237]. Subsequently, we performed the same experiment on the 
cerebral cortex. This has never been done before and we demonstrated that, like in the liver, the 
DNA-binding pattern of core clock genes varied as a function of time-of-day. We then performed a 6h 
SD and observed a significant decrease in DNA-binding of CLOCK and BMAL1 to Dbp. This is con-
sistent with a decrease in Dbp mRNA levels after SD. The DNA-binding of NPAS2 and BMAL1 to Per2 
was similarly decreased following SD. However, SD has been previously shown to increase Per2 ex-
pression in the cortex which seems paradoxical [48, 238, 239]. It could be argued that the Per2 in-
crease after SD is not driven by BMAL1::CLOCK/NPAS2 but rather, among others, through glucocorti-
coids and/or cAMP response element binding protein (CREB) binding to the Per2 promoter [240], an-
other pathway that has been linked to sleep regulation [241]. Our results demonstrate that sleep-
wake history can affect the molecular clock machinery directly at the level of the chromatin thereby 
altering the cortical expression of Dbp and Per2, and likely other targets. However, the precise dy-
Figure 15  Hypothesis of the project: changing in sleep/wake behavior preforming a SD might contribute to driven transcription 
through clock machinery 
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namic relationship between DNA-binding and mRNA expression, especially for Per2, remains elusive. 
This work has been published in 2011 in PLoS One [242], where I contributed as co-first author with 
Valérie Mongrain, performing all experiments, analyzing the data and writing the paper. Refer to 
chapter VI. 
2. Circadian rhythms, sleep architecture and homeostasis in Period mutant mice  
The molecular organization of circadian rhythms is based on interlocking transcriptional feedback 
loops involving the core clock genes: Bmal1, Clock, Npas2, Cry1, Cry2, Per1, and Per2, among others 
[158]. These genes seem also to be involved in sleep homeostasis [26, 233]. Indeed, the brain expres-
sion of clock genes, especially that of Per2, increases as a function of time-spent-awake and mice 
lacking clock genes display altered sleep homeostasis. However, Per2 mutant (Per2m/m; i.e., Per2tm1Brd 
or Per2tm1Drw) mice might be an exception because homeostatic sleep regulation was found to be 
largely unaffected [201, 203]. For my second project I performed an in depth characterization of cir-
cadian rhythmicity, sleep architecture, EEG analysis, and response to SD in full null-Per2 knock-out 
(Per2-/-; i.e., Per2tm1Ccl) mice, and Per1 knock-out (Per1-/-; i.e., Per1tm1Brd) mice, as well as their double 
knock-out offspring and littermate Wt mice. The techniques used include locomotor activity record-
ing by PIR, EEG/EMG surgery, recording, and analysis, and cerebral cortex extraction and quantifica-
tion of mRNA levels by qPCR. I found that although several aspects of sleep and circadian rhythmicity 
are shared between Per2-/- and Per2m/m mice, the arrhythmicity tendency under DD was clearly more 
severe in the Per2-/- mice and proved to be sex-depended. Under standard LD12:12 conditions, I 
found that  wakefulness onset was advanced by about 2h in Per2-/- mice compared to Wt mice.  The 
time courses of clock gene expression in the brain and corticosterone plasma levels were equally ad-
vanced. When released under constant dark conditions (DD) almost all Per2-/- mice (97%) became 
arrhythmic immediately. From these observations, we conclude that while Per2-/- mice seem to be 
able to anticipate dark onset, this does not result from a self-sustained circadian clock. Our results 
suggest instead that the earlier onset of activity results from a labile, not-self sustained 22h rhythm 
linked to light onset. Analyses of sleep under LD12:12 conditions revealed that in both Per2-/- and 
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Per1,2-/- mice the same sleep phenotypes are observed compared to Wt mice: increased NREM sleep 
fragmentation and less compensation of NREM sleep time lost. That suggests a possible role of PER2 
in sleep consolidation and recovery. This work is currently in preparation and will be summited the 
coming months; I contributed as first author by performing the experiments, analyzing the data and 
writing the paper. Refer to chapter VII. 
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VI. DNA-binding of clock transcription factors as a function of sleep loss  
1. Introduction 
Sleep loss has a profound, negative impact on cognition, learning, mood, and diverse aspects of men-
tal health [243]. Although chronic sleep debt is a growing problem in our society, the molecular and 
cellular sources of its deleterious effects remain poorly understood. Sleep is known to be regulated 
by the tight interaction between two main processes [106, 244]: a sleep homeostat that tracks sleep 
need according to the duration of time spent awake and asleep, and a circadian timing system that 
determines the propensity for wakefulness according to an about 24h rhythm. 
At the molecular level, the regulation of the circadian timing system has been extensively 
studied and it is now well-established that circadian rhythms originate from interacting transcrip-
tional-translational feedback loops involving clock genes and their protein products [245]. In con-
trast, the molecular wiring of the sleep homeostat remains to be defined. The function of the core 
clock transcription factors CLOCK, NPAS2, and BMAL1 resides in their hetero-dimerization and bind-
ing to E-box (CANNTG) or E-box like (E’-box) elements of target genes from which transcription is ini-
tiated [236, 246]. Some specific targets such as Per-1 and -2, and Cry-1 and -2 genes subsequently 
provide negative feedback by interfering with the CLOCK::BMAL1 or NPAS2::BMAL1 transcriptional 
complexes thereby inhibiting their own transcription [245]. In addition, other target genes such as 
the orphan nuclear receptor families Rev-Erb and Ror, respectively suppress and promote the expres-
sion of Npas2, Bmal1, and Cry1. These feedback loops, in combination with diverse post-translational 
mechanisms, result in a rhythmic (about 24h) expression of clock genes, of their protein product, and 
of a number of output genes (or clock controlled genes) governing a multitude of physiological func-
tions. 
It was initially reported that rhythmic gene expression did not depend on rhythmic binding of 
BMAL1 and CLOCK to the E-box element of a target gene, that of Per1 in particular [247]. More re-
cent reports clearly demonstrate, however, that BMAL1 and CLOCK bind to clock genes, notably to 
Per1, Per2, Cry1, Cry2, and Dbp, in a time-of-day dependent manner in the mouse liver [234-237]. 
70 
 
These data imply that, at least for some clock genes, changes in binding of the core clock transcrip-
tion factors to their genomic sequence play a role in the circadian modulation of their expression. 
In addition to their well-established role in generating circadian rhythms, clock genes also 
play a circadian-independent role in sleep homeostasis [26]. First, mutations in some clock gene 
change the EEG and molecular markers of sleep pressure in mice [137, 238, 248-250]. For instance, 
Npas2-/- mice show an attenuated EEG delta power response to SD, revealed between 1- 2Hz, com-
pared to Wt littermates [238], whereas this marker of sleep intensity is greatly increased during 
normal sleep in Cry1,2-/- mice [250]. Secondly, an increase in sleep pressure achieved by SD changes 
the expression of several clock genes in the forebrain of various inbred mouse strains, notably that of 
Per1, Per2 and Dbp [250-252]. Moreover, although some of these sleep/wake-dependent changes, 
especially those of Per1 and Per3, were driven by the corticosterone surge associated with the SD, 
the increase in Per2 expression and the decrease in Dbp expression were largely independent of cor-
ticosterone [239]. This last finding suggest that the SD-induced changes in the expression of these 
two clock genes are likely caused by modifications in the activity of the core clock transcription fac-
tors (i.e. BMAL1, CLOCK, and NPAS2) upon their respective promoter. The fact that the SD-mediated 
increase in Per2 in the brain is reduced in Npas2-/- mice [238] and increased in Cry1,2-/- mice [252] 
further supports such notion. 
In this project we investigated the potential role of changes in DNA-binding activity of core clock 
transcription factors in the modulation of clock gene expression observed with elevated sleep pres-
sure. Specifically, we hypothesized that SD modifies the binding of clock transcription factors to the 
E-box and/or E’-box sequences of specific clock genes, especially that of Per2 and Dbp, in the mouse 
cerebral cortex. Using ChIP of cortical tissue, we first observed that the binding of clock transcription 
factors to several clock genes depended on time-of-day in the mouse cortex in a way comparable to 
the time course previously described for liver [235-237]. Importantly, we found that SD alters the 
binding of clock transcription factors to their target genes. This effect was both transcription factor 
and target gene specific. Our findings thus reveal that sleep pressure, in addition to internal time-of-
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day, can modify the DNA-binding properties of core clock proteins in the brain, providing a mecha-
nism by which clock components can sense homeostatic sleep need. 
2. Material and methods 
a. Animals and protocol 
C57BL/6J mice originally purchased from Jackson Laboratory (Bar Harbor, ME, USA) were bred on site 
and maintained under standard animal housing conditions (free access to food and water, 12h-
light/12h-dark cycle, 23°C ambient temperature). Males between 11 and 15 weeks at the time of the 
experiments were used in this study. For the time-of-day experiment (Fig.16), mice were sacrificed at 
ZT0 (Zeitgeber time 0: lights ON), ZT6, ZT12 (lights OFF), and ZT18 by cervical dislocation and the liver 
and cerebral cortex were immediately removed and fixed (within 1min), and processed for chromatin 
extraction. For the sleep deprivation (SD) experiment, mice were sleep-deprived for 6h starting at 
ZT0 by gentle handling [253], and sacrificed at ZT6 together with non-sleep-deprived controls. Cere-
bral cortices were immediately sampled, fixed and processed for chromatin extraction. Experiments 
were performed 4 to 6 times with 2 to 4 animals per time (ZT) and condition (SD vs. control). Samples 
were processed randomly. All experiments were approved by the cantonal veterinary office of Vaud. 
Figure 16  Overview of the time-of-day experiment with A sacrifice at 4 different points (in orange), B harvest of both liver and brain, C 
chromatin extraction and sonication, D pre-clearing step, E collection of the input F antibody addition except in control no-antibody condition, 
G purification by magnetic bead, H wash, elution and DNA isolation, I quantification by qPCR. Modified from Dahl J. & Callas P. (2008) 
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b. Chromatin immunoprecipitation (ChIP) 
Chromatin extraction and immunoprecipitation was performed with the Magna ChIP G commercial 
kit (Millipore Corporation, Billerica, MA, USA) according to the manufacturer's instructions. Briefly, 
cortices were chopped in small pieces and incubated for 10min in 1% formaldehyde followed by a 
5min glycin-quenching. After washes and cellular and nuclear lysis, chromatin breakdown was per-
formed with a Bioruptor UCD-200TO (Diagenode SA, Liège, Belgium) to achieve a range of 300-
1000bp chromatin lengths as determined by ethidium bromide agarose gel electrophoresis (cycles 
30sec ON-30sec OFF at maximum intensity for 15min). A pre-clear step was performed (1h at 4°C 
with 40µl of magnetic beads) before overnight incubation of chromatin and beads with antibodies. 
Anti-BMAL1 antibody was from Abcam (Cambridge, England, product #ab3350), and anti-CLOCK from 
Abcam (product #ab461) or Santa Cruz Biotechnologies (product #sc-6927). These commercial anti-
bodies have been used by independent groups for circadian rhythm research including for ChIP [254-
256]. Custom anti-NPAS2 antibodies were produced from rabbit immunization using 
a peptide directed against amino acids 796 to 810 of the C-terminal domain of 
NPAS2 (accession #NP_032745) by Lucerna-Chem AG (Lucerne, Switzerland). The 
specificity of this antibody was verified by ELISA (by the company) and Western blot 
(Fig. 17) on cortical cortex protein extracts (91kDa). All samples were also identically 
submitted to a no-antibody condition (mock condition) used to take into account 
nonspecific binding. DNA purification was performed using the silica columns pro-
vided with the kit (Magna ChIP G, Millipore). 
c. Quantitative PCR 
Quantitative PCR was performed according to Applied Biosystems protocol using a 7900HT Fast Real-
time PCR System with SDS2.3 software (Applied Biosystems, Foster City, CA, USA). For each qPCR re-
action, purified immunoprecipitated DNA was slightly diluted (4/5) and mixed with 0.9µM of each 
primers, 0.25µM of probe and MasterMix reagent (Applied Biosystems) or FastStart Universal Probe 
Master (Roche Diagnostic GmbH, Mannheim, Germany). The qPCR was performed under standard 
Figure 17  Western blot  
1/1000 α-NPAS2 in 
mouse cortical cortex. 8 
% gel, PVDF membrane. 
Specific band at 91kDa. 
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cycling conditions (i.e., 50°C for 2min, 95°C for 10min, followed by 45 cycles of 95°C for 15sec and 
60°C for 1min). Each qPCR reaction was done in triplicate. Primers and probes were designed with 
Primer Express v2.0 (Applied Biosystems) to amplify E-boxes and E’-boxes containing genomic re-
gions of the four target clock genes (Cry1, Dbp, Per1 and Per2). More precisely, the amplicons target-
ed functional sequences located in the promoter region: most proximal E-box (CACGTG) and E’-box 
(CACGTT) of Cry1 (similar to [234], same as [257]), the most proximal E-box (CATGTG) of Dbp [236], 
the first E-box (CACGTG) of Per1 [246, 258], and two E-boxes (CAGATG, CATTTG) of Per2 [258]. As an 
additional negative control, an amplicon targeting a non-CLOCK::BMAL1 target (i.e., exon 5 of periph-
eral myelin protein 22 as Pmp22) was also amplified for liver samples and for half of cortical samples. 
The oligonucleotide sequences and their source are provided in table 4. Primers were purchased 
from Invitrogen or Microsynth (Balgach, Switzerland) and probes from Eurogentec SA (Seraing, Bel-
gium). 
 
 
 
 
 
Gene Sequence  (5’ --> 3’) Accession
Forward CCC CGG CTT CTC ATT GG
Reverse CAG TGT AGT AAA CAC ACT TCA GAA ACG T
Probe FAM-CCC CAC GTG ACC ACC GGC A-BQH
Forward ACA CCC GCA TCC GAT AGC
Reverse CCA CTT CGG GCC AAT GAG
Probe FAM-CGC GCA AAG CCA TGT GCT TCC-TAMRA
Forward AGC TTT AGC CAC GTG ACA GTG A
Reverse GGC AAG TGA AGA GGC CAA CA
Probe FAM-TGC ACT TAA CAG CTG ATT ATG TCA GCC GC-BHQ
Forward AGA AAA GCC CTG CTG TTC CA
Reverse CCA AAT GCG GTG GTG TAG TTT
Probe FAM-CCG CTT CCA TAG TTC CTG TAA GGT-BQH
Forward TTC GTC AGT CCC ACA GTT TTC TC
Reverse ACT CGC TAG TCC CAA GGG TCT A
Probe FAM-CGG TCG GAG CAT CAG GAC GAG C-BHQ
Per2 AF491941
Pmp22 NM_008885
Cry1
NCBIM37:10
:84593000:8
4647800:1
Dbp
NCBIM37:7:
52959000:52
965561:1
Per1 AB030818
Table 4   Primers and probes used for quantitative PCR 
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d. Statistical analysis 
Tissue sampled from each animal was treated separately and data from the repeated experiments 
were combined. Similar to what was performed previously [234-237], binding was initially analyzed 
as a fold relative to input chromatin in both liver and cerebral cortex. However, we observed that 
non-specific binding (no-antibody condition) varied and was influenced by time-of-day for liver 
(Fig.18). Thus, data were expressed in fold-change relative to the no-antibody negative control condi-
tion, as performed in other studies [259, 260], in order to control for non-specific binding and also for 
between-experiment differences. The number of biological replicates (i.e., the number of individual 
mice) contributing to each data point is indicated in each figure. Numbers vary because of data loss 
and removal of outliers; i.e. values more than two standard deviations away from the mean (<6% of 
Figure 18  BMAL1 and CLOCK binding onto the promoter of 4 clock genes in the mouse liver (A) and cerebral cortex (B). Mice were sacri-
ficed every 6 hours for 24 hours, and brain cortices were rapidly processed. Chromatin immunoprecipitation (ChIP) was performed using 
antibodies against BMAL1 and CLOCK or no antibody (negative control), and enrichment of putative promoter sequences of Cry1, Dbp, 
Per1 and Per2, and of a non-CLOCK::BMAL1 target, Pmp22, was measured using quantitative PCR. Data were expressed relative to input 
DNA. A Time-of-day affected non-specific binding (no antibody) to Cry1 (F3,23 = 4.2, p<0.05), Dbp (F3,22 = 3.9, p<0.05), and Per1 (F3,22 = 3.9, 
p<0.05, all plotted in both BMAL1 and CLOCK columns), but not that of BMAL1 or CLOCK to the control gene Pmp22. B Time-of-day did not 
significantly affect non-specific binding (no antibody), neither that of BMAL1 or CLOCK to the control gene Pmp22. Data are presented as 
mean ± SEM (n= 5, 5, 5, 5 for all genes for BMAL1; Cry1 n= 5, 6, 5, 6; Dbp and Per2 n= 5, 5, 5, 5; Per1 n= 6, 6, 5, 5 for CLOCK for ZT0, -6, -12, 
and -18, respectively). Grey lines connect double-plotted data, and light grey areas represent 12 h dark periods.  
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all values). Fold enrichments were calculated as a ratio of the power of Ct between sample and the 
respective no-antibody control (i.e. fold enrichment   
           
                
 . The effect of time-of-day on 
chromatin binding was assessed by one-way ANOVA, and significant effects were decomposed using 
Tukey tests. For assessing the SD effect on chromatin-binding, between-experiment differences were 
taken into account by expressing each SD enrichment level in percent of the enrichment level of a 
non-sleep deprived control processed in the same batch ( 
                  
                       
    ). The effect of 
SD was then analyzed using two-tailed single sample t-tests. Statistical analyses were performed with 
GraphPad Prism 4 (GraphPad Software Inc., San Diego, CA) or Statistica (Statsoft Inc., Tulsa, OK). The 
threshold for statistical significance was set to <0.05 and results are reported as mean  SEM.  
3. Results and discussion 
a. Rhythmic binding of BMAL1 and CLOCK to selected clock genes 
We have previously shown that SD does not uniformly affect the expression of all clock genes in the 
brain [48, 238, 239, 250-252, 261]. For the present chromatin binding study, we selected Cry1 which 
shows either no change or a small amplitude decrease or increase following SD, Dbp for which mRNA 
consistently decreases after SD, and Per1 and Per2 which mRNA are increased by SD. To validate our 
technique, we first confirmed rhythmic binding of CLOCK and BMAL1 to the E-box or E’-box elements 
of the promoter of the four selected clock genes in the mouse liver. Livers collected at 4 different 
times of day (ZT0, -6, -12, and -18) were processed using ChIP. Consistent with the literature [234-
236], we observed that the binding of BMAL1 and CLOCK to Cry1 and Dbp was higher at ZT6 (i.e., 6h 
after lights on) than at ZT18 (i.e. 6h after lights off) or ZT0. A similar phase was observed for BMAL1 
and CLOCK binding to Per1 and Per2 promoters (Fig.19). 
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Daily changes in chromatin binding of core clock transcription factors to the target genes of 
interest have not been assessed in the mammalian brain. Therefore, to put the eventual changes in-
curred by the SD into context (see below), we determined the time-of-day variations in DNA-binding 
of BMAL1 and CLOCK to the four selected clock genes in the mouse cerebral cortex. Cortical tissue 
from the same 4 different times of day (ZT0, -6, -12, and -18) were analyzed using ChIP. The binding 
of both core clock transcription factors to their four target genes exhibited highly similar time-of-day 
variations (Fig.20). Specifically, CLOCK bound to the four target genes in a time-of-day-dependent 
manner with maximum binding reached at ZT6 and lowest binding at ZT18 or -0 for Cry1 (one-way 
ANOVAs: F3,48=3.9,  p=0.01), Dbp (F3,49=6.8,  p<0.001), and Per2 (F3,59=4.6,  p<0.01), while the binding 
to Per1 peaked at ZT12 and reached a minimum at ZT18 (F3,54=3.8,  p<0.02). BMAL1 binding showed a 
similar pattern with maximal levels reached at ZT6 and a minimum at ZT18 or -0 for Cry1 (F3,56=4.3, 
p<0.01) and Dbp (F3,56=2.9,  p<0.05), whereas, although similar, the time-of-day changes in Per1 and 
Per2 binding did not reach statistical significance (F3,60=1.7, p=0.2, n.s. for Per1; F3,67=2.2, p=0.09, n.s. 
for Per2). 
Figure 19  The effect of time-of-day (ZT) on BMAL1 and CLOCK binding onto the promoter of 4 clock genes in the mouse liver. Mice were 
sacrificed every 6 hours for 24 hours (ZT0=Lights ON), and livers were rapidly sampled and processed. Chromatin immunoprecipitation (ChIP) 
was performed using antibodies against BMAL1 and CLOCK, and enrichment of E-box or E’-box containing sequences of the putative promoter 
region of Cry1, Dbp, Per1, and Per2 was measured using quantitative PCR. Data were normalized to a negative control condition (no-antibody). 
Time- of-day significantly affected the binding of BMAL1 (F3,19=4.3, p˂0.05) and that of CLOCK (F3,21=4.1, p˂0.05) to Cry1. Similar trends were 
also observed regarding binding to Dbp (BMAL1: F3,19=2.4, p=0.1, n.s.; CLOCK: F3,19=2.7, p=0.08, n.s.) and CLOCK binding to Per1 (F3,21=2.0, p=0.1, 
n.s.). Data are presented as mean ±SEM (n= 5, 5, 5, 5 for all genes for BMAL1; Cry1 n= 5, 6, 5, 6; Dbp and Per2 n= 5, 5, 5, 5; Per1 n= 6, 6, 5, 5 for 
CLOCK for ZT0, -6, -12, and -18, respectively). Grey lines connect double-plotted data, and light grey areas represent 12 h dark periods. (*: 
p≤0.05 between indicated points; post-hoc Tukey comparisons). 
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We here demonstrate, that in the cerebral cortex, the binding of BMAL1 and CLOCK to the 
targeted clock genes varies in function of time of day. These observations are similar to the only oth-
er study having assessed BMAL1 binding in the mouse brain [262], which showed a higher binding of 
BMAL1 to the clock gene Rev-Erbα and to Maoa at ZT6 than at ZT18. Our data, in particular for Cry1 
and Dbp, are also consistent with the observations made in the liver where ChIP for BMAL1 and 
CLOCK also resulted in a higher level of amplified Cry1 and Dbp promoters at ZT6 compared to ZT18 
[234-237]. The phase positions of maximum and minimum RNA levels are similar between the brain 
and liver for the different transcripts targeted (see Fig.22 for a review). Therefore, for each target, 
similar DNA-binding rhythms between the two tissues were expected. We observed a similar phase 
regarding the binding of clock transcription factors to Per1 and Per2 promoters in the cortex. This 
rhythm seemed, however, less robust as it did not reach statistical significance for BMAL1. In the liv-
er, one study showed that BMAL1 and CLOCK binding to Per1 promoter did not vary with time-of-day 
[247], while another study indicated an inverse phase for Per2 binding by CLOCK (i.e., higher at ZT15 
than at ZT6) although binding was not quantified [263]. A recent study indicates, however, that 
BMAL1 binding to both Per1 and Per2 in the mouse liver appears to peak at ZT6 [235], similar to our 
Figure 20  The effect of time-of-day (ZT) on BMAL1 and CLOCK binding onto the promoter of 4 clock genes in the mouse cerebral cortex. Mice 
were sacrificed every 6 hours for 24 hours (ZT0=Lights ON), and cerebral cortices were rapidly sampled and processed. Chromatin immunopre-
cipitation (ChIP) was performed using antibodies against BMAL1 and CLOCK, and enrichment of E-box or E’-box containing sequences of the 
putative promoter region of Cry1, Dbp, Per1, and Per2 was measured using quantitative PCR. Data were normalized to a negative control condi-
tion (no-antibody). Time-of-day significantly affected the binding of BMAL1 to Cry1 and Dbp genes, and the binding of CLOCK to all 4 target 
genes. Data are presented as mean ±SEM (Cry1 n= 14, 16, 14, 13; Dbp n= 14, 15, 13, 15; Per1 n= 16, 16, 14, 15; Per2 n= 16, 18, 17, 17 for 
BMAL1; Cry1 n= 13, 13, 12, 11; Dbp n= 12, 14, 11, 13; Per1 n= 15, 14, 12, 14; Per2 n= 14, 15, 15, 16 for CLOCK for ZT0, -6, -12, and -18, respec-
tively). Grey lines connect double-plotted data, and light grey areas represent 12 h dark periods. (*: p≤0.05 between indicated points; post-hoc 
Tukey comparisons). 
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findings in the cortex. In the fruit fly, a highly rhythmic binding of CLOCK to Per, with a peak centered 
around ZT12, was reported and was shown to be closely linked to the rhythm of Per mRNA levels 
[260, 264, 265]. Given the variable results obtained in mice for DNA-binding to Per1 and Per2, it is 
possible that transcriptional rhythms of mammalian Per genes depend less on a highly rhythmic DNA-
binding of CLOCK and BMAL1 compared to those of Cry1 and Dbp or that of Per in Drosophila. 
b. Sleep deprivation decreases BMAL1, CLOCK, and NPAS2 binding to specific 
clock genes 
To assess the effect of sleep loss on 
the binding activity of core clock 
transcription factors to the targeted 
clock genes, we measured the im-
pact of a 6h SD performed between 
ZT0 and -6 on the binding of BMAL1 
and CLOCK to the promoter of clock 
genes in the mouse cerebral cortex 
(Fig.21). We observed that SD specif-
ically decreased the binding of 
BMAL1 to the promoter of Dbp and 
Per2 (t-tests: t=-3.0, p<0.01 and t=-
3.7, p<0.01, respectively), whereas 
binding to Cry1 and Per1 genes was not affected by SD (p>0.5, n.s.). The binding of CLOCK to Dbp was 
also significantly decreased by SD (t=-2.2, p=0.05) while CLOCK binding to the other clock genes as-
sessed (i.e. Cry1, Per1, and Per2) was not affected (p>0.5, n.s.).  
Since BMAL1 binding to Per2 and not that of CLOCK was decreased by SD, we hypothesized 
that the SD-mediated change in BMAL1 binding on the promoter of Per2 could be mediated by the 
interaction of BMAL1 with its alternative partner, NPAS2. NPAS2, a CLOCK homolog, can associate 
Figure 21  The effect of sleep deprivation (SD) on BMAL1, CLOCK, and NPAS2 binding onto   
the promoter of 4 clock genes in the mouse cerebral cortex. SD was performed between 
ZT0 and -6 after which cerebral cortices were rapidly sampled and processed together with   
non-sleep deprived controls. Chromatin immunoprecipitation (ChIP) was performed using 
antibodies against BMAL1, CLOCK, and NPAS2, and enrichment of E-box or E’-box contain-
ing sequences of the putative promoter regions of Cry1, Dbp, Per1, and Per2 was measured 
using quantitative PCR. Data were normalized to a negative control condition (no-antibody) 
and expressed relative to the control non-sleep deprived sample performed in parallel. SD 
significantly decreased the binding of BMAL1 to Dbp and Per2, the binding of CLOCK to Dbp 
gene, and the binding of NPAS2 onto Per2. Data are presented as the mean SD/control 
percentage ratio (±SEM of the ratio; n= 18, 17, 16, 14 for BMAL1; n= 10, 10, 9, 8 for CLOCK; 
n= 9, 8, 8, 6 for NPAS2 for Cry1, Dbp, Per1, and Per2, respectively). Please note logarithmic 
scaling of y-axis (+: p˂0.07, *: p=0.05, **: p˂0.01; t-tests). 
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with BMAL1 and perform a similar role in regulating clock genes transcription [266]. In addition, 
NPAS2 is predominantly expressed in the brain, particularly in the cerebral cortex and thalamus 
[267], and was shown to be involved in the response to sleep deprivation including the increase in 
EEG slow waves, in NREM sleep duration, and in Per2 mRNA [238]. We therefore also quantified the 
effect of SD on the binding of NPAS2 to the chromatin of clock genes in the mouse cerebral cortex 
(Fig.21, right grey columns). We observed that SD significantly decreased the binding of NPAS2 to 
Per2 (t=-4.6, p<0.01). A similar tendency was observed regarding the binding of NPAS2 to Dbp (t=-
2.2, p<0.07, n.s.), while, again, no change in NPAS2 binding was observed upon Cry1 and Per1 genes 
(p>0.2, n.s.).  
We thus revealed that elevated sleep pressure changes the binding of the three core clock 
transcription factors (i.e. BMAL1, NPAS2, and CLOCK) to specific clock genes. As expected, significant 
SD-dependent changes in DNA- binding were observed only for Dbp and Per2, the two clock genes 
showing a response mostly independent of the glucocorticoids surge associated with SD [239]. Re-
garding the DNA-binding to Cry1, the observed absence of changes following SD is consistent with 
the lack of a clear SD effect upon Cry1 mRNA expression. Also for Per1, we did not observe a change 
in DNA-binding following SD although SD clearly increases Per1 expression in the mouse brain [239, 
250, 251, 261]. We recently showed that this SD-induced increase in Per1 expression is mediated 
through a surge in glucocorticoids [239], which combined with the present observations suggest that 
changes in Per1 expression following SD are largely due to modifications in its transcription via the 
activation of a GRE present in its promoter [268], and not through activation involving the core clock 
components. 
Our results specifically show that SD decreases the binding of CLOCK, NPAS2, and BMAL1 to 
Dbp in the mouse brain. Since we previously observed that the SD-dependent decrease in Dbp ex-
pression was not affected by the glucocorticoid surge [239], and since core clock transcription factors 
are known to be the main transcriptional regulators of Dbp [235, 236], the decreased binding of 
BMAL1 and CLOCK, and to some extent also that of NPAS2, might be sufficient to explain the de-
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crease in Dbp expression after SD. However, the present findings cannot exclude the contribution of 
other pathways in mediating the SD-dependent decrease in Dbp expression. For instance, TNFα was 
recently shown to decrease Dbp expression via a TNFR1 and calcium-dependent pathway [269]. 
These authors also showed that TNFα could increase Per1 expression, which could contribute, in 
combination with a GRE-mediated response [239], to the SD-dependent increase in Per1. The TNFα 
pathway is relevant to sleep regulation as reduced sleep duration was associated with increased 
TNFα in humans and rodents [270, 271], and inactivation of TNFα or TNFR1/IL1R1 alters sleep 
amounts and EEG [272, 273]. Hence, core clock transcription factors are most likely not the sole con-
tributors to the SD-dependent changes in clock gene expression, and future studies aiming at as-
sessing the SD-dependent changes in clock gene expression in animals bearing mutations of core 
clock transcription factors will be required to understand their specific contribution. 
The observation of a SD-dependent decrease in NPAS2 binding and a lack of effect of SD up-
on CLOCK binding on Per2 was unexpected given the overlapping roles of CLOCK and NPAS2 in the 
maintenance of circadian rhythmicity in behavior and gene expression [266, 274]. In peripheral tis-
sues expected brain and cortical spin, the presence of CLOCK was shown, however, to be required for 
the persistence of rhythmic gene expression [275]. The sequence of CLOCK and NPAS2 are similar 
except for the presence of an extra 43aa at the carboxy end of CLOCK. In addition, NPAS2 also lacks 
an acetyl-CoA binding motif (656-664aa) and a poly-glutamine sequence (753-776aa) compared to 
CLOCK. The acetyl-CoA binding motif has been involved in conferring CLOCK with a HAT activity [276]. 
These sequence differences might prevent elevated sleep pressure from changing CLOCK binding to 
Per2, whereas allowing it for Dbp. This indicates that, within the same tissue, the effect of elevated 
sleep pressure on clock gene expression involves complex and different patterns of transcriptional 
regulation which are highly specific to each clock gene. 
We observed that the increase in Per2 expression following SD [239, 250, 251, 261] was ac-
companied by a decrease in binding of BMAL1 and NPAS2 to its promoter, which seems paradoxical. 
It could be argued that the SD-dependent increase in Per1 and Per2 mRNA followed by an increase in 
81 
 
protein [48] would not initially be driven by BMAL1::CLOCK/NPAS2 but rather, among others, 
through glucocorticoids::glucocorticoid receptor binding to GRE and/or CREB binding to CRE [240], 
another pathway that has been linked to sleep regulation [241]. Subsequently, increase in nuclear 
PER2 could decrease the DNA binding activity of core clock transcription factors and subsequently 
mRNA levels of their target genes like Dbp. This possibility is supported by our observation that Per1 
and Per2 mRNA levels are increased as early as after 1h of SD whereas the Dbp decrease occurs after 
3 to 6h of SD [251]. To address this possibility, the detailed time course of core clock transcription 
factors binding and of glucocorticoid receptors binding to the target DNA regions of Per1 and Per2 
and their relation to nuclear levels of PER1 and PER2 protein levels will need to be assessed over the 
course of SD. To further complicate matters, BMAL1 and CLOCK were recently shown to be able to 
repress glucocorticoids-mediated transcription [277]. 
c. Core clock transcription factor binding and transcriptional activation 
To clarify the link between DNA binding and mRNA levels, we examined the relationship between the 
two in the mouse liver and brain. We first observed that during the time when SD is usually per-
formed (i.e. between ZT0 and -6), the binding of BMAL1 and CLOCK to all clock genes assessed grad-
ually increases during control conditions when animals are mainly asleep (Fig.19 and 20). Increased 
DNA-binding during this time is not always linked to a mRNA increase of the corresponding gene. For 
instance, while the expression of Dbp is increasing during that interval, the mRNA levels of Cry1, 
Per1, and Per2 are decreasing [251, 261]. The current literature indeed supports a range of phase 
relationships between the two rhythms (Fig.22).  For Cry1, the peak in chromatin binding is in anti-
phase with the peak in mRNA levels for both liver and cortex (about 12h apart). This contrasts the 
data regarding Dbp for which the peak in chromatin binding and mRNA expression coincide. Regard-
ing Per1 and Per2, there is a phase delay of about 6h such that when BMAL1 and CLOCK binding 
begin to decrease, the mRNA levels reach their peak. These observations are consistent with a recent 
report that assessed both the time-of-day rhythm of BMAL1 binding to these clock genes and the 
mRNA expression rhythms in the mouse liver [235]. Accordingly, elevated or decreased BMAL1 and 
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CLOCK DNA-binding are not directly linked to increased or decreased mRNA levels, respectively, and 
this seems especially true for Cry1, Per1, and Per2, and in both the cerebral cortex and liver. 
  
Figure 22  Overview of the phase relationship between RNA expression and chromatin binding. Time-of-day or circadian variations in mRNA 
expression for the selected clock genes (i.e. Cry1, Dbp, Per1, and Per2) for liver and brain samples from selected literature together with varia-
tions in DNA-binding of CLOCK (C) and BMAL1 (B) onto these clock genes shown from all previous literature in mice (i.e. liver) and the present 
study. Relative heat scales go from blue (minimum) to red (maximum). ZT: Zeitgeber time with ZT12=dark onset; CT: Circadian time with 
CT12=activity onset. For Cry1, RNA expression and DNA-binding seem to be in antiphase for both liver and brain, whereas the two rhythms are 
always in-phase for Dbp. Regarding Per1 and Per2, the peak in DNA-binding precedes by several hours that of RNA expression for both tissues. 
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Previous work described several molecular mechanisms likely to contribute to the delay be-
tween chromatin binding and gene expression. For instance, it has been suggested that the phase of 
some transcripts is due to the interplay between several different transcriptional regulators acting on 
their promoter [278]. Similarly, Rey et al. [235] proposed that the higher the dependence on BMAL1 
transcriptional regulation, the smaller the time lag between chromatin binding and gene expression. 
In particular, REV-ERBα could prevent the recruitment of RNA polymerase II to the Cry1 promoter at 
CT6, thereby interfering with CLOCK::BMAL1 transcriptional activation [234]. Furthermore, the 
CLOCK::BMAL1 complex itself was shown to repress Cry1 gene expression when CRY1 bound to the 
complex [279]. In Drosophila, the regulation of Per and Tim expression was shown to depend on the 
delicate balance between the binding of CLOCK and that of the repressor PER [264], which was sug-
gested to drive two phases of repression: an ON-DNA phase and an OFF-DNA phase. Also other regu-
lators such as the repressor DEC1, can affect Per expression [280]. Such mechanisms might be rele-
vant to our observation of a decrease binding to Per2 simultaneous to an increase mRNA level after 
SD, and stress the complex transcriptional regulation of clock genes by clock elements in addition to 
their regulation by non-clock elements (see above). Also, chromatin state importantly contributes to 
the relationship between DNA-binding and transcriptional activation as transcription is possible only 
when chromatin is in a permissive configuration. As mentioned earlier, CLOCK is a HAT required for 
rhythmic expression of Dbp and Per1 independent of DNA-binding [276]. Furthermore, MLL1, a his-
tone methyltransferase, was recently identified as a protein partner of CLOCK and an essential com-
ponent to both Dbp and Per2 rhythmic expression [281]. These mechanisms are likely to contribute 
also to the highly specific transcriptional regulation of individual clock genes. This specificity seems to 
be similarly reflected at the level of the so-called circadian and the sleep pressure-dependent chang-
es, since the various phase relationships between rhythms of chromatin binding and gene expression 
(antiphase, in-phase, delayed) are also linked to a specific response to SD in terms of mRNA levels 
(Cry1 no distinct change, Dbp decrease, Per genes increase, respectively) and core clock transcription 
factor binding. 
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In the present study, the effect of SD on DNA binding was assessed at the time when the 
binding of core clock transcription factors peaks (i.e. ZT6; Fig.20). This could have biased our results 
towards emphasizing decreases in binding as opposed to increases. To address this issue one could 
assess the effects of SD on DNA-binding at different circadian phases. Moreover, it is possible that 
the SD protocol could have shifted the phase of core clock transcription factors binding to the DNA of 
their specific targets, namely that of Dbp and Per2. This could occur either through a direct effect of 
wakefulness on the cerebral cortex molecular clock machinery or via resetting of the suprachiasmatic 
nucleus clock, which was shown to respond to behavioral stimulation (arousal and locomotor activi-
ty) [282]. Along this line, it is of interest to note that the main normal waking episode in mice, occur-
ring between ZT12 and -18, is also accompanied by a decrease in Per2 DNA binding by clock tran-
scription factors and increased levels of Per2 mRNA (Fig.22). Thus, the distribution of sleep and wak-
ing under baseline conditions might contribute to the so-called circadian changes in DNA-binding and 
gene expression in the mouse brain as we recently modeled in detail [48]. 
4. Conclusions and perspectives 
Neuronal plasticity and neuroprotection are among the functions likely to be direct correlates of 
sleep need [12, 239, 261]. Clock genes have been shown to be involved in plasticity, particularly Per 
genes and Npas2 [283, 284]. For example, impaired hippocampal LTP was observed in Per2 mutant 
mice [285], and decreased long-term memory of courtship and waking experience-dependent in-
crease in sleep in Per mutant flies [286, 287]. Therefore, clock genes could modulate cortical syn-
chrony and synaptic equilibrium associated with vigilance states, which is further illustrated by the 
effect of clock-gene mutations on sleep homeostasis [288]. Combining ChIP with high throughput 
sequencing of cerebral cortex sampled either after sleep or SD could help to identify further targets 
of BMAL1 and CLOCK/NPAS2 relevant to synaptic plasticity. 
The transcriptional response to SD depends on brain area [289, 290]. Also the change in Per 
expression after SD was shown to express a characteristic neuroanatomical pattern, with elevated 
sleep pressure producing more pronounced increases in the cerebral cortex [251, 252]. In the pre-
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sent study, the SD-dependent changes in chromatin binding were specifically assessed in the cerebral 
cortex to more closely investigate their role in the recovery aspect of sleep which is known to be 
linked to EEG activity in slow frequencies [12, 106]. Nonetheless, the role of clock genes could extend 
to other, non-cortical brain areas. Also, we measured the binding of BMAL1, CLOCK, and NPAS2 to a 
single E/E’-box containing sequence. It is believed that the number of different E/E’-box containing 
sites bound by those transcription factor complexes within a gene will strengthen transcriptional 
control [235]. Accordingly, characterization of the SD effect upon binding to several sites in the pro-
moter and intronic regions of our genes of interest will be useful to clarify the detailed molecular 
mechanisms governing SD-dependent changes in clock genes expression. 
In conclusion, we reported that in the mouse cerebral cortex, core clock transcription factors 
bind to the DNA of target clock genes in function of time-of-day. Moreover, we revealed that ex-
tended wakefulness changes the binding of core clock transcription factors to the promoter of specif-
ic clock genes; specifically, SD decreased CLOCK binding to the promoter of Dbp, and decreased 
BMAL1 and NPAS2 binding to Per2 and Dbp. These sleep-wake dependent changes in DNA-binding 
are likely contributing to the observed alterations in gene expression following SD, and also to 
changes observed with time-of-day. Together, our data further support a role for clock genes in the 
homeostatic regulation of sleep. An avenue we are currently following up on, is how elevated sleep 
pressure changes the multi-clock protein complex associated to the BMAL1::CLOCK/NPAS2 dimers. 
Also,   future   research studying   the   link   between   clock   genes   and   sleep   homeostasis should   
focus   on   the   involvement   of   post-translational   modifications,   for   instance   on   the   acetyla-
tion   status   of   the   core   clock proteins that was shown to tightly regulate their function [291, 
292]. 
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VII. Circadian rhythms, sleep architecture and homeostasis in Period knock-
out mice  
1. Introduction 
Sleep is regulated by the tight interaction between the homeostatic process and the circadian pro-
cess introduced above [106, 244, 293]. The regulation of this circadian process has been widely stud-
ied and is largely understood at the molecular level [160, 161]. The circadian clock is generated prin-
cipally by a positive limb involving the hetero-dimerization of BMAL1 with CLOCK or NPAS2 allowing, 
via E-box sequence binding, the transcription of many target genes. The resulting proteins of specific 
targets such as Cry1 and Cry2 genes and Per1 and Per2 genes form complexes and move back into 
the nucleus to inhibit the transcription of their respective genes by interfering with the 
BMAL1::CLOCK/NPAS2 dimers  [162]. This negative feedback in association with the positive limb is 
essentially responsible for the endogenous oscillation of all downstream genes (as Dbp, REVERB, 
ROR, PPAR, LDHA, etc.) [26]. In contrast, the molecular wiring of sleep homeostasis remains to be 
defined.  
Mutations in core clock genes can impact period length like in Npas2-/- [103], Clockm/m [193], 
Cry1-/- and Cry2-/- mice [195] or can induce arrhythmicity like in Bmal1-/- [163], Clock-/-Npas2 -/- [136] 
and Cry1,2-/- double mutant mice [196]. Intriguingly, the effects of Per mutant mice are less straight-
forward. Many studies were performed using Per1 and Per2 mutant mice, using different constructs 
targeting these genes on various genetic backgrounds, producing conflicting results. Both Per1tm1Brd 
on a 129S7/SvEvBrd background [165] and Per1tm1Saco on a mixed 94%C57BL/6-6%129S2/SvPas back-
ground [198] remained rhythmic albeit with a shorter period (22.6h±0.2 and 23.2h±0.2, respectively) 
compared to Wt mice (23.7h±0.1 for both strain) under DD, while the majority of Per1tm1Drw mice on a 
129S4/SvJae background lost their rhythmicity (22.6±0.3h) after about 10-14 days [197]. In this study, 
I used Per1tm1Brd mice on a C57BL6/J background which I will refer to as Per1-/- for simplicity, hereaf-
ter.  
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Per2tm1Drw mice on a 129S4/SvJae background initially displayed a period (23.0h±0.3) similar 
to Wt mice (23.1±0.1), before becoming arrhythmic under DD conditions [197]. However, when 
backcrossed onto a C57BL6/J background, these mice remained rhythmic with a normal period 
throughout DD [200]. Per2tm1Brd on a 129S7/SvEvBrd x C57BL6 mixed background displayed a short 
period of 22.1h±0.1, shorter than Wt mice which have a period of 23.7h±0.1. Moreover, some mu-
tant mice became arrhythmic between 2-18 days under DD conditions [199]. These examples power-
fully demonstrate the profound effects genetic background has on circadian phenotypes and how 
background can “rescue” the effects of gene mutations. 
Importantly, all Per2 mutant mice presented above still produce a mutant transcript that can 
be translated. Per2tm1Drw mice produce several Per2 transcripts that can generate truncated proteins 
from the first four exons. These exons encode the first 147 residues of PER2 but lack the entire PAS 
domain [197]. PAS domains in PER2 allow, inter alia, its protein dimerization with BMAL1, CLOCK and 
NPAS2, but also protein-protein interactions with other PER proteins [220]. However, a relatively rare 
transcript was detected in which exon 4 was spliced directly to exon 7. This splicing event maintains 
the reading frame as in native PER2 and the resulting transcript could, if translated, form a mutant 
PER2 protein lacking only the 108 amino acids of the PAS domain encoded by exons 5 and 6 (residues 
148–255) [197]. Regarding Per2tm1Brd, the presence of a mutant transcript was also detected that if 
translated, would generate a protein with a deletion of 87 amino acids in the PAS domain [199]. Thus 
both Per2tm1Drw and Per2tm1Brd mice cannot be considered as full null-Per2 mutants. Even if the PAS 
domain is dysfunctional, it is impossible to predict the implication that the mutant transcript would 
have if translated. For instance, the domain permitting the binding of the CKIε and CKIδ [294] or the 
N-terminal domain of the PER2 protein which bind CRY1 and -2 [230] are still present. Note that dou-
ble mutant Per1,2tm1Drw mice on a 129S4/SvJae background were arrhythmic under DD, demonstrat-
ing central role of both PER1 and -2 within the circadian machinery [197, 201]. In conclusion, most of 
Per1 and Per2 mutant mice had a shorter period than Wt and several Per2m/m became arrhythmic 
under dark constant condition. In addition not all individuals carrying a specific construct on same 
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background behave the same phenotype, some were arrhythmic and some were not; that suggests a 
variability in genetic penetrance. 
In addition to the partial deletion mutation described above and used in most of the litera-
ture, a full null-Per2 mutant mouse was generated: Per2tm1Ccl by Cheng Chi Lee. These mice have not 
been widely used or characterized. It was only mentioned that they display a similar circadian pheno-
type as Per2tm1Brd on a mixed 129/C57BL6 background, while completely lacking all PER2 polypeptide. 
[120]. For my work I used Per2tm1Ccl mice which I will refer to as Per2-/-, hereafter. 
Per2 seems to have a particular importance in the circadian circuitry. Several different path-
ways activate Per2 transcription to fine tune period length or to reset phase. For instance, the gluco-
corticoid pathway (such as stress hormone corticosterone [208], female hormone estrogen [210] or 
synthetic drug dexamethasone [99]) via the GRE domain in the Per2 promoter are important for syn-
chronization of circadian rhythms in peripheral tissues [209]. Light via activation of the CRE domain 
can induce Per1 and -2 in the SCN [125, 212, 214, 215]. Changes in temperature via HSE domains 
permit cells to synchronize in vitro [130]. Finally DBP and its antagonist E4BP4 via D-box domains 
[216]. PER2 is also responsible of the period length in human. Patients suffering from FASPS or DSPS 
have mutations in the CSNK1-binding domain of PER2 or in the CKIε/δ kinase responsible of the 
phosphorylation of PER2. All these mutations decreases substantially CKIε/δ enzymatic activity alter-
ing PER2 protein stability its translocation into nucleus [147].  
In addition to their well-established role in generating circadian rhythms, clock genes seems 
to play also a circadian-independent role in sleep homeostasis [26]. Some single clock gene mutation 
were enough to modify the homeostatic process; examples are Npas2-/- [194], Bmal1-/- [46] and Rev-
erbα-/- [205]. Moreover, when pairs of redundant clock genes were removed altered homeostatic 
sleep regulation was observed as well, like in Cry1,2-/- [191]. However, for both studies done in 
Per2m/m [201, 203] and also Per1,2 double mutant mice [201], it was concluded that sleep homeosta-
sis regulation of sleep is not affected because EEG delta power responded in the same way in all gen-
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otypes after a sleep deprivation, despite the fact that they observed lowest EEG delta power in re-
sponse to a SD in Per1m/m and Per2m/m mice compared with the Wt mice [203]. 
As mentioned above, genetic background has an effect on the phenotype such as the home-
ostatic process [36, 46] and could also modulates the effects of a gene mutation (e.g. Per2tm1Drw x 
129S4/SvJae mice become arrhythmic  under DD [197] while Per2tm1Drw x C57BL6/J mice remain 
rhythmic [200]). For these reasons, in my project I backcrossed between 7-11 times Per1-/- and Per2-/- 
mice onto C57BL6/J inbred mice to have at least 99.2% of recipient genome. Most mice used were 
backcrossed 9+ times and were considered as congenic mice.  
In this project I recorded locomotor activity, EEG/EMG signals and measured gene expression 
of Per1-/-, Per2-/- , Per1,2-/-  and Wt mice. Locomotor activity was used to characterize the circadian 
clock, while the EEG/EMG recordings were used to determine sleep architecture and the sleep ho-
meostat. In mice kept under LD12:12 conditions I observed that lack of Per2 advanced activity onset 
of clock gene expression and corticosterone levels.  Although, earlier activity onset could be inter-
preted to indicate the presence of a circadian rhythm allowing the animals to anticipate dark onset, 
the immediate loss of circadian organization of locomotor activity upon release in DD in 94% of the 
mice studied indicates that self-sustained rhythms are not present under LD12:12 and that instead 
these changes are light-dark driven. Moreover, I found that NREM sleep is less consolidated both in 
Per2-/- and Per1,2-/- mice. In addition, although the homeostatic regulation of sleep intensity did not 
differ between genotypes, the homeostatic regulation of sleep duration did importantly differ and 
during the first 5h of recovery after a 6h SD, mice lacking Per2 expressed less sleep than during base-
line.   
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2. Materials and methods 
a. Animals 
Per1-/- mice were described in Zheng et al [165]. Fifteen exons (from exon 4 included) of the Per1 
gene were replaced by a hypoxanthine phosphoribosyltransferase (Hprt) mini-gene deleting the en-
tire PAS domain and preventing protein translation due to a shift in the reading frame. The Per1-/- 
construct is considered a null allele [165]. Per2-/- mice were generated by Cheng Chi Lee and col-
leagues and were mentioned for the first time in [120]. The entire PAS-B domain (from the 9th exon 
to 11th included) of the Per2 gene was deleted generating a reading frame shift which prevents PER2 
translation (Fig.23).  
 
 
 
 
Figure 23  Generation of Per1-/- and Per2-/- knock-out mice. A  Genomic structure of the murine Per1 gene, the targeting vector, and the 
predicted  structure of the targeted allele. Exons are indicated by vertical black bars with the first and last exons numbered. WT: wild-
type; R: EcoRI; Hprt: hypoxanthine phosphoribosyltransferase gene; TK: Herpes Simplex Virus thymidine kinase gene. A 1.6 kb 3’ external 
probe that detects a 20 kb wild-type EcoRI  fragment and an 11.8 kb mutant EcoRI fragment were used to detect targeted ES cell clones 
and to genotype test mutant mice. A  1.5 kb 5’ internal probe that detects a 20 kb  wild-type EcoRI fragment and a 7.4 kb mutant EcoRI 
fragment were used to confirm correct  targeting at the 5’ homology region (data not  shown). B Southern analysis of F2 littermates 
obtained from intercrosses between (C57BL/6Tyrc-Brd x 129S7) F1 heterozygous mice using the 3’ probe and EcoRI digestion. +: wild- type 
allele; m: mutant allele. Southern analysis with a probe within the deleted region confirmed the deletion in homozygous mutants (data 
not shown). C The targeting vector and the predicted structure of the targeted allele. A replacement vector is designed to delete the 
exons 9–11 in the Per2 gene, which encode the entire PAS-B domain. When spliced, the mutant Per2 mRNA is out-frame with the wild-
type mRNA in the sequence 3’ to exon 11 due to frame-shifting, so that the targeted Per2 allele is a null allele. D Southern blot analysis 
of Bam HI digested genomic DNA obtained from F2 littermates using the 5’ probe. AB: from Zheng B. et al. (2001) [165]; CD Fu L. et al. 
(2002) [120]. 
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Western blot analysis showed no PER2 protein signal in cere-
bral cortex and forebrain of Per2-/- mice (Fig.24). The antibody 
used bound the C-terminal part of the protein. Furthermore, 
Cheng Chi Lee confirmed that no PER2 protein was detected 
by western (data not shown). Moreover, no Per2 mRNA was 
detected by qPCR (Fig.32, 41). The primers used amplified the 
11th exon of Per2 (see table 5). Both Per1-/- and Per2-/- original breeding kept on an unknown mixed 
background were kindly sent to us by Cheng Chi Lee. Per1-/- and Per2-/- knockout mice were back-
crossed at least 7 times to C57BL/6J mice purchased from Jackson Laboratory (Bar Harbor, ME, USA) 
to have a purity of minimum 99%. Their offspring were then crossed to obtain double mutant (Per1,2-
/-) mice. Usually coupling was done with Per heterozygote female and C57BL/6J male mice, but to 
prevent any genetic anomaly in mitochondria, once in a while mice were backcrossed to C57BL/6J 
females. Wild-type (Wt) mice used as control were littermates with homozygous for Per1-/- and Per2-/- 
mice. When heterozygote Per1+/- (or Per2+/-) were backcrossed together, we obtained 25% of Per1-/- 
(full knock-out), 50% Per1+/- (heterozygote) and 25% Per1+/+ mice. Wt mice from the same litter were 
used as control mice for Per1-/- and Per2-/- mice. Given the fact that is statistically too difficult to ob-
tain enough double knock-out (Per1,2-/-) and Wt mice in the same litter, I used a group of Wt animals 
composed by 50% from Per1 litter and 50% from Per2 litter. No statistical difference was observed 
among the 3 groups of Wt (Per1+/+, Per2+/+ and 50%Per1+/+ 50%Per2+/+) mice, and thus the datasets 
were merged. All mice were bred on site and maintained under standard animal housing conditions 
(food and water ad libitum, 12h-light/12h-dark cycle (LD), 23-25°C ambient temperature). All experi-
ments were approved by the cantonal veterinary office of canton Vaud.  
b. Genotyping 
Mouse ears were punched to have small piece of skin of about 0.3mm diameter and put in a sample 
with 350µl Tail buffer at pH=8 (50mM Tris-Cl, 100mM EDTA, 100mM NaCl, 1% SDS) supplemented 
with 300 µg of proteinase K (Promega, Madison, WI, USA). Then, tubes were vortexed and incubated 
Figure 24  Western blot analysis of PER2 protein 
in the forebrain and in the cerebral cortex. The 
PER2 protein was only observed in the Wt mice at 
the expected weight of 140 kDa, while no PER2 
protein was detected in Per2-/- mice in both fore-
brain and cortex. 
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overnight at 55°C expecting the total tissue dissolution. Subsequently, 175µl NaCl 6M was added at 
room temperature (RT), mixed energetically by hand, incubated 5min on ice and then centrifuged at 
>8000g 20min 4°C. The supernatant (450µl) was placed in a new tube with 50µg Ribonuclease A 
(Sigma-Aldrich, St.Louis, MO, USA) and incubated 15min at 37°C. Then, DNA precipitated adding 
450µl isopropanol at RT, gently mixed by hand and then centrifuged again at >8000g 20min 4°C. Sub-
sequently, supernatant was discarded and 800µl ice cold EtOH 70% was added. The tubes was centri-
fuged at >8000g 15min 4°C. Then the supernatant was discarded carefully taking care to not remove 
the DNA pellet. The tubes were completely dried at 55°C (take about 1h). 50µl TE buffer at pH=8 
(10mM Tris-Cl, EDTA 1mM) was added and incubated 1h at 65°C. After a quick spun, DNA quantifica-
tion was performed on a Nanodrop ND1000 (Wilmington, DE, USA) with a consistent 260/280 ratio 
between 1.8 and 2.1. DNA was diluated in nuclease free water to have a final concentration between 
10 and 20ng/µl. 
Then DNA was amplified by polymerase chain reaction (PCR). For each reaction, 2.5µl of the 
diluted DNA was supplemented with 0.125µl HotStar Taq DNA polymerase (5u/µl from Qiagen, Hil-
den, Germany), 2.5µl Buffer 10x containing MgCl2 15mM, 1µl dNTP (5mM each one) and 10pM of 
each four primers for a total reaction mix of 25µl. The Per1 PCR reaction was performed under fol-
lowing cycling conditions: 95°C for 15sec, followed by 35 cycles of 94°C for 1min, 58°C for 1min and 
72°C for 1min; to conclude at 72°C for 10min. For the Per2 PCR reaction, the annealing step tempera-
ture was fixed at 56°C instead 58°C. The primers sequences used can be found in table 5. Primers 
were purchased from Eurogentec (Seraing, Belgium). 
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Then loading buffer was added to PCR reac-
tions, before to be loaded on a 2% agarose gel 
with TAE buffer supplemented with Midori 
Green DNA Stain (10µl for 100ml, Nippon Ge-
netics, Dueren, Germany). As you can see in 
figure 25A, for the Per1 Wt fragment size ap-
peared at 400bp, while Per1 ko at 290bp. Per2 
Wt fragment size appeared at 310bp, while Per2 ko at 510bp (Fig.25B). 
c. Locomotor activity recordings and analyses 
Locomotor activity was recorded in both males and females of each genotype (Per1-/-, Per2-/-, Per1,2-/-
- and Wt; n=4/4, 21/11, 11/3, and 5/3, respectively, for males/females). All mice were between 11 
and 15 weeks old. Locomotor activity was measured using PIR sensor (Visonic, Tel Aviv, Israel) and 
recorded and analyzed with Clocklab (Natick, MA, USA). Animals were recorded for at least 12 days 
under standard LD conditions before being released to DD condition for at least 21 days to determine 
period length (tau, τ) of its “free running” circadian rhythm. Subsequently, LD conditions were rein-
stated to study re-synchronization of the free-running rhythms to the Zeitgeber. Presence and period 
of rhythms during freerunning were determined by a chi2-periodogram analysis (Clocklab) after re-
moving the first 3 days under DD [295, 296]. Periodogram analysis assesses the period of rhythmicity 
in a data set by fitting the data set to candidate periods within a specified range. To be defined as 
Table 5  Primers used for PCR genotyping 
Gene Genotype
Forward CCT CAC CTT AGC CTG TTC CTT CT
Reverse ACA ACT CAC TCA CCC TGA ACC TG
Forward TGA ATC TTT GTC AGC AGT TCC CT 
Reverse CTC ACC ATC ACT TTA TAC CCC CA
Forward TGG GAG GAA CTC TTG TAA GCA GA
Reverse AGC ATC ATG GCT GCA ACA CA
Forward TGT CTA AAG CAT CCC TAG CTG CT
Reverse GTT GGC TAC CCG TGA TAT TGC T
Sequence  (5’ --> 3’)
Per2
Per1
Per1
Per2
Wt
Ko
Wt
Ko
Figure 25  Per1 and Per2 genotyping samples. A Per1 Wt and ko 
fragments appeared at 400bp and 290bp, respectively. The first 
two lanes were full Wt mice, and the third was a heterozygote 
mouse. B Per2 Wt and ko fragments appeared at 310bp and 
510bp, respectively. The first lane was heterozygote mouse and 
the second was a full Wt mouse. 
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rhythmic, an animal must show a major and statistically significant (p<0.01) peak in the circadian 
range (24h ±4h) with periodogram analysis. Animals with only ultradian rhythms (shorter than 18h) 
or with many small significant peaks but with lacked a major significant peak in the circadian range 
were considered as arrhythmic. 
d. EEG and EMG surgery, monitoring and analyses 
EEG and EMG surgery and recording methods were previously described by Mang and Franken [32]. 
Briefly, from 10 to 13 weeks old Per1-/-, Per2-/-, Per1,2-/-, and Wt male mice (n=10, 9, 10, and 21, re-
spectively) were implanted with EEG and EMG electrodes under deep anesthesia done by 1ml/kg 
body weight intraperitoneal injection of a mixture containing 75mg/ml of ketamine (Ketazol-100, 
Graeub, Bern, Switzerland) and 10mg/ml xylazine (Rompun 2%, Provet, Lyssach, Swtitzerland) in 
0.55% NaCl. The mixture had to be protected from light and injected at least at 25°C.  
After making a longitudinal incision using a scis-
sor, along the midline of the scalp, the skull peri-
osteum was removed and skull was thoroughly 
cleaned with ethanol. It’s very important that at 
any time of surgery the cranium was clean and 
dry. Then five holes were drilled cautiously into 
the skull at precise location for the EEG screws 
and anchor screws (Fig.26). These latter were placed first, then two gold-plated screws EEG electrode 
were fixed in the right hemisphere. The frontal EEG electrode was placed at 1.7mm right from the 
midline and at 1.5mm anterior to the bregma; the parietal at 1.7mm right of midline and at 1.0mm 
anterior to lambda (Fig.26). This placement was chosen to ensure an optimal distinction between the 
different behavioral states [32]. The frontal electrode was sited over the frontal cerebral cortex to 
detect the slow waves oscillations (<5Hz) characteristic of NREM sleep. The parietal electrode was 
placed just over the hippocampal structure to capture the theta oscillation (5-7Hz) characteristic of 
the REM sleep. This bipolar acquirement permits to measure the potential difference between the 
Figure 26  Layout of electrode 
placements on mouse skull. 
Two EEG screws electrodes 
were positioned over the right 
cerebral hemisphere in red (F: 
frontal; P: parietal). Four an-
chor screws were represented 
in beige. Two EMG gold-wires 
were inserted into the neck 
muscle. Modified from Mang 
G.M. and Franken P. (2012) [32] 
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electrodes [33]. Then two gold-wires used as EMG electrodes were inserted into the neck muscle to 
record muscle tone. Adhesive resin (3M ESPE, Rüschlikon, Switzerland) was added to cover the elec-
trodes and to fix to the assembly to the skull. When the cement was exposed to UV light, the skin 
was stitched in front and in the back of the cement. Then a connector plug was soldered to the EEG 
and EMG electrode ends taking care that the solder does not short circuit any electrodes. Finally all 
visible contacts were covered with dental cement (Paladur, Heraeus Kulzer, Hanau, Germany). After 
surgery, mice were individually housed under standard conditions and were allowed a minimum of 
10 days of post-surgical recovery before to start the recording. EEG and EMG signals were recorded 
between 11 to 14 weeks of age.  
After two days of baseline, mice were sleep deprived for 6h between ZT0-6 (Zeitgeber time 
or ZT0 = light onset; ZT12 = dark onset usually coinciding with activity onset) by gentle handling 
[253]. The subsequent 18h were considered recovery. At least 6 days before the recording time, mice 
were connected to the recording leads which allows the mouse to habituate to the cable. This latter 
was connected to a swivel contact (3)  allowing the tethered animal to move unconstrainly as you 
can see in the schematic description in figure 27. The swivel connector was linked to a commutator 
which transfers the signal to the acquisition unit (Fig.27.4). In fact the recorded EEG and EMG signals 
were filtered, amplified, and analog-to-digital (AD) converted using Embla (Flaga, Reykjavík, Island) 
for hardware acquisition. To perform this AD conversion, the theoretically sampling rate should be at 
Figure 27  Schematic description of 
the experimental recording setup. 
The mouse has been implanted with 
EEG/EMG electrodes and connected 
to a head-mounted connector (1). 
The connector was attached to a 
recording cable (2) that is linked to a 
commutator (3) which transfers the 
signal to the acquisition unit (4). The 
processed signal is then transferred 
to a computer installed with a spe-
cific EEG/EMG acquisition and anal-
yses software (5). Drawing by La 
Spada F. in Mang G.M. and Franken 
P. (2012) [32] 
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least twice that of the frequency of the EEG activity of interest, although oversampling is recom-
mended. In fact, inappropriate filtering and sampling rates can lead to artifacts in sub sequent signal 
analysis. The signal was digitized at 2000Hz (i.e., a sampling interval of 0.0005 sec) and then down-
sampled at 200Hz and a high-pass filter at 0.0625 Hz was set to reject DC signal. A 50-Hz notch filter 
was used to eventual discard like-artefacts activity caused by interference from surrounding electri-
cal equipment. The processed signal was then transferred to a computer installed with a specific 
EEG/EMG acquisition and analyses software (Fig.27.5). The acquisition software used was Somnolog-
ica 3 (Embla). The EEG signal was transformed with a Discrete-Fourier Transformation (DFT) yielding 
power spectra between 0 and 100 Hz with a 0.25 Hz frequency and 4-sec time resolution (corre-
sponding to one epoch) [32]. We chose this window function of 4-sec which matches the resolution 
at which we determine behavioral state. By visual inspection of the digitized EEG and EMG traces, 
each 4s-epoch was classified as wakefulness, NREM sleep, or REM sleep (Fig.28). Artefacts were 
marked and removed from subsequent EEG analyses. 
  
Briefly, wakefulness is characterized by a small amplitude EEG signal with irregular signal coupled 
with high and variable muscle tone (EMG). NREM sleep is characterized by high amplitude and low 
frequency < 5 Hz EEG, while muscle tone is low. REM sleep is composed by very regular theta (6 to 
9Hz) waves, while its EMG signal is especially low flat (muscle atonia). However occasioned twitches 
can sometimes be observed.  
Figure 28  Example of EEG/EMG signals for wakefulness, NREM and REM sleep. During wakefulness, the 
EEG trace is composed of mixed frequencies, and muscle tone is present on the EMG. NREM sleep is charac-
terized by high amplitude and low frequency from 1 to 4 Hz in EEG, while muscle tone is low in EMG. During 
REM sleep, EEG shows regular theta waves (6 to 9 Hz) and EMG is flat except for rhythmic heart-rate artifact. 
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Time spent in each sleep-wake state was summed over the light period, the dark period and 
over 24h. To determine NREM sleep fragmentation, the amount of different time intervals of NREM 
sleep was accounted during 48h of baseline. Time intervals: 4sec, 8-12sec, 16-28sec, 32-60sec, 64-
124sec, 128-252sec, 256-508sec, 512-1020sec, >1024sec.  
EEG power spectra quantify the contribution of the various frequencies in EEG signal. EEG 
spectra were calculated for each behavioral state for each genotype for 48h of baseline. The fre-
quency range depends on the sampling rate (for instance a sampling rate of 200Hz, the full frequency 
range will be between 0-100Hz) and the frequency resolution depends on the window size (with a 4-
sec window the frequency resolution will be 0.25Hz). EEG spectral density analysis was limited to 
0.75 – 45.0Hz with a resolution 0.25Hz. Mean EEG spectra was calculated for each state by adding all 
the artifact-free 4-sec windows scored as that state, the power density in each frequency bin, and 
then dividing by the total number of windows obtained for each state and animal. It’s necessary to 
correct inter-individual differences in EEG amplitude by a normalization using a reference value, be-
cause absolute EEG values can vary due to e.g., electrode placement. To calculate such a reference 
value, EEG power was summed and averaged and the weighted according to the contribution of 
wakefulness, NREM sleep and REM sleep. The reference did not statistically vary with genotype (1-
way ANOVA; p = 0.89; Per1+/+ 30.4 ± 2.3; Per2+/+ 28.8 ± 3.1; Per1,2+/+ 28.8 ± 2.4). Note that the Per1,2-
/- group was reduced to n=9, as one mouse had to be rejected from this analysis due to a high num-
ber of EEG artifacts. 
EEG delta power was calculated as the power in only the 1 to 4Hz range. A time course of 
EEG delta power was constructed by selecting 12 intervals during the light period, 6 during the dark 
period, and 8 for sleep recovery in the light period, to which an equal number of 4s NREM sleep 
epochs contributed (i.e., percentiles). The number of intervals selected within a given recording sec-
tion was determined by NREM sleep prevalence. Besides NREM sleep EEG activity in the delta fre-
quency range, full EEG spectral profiles were calculated for each sleep-wake state over the 48h of 
baseline recording to assess genotype differences in the contribution of the various frequency com-
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ponents to rhythmic brain activity. Only EEG spectra of 4s-epochs in between two epochs of the 
same state and artifact free were included in the analyses.  
e. Gene expression in cerebral cortex and corticosterone quantification  
For the SD experiment, Per2-/- and Wt mice were sleep-deprived 6h by gentle handling [253] (be-
tween ZT0 and -6), then quickly anesthetized with isoflurane (Minrad Inc., Buffalo, NY, USA), and 
immediately sacrificed by decapitation at ZT6 together with the corresponding non-sleep-deprived 
control mice. Cerebral cortex were quickly harvested and immediately put in liquid nitrogen to be 
stored at -80°C. For the 12h time-course experiment, 4-6 Per2-/- and Wt mice were sacrificed every 
2h starting at ZT2 and ending at ZT14. At each time point, the cortical cortex was harvested and 
roughly 500µl of blood were supplemented with 10µl heparin (2units/µl) (Sigma-Aldrich) at 4°C; after 
centrifugation at 1700g for 5min, the plasma (supernatant) was recovered. Blood plasma were frozen 
in liquid nitrogen and stored at -80°C. 
Corticosterone levels in plasma blood were quantified by enzyme immune assay using a Cor-
ticosterone EIA kit (Enzo Life SciencesAG, Lausen, Switzerland) according to manufacturer’s instruc-
tions.  Test samples were diluted 40 times in the provided buffer and the optical density was meas-
ured with Safire2 (Tecan, Grödig, Austria) at 405nm using Magellan 6.6 software (Tecan).  
Total mRNA were extracted from 30mg of cortical tissue (if bigger, it was divided in two parts 
and pooled after purification) using the RNeasy Mini kit (Qiagen) following the manufacturer's proto-
col. Briefly, each sample was homogenized by pestle using 350µl of RLT buffer (supplemented with 
β–mercaptoethanol from Sigma-Aldrich instead DTT) on ice and passed on a QIAshredder column 
(Qiagen). Contaminating DNA was removed with DNase I (Qiagen). RNA quantification was per-
formed on a Nanodrop ND1000 with a consistent 260/280 ratio between 1.8 and 2.1. 
Reverse transcription from 500ng of RNA was performed using the SuperScript II Reverse 
Transcriptase (Invitrogen, Carlsbad, NM, USA) following manufacturer’s instructions. The comple-
mentary DNA (cDNA) was diluted 10 times in DNAse free water. Reactions without enzyme (NEC) and 
without the template (NTC) were performed in parallel as negative controls. 
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qPCR was performed according to the Applied Biosystems protocol using a 7900HT Fast Real-
time PCR System with SDS 2.3 software (Applied Biosystems, Foster City, CA, USA). For each reaction, 
7.2µl of the diluted cDNA was supplemented with 18µl FastStart Universal Probe Master 2x (Roche 
Diagnostic GmbH, Mannheim, Germany), 0.9µM of each primers and 0.25µM of probe for a total re-
action mix of 36µl. The qPCR was performed under standard cycling conditions (50°C for 2min, 95°C 
for 10min, followed by 45 cycles of 95°C for 15sec and 60°C for 1min). Each qPCR reaction was per-
formed in triplicate. The oligonucleotide sequences used can be found in table 6. Primers and probes 
were purchased from Invitrogen or Eurogentec and all probes were dual-labeled with 5'FAM/3'BHQ 
as fluorophore and quencher. Ribosomal protein S9 (Rsp9), eukaryotic translation elongation factor 
1A (Eef1a) and glyceraldehyde-3-phosphate dehydrogenase (Gapdh) were used as endogenous con-
trol genes (Fig.29) to normalize qPCR experiments.  Briefly, for every control gene we determined the 
pairwise variation with other two control genes as the standard deviation of the logarithmically 
transformed expression ratios, and defined the internal control gene-stability measure M as the av-
erage pairwise variation of a particular gene with all other control genes. The systematic variation 
was also calculated as the pairwise variation, V, for repeated RT-PCR experiments on the same gene, 
reflecting the inherent machine, enzymatic and pipet variation. M and V values had to be lower than 
0.5 and 0.2, respectively, to consider the housekeeping gene stable enough to be used as control 
genes [297]. Then the normalization factor calculation was based on the geometric mean of the 
three control genes. Geometric mean was chosen because its controls better for possible outlying 
Figure 29   Time-course of expression of house-keeping genes across 12 hours in the cerebral cortex. Relative expression of the house-
keeping genes Rsp9, Eef1a, and Gapdh in the cortex of Per2-/- and Wt mice across 12h starting at ZT2 at 2h intervals. For each time point 
4 to 6 mice were used. Data are presented as mean ±1SEM. White and grey areas represent light and dark period, respectively. For none 
of the transcripts was a significant effect observed (2-way ANOVA, factors ‘genotype’ and ‘ZT’ P=0.44; 0.49; 0.19, respectively). 
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values and abundance differences between the different genes [297]. Finally, the relative quantifica-
tion was calculated with a modified ΔΔCt method [298]. All stability calculation, normalization and 
quantification were performed using qbasePLUS 1.5 (Biogazelle, Machelen, Belgium).  
 
 
Gene Sequence  (5’ --> 3’) Accession
Forward CCT GGC AAG CCC ATG TGT
Reverse TCA TGT CAC GAA CAG CAA AGC
Probe TGA GAG CTT CTC TGA CTA CCC TCC ACT TGG T
Forward TCC ATG ACA ACT TTG GCA TTG
Reverse CAG TCT TCT GGG TGG CAG TGA
Probe AAG GGC TCA TGA CCA CAG TCC ATG C
Forward GAC CAG GAG CTA AAG TTG ATT GGA
Reverse TCT TGG CCA GGG TAA ACT TGA
Probe AAA CCT CAC GTT TGT TCC GGA GTC CAT ACT
Forward
Reverse
Probe
Forward
Reverse
Probe
Forward
Reverse
Probe
Forward ACC AGC GTG TCA TGA TGA CAT AC
Reverse CTC TCC CGG TCT TGC CTT CAG
Probe CCG TCC AGG GAT GCA GCC TCT
Forward ATG CTC GCC ATC CAC AAG A
Reverse GCG GAA TCG AAT GGG AGA AAT
Probe ATC CTA CAG GCC GGT GGA CAG CC
Forward GTT GGC CGG CTC TTC CA
Reverse CAA GAT CCT CAA GAC ACT GAA GCA
Probe CGT GGG CAT CAA CAG GTG GCG
Forward CCG CCT GGA CAA GCA CTT
Reverse GCA TTC ATC CGA GGT CTC TCA
Probe CGG AAG GCC TGG GTT GCC AAC T
Forward CGT GGA GGT GCT TAA TGA CCT TT
Reverse CAT GGC CTG GAA TGC TTG A
Probe AAC CTG ATC CCG CTG ATC TCG CC
Forward GCA TTG CCA TTT CCA CAT AGG
Reverse ATG AAC TTC CAT ATT TAT CCA CCT TAC TT
Probe ACA CAT TCA ATT CAG CAA TCA TGA
Dbp
Homer1a NM_011982.2
NM_016974.3
NM_010106.2
NM_001001303.1
NM_029767.2
Eef1a1
Gapdh
Rps9
Cry1
Cry2
Per1
Per2
Npas2
NM_011065.4
NM_009963.4
Bmal1 NM_007489.4
Clock
Mm00500226_m1 (Invitrogen)
NM_007771.3
NM_011066.3
NM_007715.5
NM_008719.2Mm00500848_m1 (Invitrogen)
Mm00455950_m1 (Invitrogen)
Table 6  Primers and probes used for quantitative PCR 
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f. Western blotting 
To verify the absence of PER2 in the brain of Per2 knock-out mice, both Per2-/- and Wt mice were 
quickly anesthetized by isoflurane inhalation and sacrificed by cervical dislocation at ZT16.5 and cor-
tical cortex or forebrain (that implies whole brain without cerebellum) were harvested. At this time, 
maximum expression of PER2 protein was expected [299, 300].Tissues were immediately immersed 
in gentleMACS tubes (Miltenyi Biotec, Bergisch Gladbach, Germany) containing ice cold RIPA buffer 
(5ml for forebrain, 2ml for cortex) supplemented with protease inhibitor cocktail (Roche, Mannheim, 
Germany), 1% NP40 (AppliChem, Darmstadt, Germany) and 1% sodium deoxycholate (AppliChem). 
Subsequently, tissues were grinded in a gradual manner for 35sec with Dispomix Drive (Medic tools, 
Zug, Switzerland). Then the tubes were gently spun on a wheel for 30min 4°C, centrifuged at 1700g 
20min 4°C, the supernatant was placed in a new tube and centrifuged again at >8000g 10min 4°C and 
finally the supernatant containing the total protein fraction was recovered. The protein concentra-
tion was quantified by BCA protein assay kit (Thermo scientific, Rockford, IL, USA) and the absorb-
ance was read on a Safire2 (Tecan) instrument using Magellan 6.6 software (Tecan). 90µg of protein 
were supplemented with Laemmli buffer 5x, heated at 95°C for 5min, loaded on a 6.5% SDS-page gel 
(BioRad, Mississauga, ON, USA) and transferred onto a PVDF membrane (Whatman, Sanford, ME, 
USA) [301]. Antibodies used were: α-PER2 rabbit antibody (1/1000; αPER2 antibody kindly provided 
by David Gatfield) and α-rabbit HRP-conjugated antibody (1/2000, P0448, Dako, Glostrup, Danmark). 
Membranes were revealed with Amersham ECL Prime Western Blotting Detection Reagent (GE 
Healthcare, Buckinghamshire, UK) and Amersham Hyperfilm ECL (GE Healthcare), and developed 
with a SRX-101A (Konica Minolta, Tokyo, Japan). 
g. Statistical analysis  
To evaluate statistical differences on time-spent-awake and -asleep, we performed a 1-way ANOVA 
with as main factor ‘genotype’ (Per1-/-, Per2-/-, Per1,2-/- and Wt). Post-hocs Holm-Sidak tests were 
used to contrast the results in knock-out mice to Wt. To evaluate the time course of waking, NREM, 
and REM sleep, and for the SD effect, we performed 2-way ANOVAs with the factors ‘genotype’  and 
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‘time’ (from ZT1 to 24 in baseline and from ZT6 to 24 in recovery period after a SD). For the compari-
son between all knock-out mice with the Wt at each ZT, Holm-Sidak was used as post-hoc tests. 
Within each genotype the effect of SD was also evaluated by performing t-tests between knockout 
and Wt mice for each 1h increment in order to assess the accumulation of the recovery-to- baseline 
differences in NREM sleep starting at ZT6 after the SD; i.e., the start of recovery sleep. NREM sleep 
fragmentation was determined using a 2-way ANOVA comparing all genotypes with different time 
intervals. Holm-Sidak was used as post-hoc test to compare all knock-out with Wt mice for each time 
interval. A 2-way ANOVA was performed to compare all genotypes with the ZT for the EEG delta 
power. Holm-Sidak was used as post-hoc test for the comparison between all knock-out and Wt mice 
at each ZT. The threshold for statistical significance was set to p<0.05 and the results are reported as 
mean SEM. A 2-way ANOVA was performed to compare Per2-/- and Wt mice with control and SD 
conditions for the effect on mRNA level in the cortex of the 6h period SD. Holm-Sidak was used as 
post-hoc test. A 2-way ANOVA was performed to compare Per2-/- and Wt mice as well as different 
time points (ZT). Holm-Sidak was used as post-hoc test for the time-course experiment monitoring 
corticosterone level and mRNA expression across 12h. Additionally, for the EEG spectral analysis, t-
tests were performed to compare power density measured for each frequencies bin of all knock-out 
mice to the Wt. All data were managed with Pascal and Microsoft Excel (Redmond, WA, USA), the 
statistical analysis and graphical representation were performed with SigmaPlot v12.3 (Systat Soft-
ware, Erkrath, Germany). 
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3. Results and discussion 
a. Per2-/- mice become immediately arrhythmic in DD despite dark-onset antic-
ipation in LD 
Circadian rhythms in locomotor activity were characterized in both male and female mice of the 4 
genotypes (Per1, Per2, Per1,2, and their Wt controls) (Fig.30 and 31). All mice were entrained to a 
12/12 light/dark (LD) cycle which was confirmed by periodogram analyses yielding a period length (τ) 
of 24h (Fig.30 HA LD). Under DD, Wt and Per1
-/- mice had a specific free-running pattern which allows 
the calculation of the endogenous τ. Within each genotype, sex did not affect the results (analyses 
not shown) and the datasets were therefore merged. It was previously reported that Per1-/- mice on 
a 129S7/SvEvBrd background had a shorter τ (22.6h ± 0.2) compared with Wt mice (23.7h±0.1) [165]. 
However, in our hands, the shortening of τ in Per1-/- mice on a C57BL6/J background were significant 
but not as marked (23.4h ±0.1, n=8) compared to Wt mice (23.8h ±0.0, n=14; p<0.05 t-test; 
Fig.30E,F). All Per1,2-/- mice became immediately arrhythmic under DD (n=8; Fig.30G, Fig.31G). Con-
firming previous observations, the double mutant Per1,2tm1Drw mice on a 129S4/SvJae background 
[197, 201]. Per2-/- mice on a C57BL6/J background have not been studied and only one publication 
mentioned that Per2-/- mice were similar to Per2tm1Brd mice (both on a mixed 129S7/Sv x C57BL6 
background) in that both lines had a short τ (22.1h) in the beginning of the DD and then became ar-
rhythmic after a range of 2 to 18 days.  
In stark contrast to Per2tm1Brd and Per2tm1Drw mice, 94% of Per2-/- mice kept under LD 12:12 be-
came directly arrhythmic when released under DD. 90.5% (n=21) of the Per2-/- males became and 
remained arrhythmic throughout DD (Fig.30A,C). Only two male Per2-/- mice did not follow in this 
pattern; one displayed a circadian rhythm of short period throughout DD (τ=22.8h; Fig.30D) with ac-
tivity onset free-running from the activity onset during LD12:12, while a second male maintained an 
unusual circadian component of wild-type period length (τ=23.7h) but of small amplitude  with activi-
ty onset not following activity onset observed during the preceding LD12:12 but about 5h earlier (at 
ZT5 instead ZT10; Fig.30B). Apparently, Per2-/- mice on a C57BL/6J background had a stronger pheno-
type that Per2tm1Brd in 129S7/Sv x C57BL6 mixed background. Moreover, Per2tm1Brd mice showed an 
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earlier locomotor activity onset before the dark period under LD 12:12 conditions. Both male and 
female were used without distinction [199]. This advanced locomotor activity onset was also found in 
our Per2-/- mice under LD12:12 in both sexes without statistic distinction (2-way ANOVA, factors 
‘genotype’ and ‘sex’; genotype effect: p<0.001), and was set at ZT=10.6 ± 0.1h (n=32) in the mice; 
i.e., advanced by about 1.5h (p<0.001 with Holm-Sidak as post-hoc test) compared to Wt, Per1-/- and 
double knock-out mice for witch the following activities onset values were found ZT=12.0±0.0 (n=14), 
ZT=12.3±0.1 (n=8), and ZT=12.7±0.1 (n=8), respectively. 
b. Rhythmicity could be triggered Per2-/- female 
100% (n=11/11) of the females became completely and immediately arrhythmic upon release into 
DD. Surprisingly, they became rhythmic at the same time with a short τ (21.9±0.2, n=6; Fig.31A,B) 
throughout the remainder of DD after several days under DD. Only in one female we observed sec-
ond loss of rhythmicity (Fig.31C). The event triggering this rhythmicity was associated with checking 
the status of the mice under DD. The trigger signal could be one of many; e.g., fresh food, noise, 
odor, red dim light (Fig.31A,B,C). When female mice were not disturbed, they remained arrhythmic 
until the end of the DD (n=4; Fig.31D). To conclude, Per2-/- males and undisturbed Per2-/- females 
maintained arrhythmicity throughout DD despite the fact that they seem able to anticipate the dark 
onset under LD12:12 conditions and that when disturbed, females could display self-sustained 
rhythm. The 1.5h earlier onset under LD is consistent with an intrinsic period of 22h observed in fe-
males and the 1 male although, this rhythm under LD cannot be considered circadian because it is 
not self-strained.  
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Figure 30  Actograms of Per knock-out male mice under LD12:12 and DD conditions. A-G. The locomotor activity is represented in 
black and double-plotted. Mice were kept on a LD cycle (time of lights off indicated by grey shading) and then put in constant dark-
ness (DD) for a minimum of 21 days and finally put again in LD. A,C Activity record of two representative Per2-/- mice (19 out of 21) 
that became immediately arrhythmic under DD. B,D Two unexpected Per2-/- mice that displayed circadian components. E,F,G Activ-
ity record of a representative Wt (E, τ=23.8h), Per1-/- (F, τ=23.6h), and Per1,2-/- mouse (G, arrhythmic). All mice had a period (τ) of 
24h in LD. H panel. Chi2 statistical graphics determined with at least 8 days for LD and 18 days for DD. Total number of male mice 
recorded: Per1-/- (n=4), Per2-/- (n=21), Per1,2-/- (n=11) and Wt (n=5).  
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Figure 31  Actorgrams of Per knock-out female mice under LD12:12 and DD conditions. A,B Activity recordings of two repre-
sentatives Per2-/- females that became immediately arrhythmic in first part of the DD (11 out of 11) and thereafter became 
rhythmic with a τ of roughly 22h . C One Per2-/- female became immediately arrhythmic under DD for 7 days, and then be-
came rhythmic (τ=22.2h) for 7 days and again arrhythmic for the last 8 days. D If Per2-/- females were not disturbed (no feed-
ing and health check) mice remained arrhythmic throughout DD. E,F,G Activity record of a representative Wt (E, τ=23.8h), 
Per1-/- (F, τ=23.4h), and Per1,2-/- mouse (G, arrhythmic). All mice had a period (τ) of 24h in LD. H panel. Chi2 statistical graphics 
determined with at least 7 days in DD for mice in panels A-D. Some DD period was split in two or three parts when the 
rhythms appeared, and were numerated DD1,-2 or -3. Total number of mice recorded: Per1-/- (n=4), Per2-/- (n=11), Per1,2-/- 
(n=3) and Wt (n=3). See figure 25 for further details. 
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c. Clock genes and corticosterone advance of 2h in Per2-/- mice 
To verify whether the advance of activity onset under LD12:12 conditions was paralleled by an ad-
vance of their circadian markers we determined clock gene expression in Per2-/- mice in cerebral cor-
tex over a 12h time span covering activity onset in Per2-/- mice; i.e. ZT2-14.. I quantified the expres-
sion of Bmal1, Clock, Npas2, Cry1, Cry2, Per1, and Per2, as well as the controlled clock gene Dbp, the 
circadian marker corticosterone and the molecular marker of sleep intensity Homer1a transcript [45, 
158].  
In the brain, Bmal1, Clock and Npas2 usually peak at ZT0-6 and reach minimum levels at 
ZT12-16 [302, 303]. Per1, Per2, Cry1, Cry2, and Dbp, on the other hand, are usually more or less in 
antiphase peaking at ZT12-16 and reaching minimum levels at ZT6, except for Dbp at ZT0 [48, 242, 
302, 304] (Fig.32). Homer1a followed sleep-wake distribution decreasing progressively from ZT0 to 
ZT12 when animals predominantly sleep and increasing form ZT12 to ZT14 when mice are most ac-
tive and awake [45, 48] (Fig.35A).  Although I only sampled half of the 24h cycle, preferring to pro-
mote the resolution instead a large scale, the observed time course fits well those described by oth-
ers. 
With the exception of Clock, all the time course of all transcripts differed between Per2-/- and 
Wt mice (2-way ANOVA, factors ‘genotype’ and ‘ZT’, Fig.32 upper panel) and levels differed at many 
points (Bmal1 at ZT 2,4,10,12,14; Npas2 at ZT2,4,14; Per1 at ZT12,14; Cry1 at ZT 0,6,8,10,12,14; Cry2 
at ZT6,12; Dbp at ZT2,4,6,12,14; and Homer1a at ZT4,12,14 (p<0.05 with Holm-Sidak as post-hoc). 
Per2 was not detected in Per2-/-mice.  
Despite all these differences, in both genotypes mRNA expression followed a similar curve. 
Assuming, based on the earlier activity onset (Fig.35A), that in Per2-/- mice also the mRNA changed 
were advanced by about 2h, delaying the Per2-/- mice data by 2h should yield a better match with the 
Wt time course. The curves for Bmal1, Clock, Npas2, Cry2, Dbp, and Homer1a now matched for the 
two genotypes (Fig.32 lower panel) and statistical differences were no longer observed for Npas2 
and Cry2. Some statistically changes were noted between Per2-/- and Wt mice (2-way ANOVA, factors  
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Figure 32  Time-course of mRNA expression concentration in cerebral cortex across 12 hours in Per2-/- and Wt mice. Upper panel 
Relative expression of Bmal1, Clock, Npas2, Per1, Per2, Cry1, Cry2, Dbp and Homer1a across 12 hours started at ZT2 and finished at 
ZT14 with a point every 2h in cerebral cortex of Per2-/- (red) and Wt (grey) mice. 2-way ANOVA: factors 'genotype' and 'ZT', interac-
tion: p<0.001 for all gene except for Cry2 (p<0.05) and Clock. *: p<0.05 with Holm-Sidak as post-hoc test between Per2-/- mice and 
Wt. For each point 4 to 6 mice were used. Lower panel Comparison between Wt and Per2-/- 2h-delayed data. Relative expression of 
Bmal1, Clock, Npas2, Per1, Per2, Cry1, Cry2, Dbp and Homer1a across 12 hours started at ZT2 and finished at ZT14 with a point every 
2h in cerebral cortex. The data for Per2-/- mice were delayed of 2h and being compared with Wt mice. Two-way ANOVA: 'genotype'-
‘ZT', with interaction (p<0.03) for all gene except for Clock, Cry2, Npas2, Rsp9, Eaf1a and GADPH. *: p<0.05 with Holm-Sidak as post-
hoc test between Per2-/- mice and Wt. For each point 4 to 6 mice were used. Controls genes (Rsp9, Eaf1a, Gapdh) were reported in 
Fig.29 
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‘genotype’ and ‘ZT’; Fig.32 lower panel) for instance Bmal1 at ZT14; Per1 at ZT14; Cry1 at ZT6,8,14; 
Dbp at ZT4,10; and Homer1a at ZT4,14 (p<0.05 with Holm-Sidak as post-hoc). Despite these statistical 
changes the curve tendency was in complete accordance between the genotype in Bmal1, Dbp and 
Homer1a. Per1 and Cry1 matched also but it seems that they possessed lower amplitude and mini-
mal vales reached seem higher in the Per2-/- mice. However to confirm this assumption, a complete 
24h cycle should have been sampled. A reduction in the amplitude of Per1 transcript oscillation was 
also observed in the Per2m/m mice of a previous study [197, 199]. We also hypothesized that there is 
also a phase advance at the molecular level due to a shorter period in the Per2-/- mice. 
To have an idea if this advance of the circadian machinery at the molecular level was also present at 
the physiological level, I looked at the time course of plasma corticosterone levels. I chose this hor-
mone because it is important glucocorticoid expressed in a circadian manner with a very stable peak 
reaching between ZT10-12 just before the dark onset and can set phase of circadian clock [48, 305]. 
Peak cortisol level is used in human studies as a circadian phase marker [306, 307]. 
Wt mice showed the predicted time course reaching maximum levels at ZT12 directly fol-
lowed by a  rapid decrease again reaching low levels at ZT14 (Fig.33A). Per2-/- mice shown a different 
distribution peaking at ZT10 followed again by a rapid decrease (2-way ANOVA: factors 'genotype' 
A B 
Figure 33  Time-course of plasma corticosterone concentration across 12 hours in Per2-/- and Wt mice. A Corticosterone meas-
urements (mean +-SEM) started at ZT2 and finished at ZT14 with a 2h resolution. 2-way ANOVA: factors 'genotype' and ‘ZT', inter-
action: p<0.001. *: p<0.05 with Holm-Sidak as post-hoc test between Per2-/- and Wt mice. B Comparison between Wt and Per2-/- 
2h-delayed data. Corticosterone concentration across 12 hours started at ZT2 and finished at ZT14 with a point every 2h in plasma 
blood. The data for Per2-/- mice were delayed of 2h and been compared with Wt mice. There is no statistical difference by 2-way 
ANOVA: factors 'genotype' and ‘ZT' between Per2-/- and Wt mice. 
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and 'ZT'; interaction: p<0.001; red star: p<0.05 with Holm-Sidak as post-hoc test; Fig.33A). If the Per2-
/- data were also delayed by 2h as the mRNA expression shown above, an almost perfect match was 
observed (Fig.33B) suggesting that also this circadian marker was advanced of 2h in mice lacking 
Per2. Nevertheless, the amplitude seemed to be reduced in the Per2-/- mice.  Together these three 
data sets (behavior, molecular, and hormonal changes) demonstrate that the circadian machinery is 
coherently advanced in Per2-/- mice in accordance with the shorter period length observed in 
females and in one males. The big unanswered question is why Per2-/- mice become arrhythmic 
when during the preceding LD12:12 a circadian rhythm appear to be present.  
d. How can an arrhythmic mouse anticipate dark onset? 
To understand this paradoxical phenotype, the following hypothesis could be forwarded. It is possi-
ble that in the Per2-/- mice under LD12:12 conditions light onset  initiates a rhythm each day of about 
22h, but that this rhythm is not self-sustained; i.e. light driven, because rhythmicity is lost immedi-
ately when light is not present. To test this idea we performed two experiments. First we verified 
whether the earlier activity onset is associated to dark onset (i.e., anticipation) or to light onset (light 
driven) by delaying dark onset by 6h thus extended the photoperiod from 12h to 18h (LD 18:6). If 
light driven, we expect activity onset to stay close to ZT10. If, on the other hand, activity onset results 
from truly entrained circadian rhythm, activity onset would trail the new dark onset time and thus 
delay by about 6h. Wt mice had an activity onset under LD 12:12 at ZT12.0h±0.0 (n=3) and at 
ZT17.9h±0.0 under LD 18:6 as can be seen in the upper half of figure 34 (experiment 1). They be-
haved as expected from mice with a true circadian clock and needed about 4 days to re-entrain activ-
ity onset (first blue line) to dark onset. The activity onset of Per2-/- mice was set at ZT10.80±0.2 
(green line, n=5) under LD 12:12 and shorter than that observed in Wt mice (2-way Anova; factors 
‘genotype’ and ‘photoperiod’; with both genotype, photoperiod effect and interaction: p = <0.001), 
while the new activity onset of Per2-/- mice in LD18:6 was set at ZT12.2±0.2 (pink line); i.e., 2h later 
than the expected ZT10 (green line) but not as much as expected when it was associated with the 
dark period onset at ZT18.  
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 In the second experiment, the same mice were re-entrained to standard LD12:12 conditions 
and thereafter put under DD for 48h and then exposed to an inverted LD12:12 cycle. The expectation 
here is that if the rhythm in Per2-/- mice is light driven, we expect to have an activity onset again at 
ZT10 (old ZT22 on the axis; pink line) from the first day. If truly circadian we expected that mice 
needed several days of adaptation before to be able follow new schedule as Wt mice (represented by 
the blue line, figure 34 experiment 2). The results support the light driven hypothesis. In fact activity 
onset of the first day of the new schedule was set at ZT10.5±0.1 in Per2-/- mice. These two experi-
ments show that despite the fact that Per2-/- male mice the 2h advance of activity, clock gene expres-
sion, and corticosterone do not result from a self-sustained functional circadian clock, but is associ-
ated with light onset and thus per definition not circadian [97]. 
Figure 34  Effect of lengthening the photoperiod and inverting the LD schedule on activity onset in Per2-/- mice. In experiment 1: mice 
were kept on a LD cycle (12:12; dark periods indicated by the grey bars behind actograms) for the first 4 days and then put under LD18:6 
for 12 days. In experiment 2: same mice were kept under LD12:12 and then put in constant dark condition for 48h and then submitted 
to an inverted LD12:12 cycle (light onset at old ZT12) for at least 7 days. The important locomotor activity at ZT6 on day 25 followed 
delivery of fresh food. A Actogram of one representative Per2-/- male mouse with activity onset (green lines) at ZT10 under LD12:12, at 
ZT12 (rose line in experiment 1) under LD18:6, and ZT22 (new ZT10; rose line in experiment 2) under the inverted LD12:12 cycle. B Activ-
ity record of one representative Wt male mouse. When the schedule is modified, Wt mice need several days of re-entrain activity onset 
(blue lines). Total number of mice recorded: Per2-/- (n=5) and Wt (n=3). 
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e. Altered sleep-wake state distribution in Per knock-out mice 
The distribution of each the three sleep-wake state wakefulness, NREM sleep and REMS sleep was 
computed across the two baseline days. Sleep analyses are a so intensive labor that only male mice 
were investigated. The overall distribution over the day was similar among the 4 genotypes with 
sleep being more prevalent in the light phase of the LD12:12 cycle and wakefulness being prevalent 
during the dark (Fig.35). Nevertheless, the time course and duration of the 3 sleep-wake states im-
portantly varied with genotype (2-way ANOVA, factors ‘genotype’ and ‘ZT’; interaction: p<0.001; 
Fig.35). 
 
Of the numerous differences I observed in this distribution, I will here focus specifically the effects of 
genotype on NREM sleep. Its main periods of wakefulness are at the first 6h from the begging of dark 
period and the last 2h of just before the dark light transition. In contrast to humans that have one 
consolidated bout of sleep (monophasic), Wt mice have many sleep episodes during 24h (poly-
phasic). A ‘nap’ normally appeared in the second part of the dark period in C57BL6/J [36]. As previ-
ously described by Kopp et al. using the same Per1 knock-out mice also on a C57BL6/J genetic back-
A B 
C 
Figure 35 Sleep-wake states across baseline in Per 
knock-out mice. Time-course of waking (A) NREM 
sleep (B) and REM sleep (C) across 24h baseline (mean 
of two days) in Per1-/- (blue, n=10), Per2-/- (red, n=9), 
Per1,2-/- (green, n=10) and Wt (dark grey,n=21) mice 
under LD12:12 conditions (ZT0 = light onset). Each 
point is the mean value (in minutes ±SEM) for 1h 
intervals. 2-way ANOVA, factors ‘genotype’ and ‘ZT’; 
interaction: p<0.001 for waking, NREM sleep and REM 
sleep.  or : p<0.05 with Holm-Sidak as post-hoc 
test between knock-out mice and Wt. 
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ground [203], after the first 3h of the dark period Per1-/- (n=10) mice showed an increase the NREM 
sleep during 3h followed by an important fall (p<0.05; Fig.35B). It thus seems that the nap was ad-
vanced by about 3h compared to Wt (n=21) mice. Otherwise, no large differences in the NREM sleep 
distribution between Per1-/- and Wt mice in the light period. Note that contrast to what was been 
reported previously in our Per1-/- mice where no NREM sleep increase was observed prior to the 
light-dark and dark-light transitions [203]. Furthermore, the amount of each sleep/wake state (table 
7) and NREM sleep and REM sleep fragmentation were not affected in Per1-/- mice (Fig.36). 
 
Baseline sleep in Per2-/- mice (n=9) displayed, as was already observed in Per2m/m mice [203], an earli-
er onset of the main wake bout before the dark onset. The wakefulness onset in Per2-/- mice was 
ZT=9.9 ± 0.2h (n=9); i.e., advanced by about 2h (Kruskal-Wallis One Way, factor ‘genotype’: p<0.05) 
compared to Wt, Per1-/- and double knock-out mice, which had values set at ZT=12.0±0.0 (n=21), 
12.0±0.1 (n=10), and ZT=11.8±0.1 (n=10), respectively. These results confirm the locomotor activity 
onset results described above. Moreover, wake onset appeared 43min before locomotor activity on-
set (t-test, p<0.01) in Per2-/- mice. In addition, Per2-/- mice was a relevant increase of the NREM sleep 
in the first half of the dark period due to its earlier and shorter wake period (p<0.001; Fig.35B). Nev-
ertheless, the total amount of the NREM sleep did not differ from Wt mice although a decrease in 
total amount of wakefulness was revealed (p=0.029, table 7). This decrease in wakefulness was bal-
anced by an increase in total amount of REM sleep (p=0.015) whose the hourly main values appeared 
at the dark-light transition (p˂0.05, Fig.35C).  
Table 7  Summary table of sleep-
wake state amounts (in min) for the 
12h light period, 12h dark period, and 
24h for all genotypes. The mean of 
two days was used (SEM). 1-way 
ANOVA: factor ‘genotype‘for Wake, 
NREM sleep and REM sleep: p<0.001. 
 or : p<0.05 with Holm-Sidak as 
post-hoc test between knock-out and 
Wt. Number of mice used: Per1-/- 
(n=10), Per2-/- (n=9), Per1,2-/- (n=10) 
and Wt (n=21). 
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Per1,2-/- mice (n=10) had an increase in the total time spent in NREM sleep in baseline 
(p=0.002), due to an excess of NREM sleep during most of the dark period compared with to Wt mice 
(p<0.05 with Holm-Sidak as post-hoc test; Fig.35B; p<0.001 with Holm-Sidak as post-hoc; table 7). 
Previous studies found no statistical changes in sleep amount among Per1-/-, Per2m/m, Per3-/-, 
Per1,2m/m and Wt mice on a 129S4/SvJae background and between Per1-/- ,Per2m/m  and Wt mice on a 
C57BL6/J background, both under LD cycle [201, 203]. Per1,2-/- mice thus show a stronger phenotype 
compared with Per1,2m/m mice [201]. 
f. NREM sleep is fragmented in mice lacking Per2 
Besides sleep duration, I was also interested in quantifying and comparing the quality of sleep among 
genotypes and therefore analyzed episode duration of the three sleep/wake states. Both Per2-/- and 
Per1,2-/- mice had more short NREM sleep episodes (between 8 to 60 seconds length) (2-way ANOVA, 
factors 'genotype' and 'episode length'; interaction: p<0.001; p<0.03 with Holm-Sidak as post-hoc 
test; Fig.36 upper panel). In addition, in both Per2-/- and Per1,2-/- mice more of the total NREM sleep 
was spent in shorter episodes (significant for 32 to 60s categroy) and less in long episodes (128 to 
252s) (2-way ANOVA: factors 'genotype' and 'episode duration'; interaction: p<0.001; p<0.001 with 
Holm-Sidak as post-hoc; Fig.36 middle panel). Similarly, both Per2-/- and Per1,2-/- mice were unable to 
sustain long waking episodes (>1024s) a category in which most time spent awake occurs (2-way 
ANOVA: 'genotype' and 'length time'; interaction: p<0.001; p<0.001 with Holm-Sidak as post-hoc; 
Fig.36 lower panel). No genotype changes were observed for REM sleep episodes (not shown). To 
resume, these findings show that Per2 specifically is needed for the consolidation of NREM sleep and 
wakefulness a phenotype not reported on earlier.  
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g. Quantitative EEG spectral profile in Period knock-out mice  
In the previous section we make use of EEG analysis to determine sleep-wake state distribution, du-
ration and consolidation, to get a fine architecture of sleep and wakefulness. However, EEG signal 
itself contains valuable information concerning rhythmic brain activity that can be quantified (qEEG) 
using spectral analysis  
To reminder the reader, the EEG during wakefulness in Wt mice encompasses a variety of 
behaviors, each with their characteristic EEG pattern. For instance, during drowsiness delta waves 
(1–4Hz) can intrude, during an exploratory behavior theta waves (5–9Hz) are characteristic, during 
quiet wakefulness with eyes closed alpha waves (8–12 Hz) were typical, and during the attention 
process gamma waves (>30Hz) were prominent [7, 35]. The EEG pattern of NREM sleep is character-
ized by a widespread synchronous activity in the delta (1–4Hz) frequency range and by spindle oscil-
lations in the sigma (12–15Hz) range [34, 36]. The structures implicated in the generation of these 
two mutually exclusive rhythms include the thalamus and the entire cerebral cortex [308]. The EEG 
profile of REM sleep is characterized by theta oscillations (4–12Hz) that can be observed in several 
regions of the limbic system, including the septum where it is thought to be generated [309, 310]. 
Figure 36  Distribution of episode dura-
tion for NREM sleep and wakefulness Per 
knock-out mice. Upper panel Relative 
frequency distribution of NREM sleep 
episode duration (4sec to >1024sec) dur-
ing 48h baseline. Values were expressed 
per h of NREM sleep. 2-way ANOVA; 
factors 'genotype' and 'episode duration'; 
interaction: p<0.001. *: p<0.001 with 
Holm-Sidak as post-hoc test between 
knock-out and Wt mice. Middle panel 
NREM sleep time spent in each category 
as % of total time spent in NREM sleep. 2-
way ANOVA; factors 'genotype' and ’epi-
sode duration'; interaction: p<0.001. *: 
p<0.001 with Holm-Sidak as post-hoc test 
between knock-out and Wt mice. Lower 
panel Same as middle panel for wakeful-
ness. 2-way ANOVA: factors 'genotype' 
and 'episode duration'; interaction: 
p<0.001. *: p<0.001 with Holm-Sidak as 
post-hoc test between knock-out and Wt 
mice. Number of mice used: Per1-/- (blue, 
n=10), Per2-/- (red, n=9), Per1,2-/- (green, 
n=10) and Wt (dark grey, n=21). 
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Both REM sleep and wakefulness  are  considered   activated   brain   states   that   share common  
EEG characteristics, such as the absence of delta and  spindle  activity and   the presence of coherent   
gamma  activity ( >30Hz) [34-36].    
During waking, Per2-/- mice showed an important increase in the β range (15-30Hz), while 
Per1,2-/- mice  had a decrease in the γ range (30-45Hz) compared to Wt mice (p<0.05, t-tests; Fig.37). 
β and γ range are a prominent feature of the EEG during quiet wakefulness [34]. No statistical chang-
es were observed among genotypes for the θ range (5-10Hz) that is associated exploratory behavior, 
learning and memory and which, in rodents, also dominates the EEG during REM sleep [34]. 
 
Concerning the NREM sleep EEG, only Per2-/- mice showed consistent deviations from Wt 
mice having a decrease in δ range (2-4Hz). δ oscillations are typical of deeper stages of NREM sleep 
and reflect the sleep homeostatic process [26]. Moreover EEG activity in the β range was increased in 
Per2-/- mice. These two EEG effects combined with their fragmented NREM sleep point a more super-
ficial NREM sleep and increased cortical arousal. Note that unusual higher β activity during NREM 
Figure 37  EEG spectral profiles of 48h baseline for each genotype. Upper panels EEG spectral profiles under 48h baseline conditions aver-
aged for all 4s epochs scored as Waking (Left), NREM sleep (Middle), or REM sleep (Right) for Per1-/- (n=10), Per2-/- (n=9), Per1,2-/- (n=9), and 
Wt mice (n=21). Lower panel Average EEG spectra normalized to total EEG power. Significant genotype differences are indicated by colored 
bars (p<0.05, by t-tests). Spectral differences as percent change for Per1,2-/- versus Wt mice (in γ range for waking state) and more especially 
in Per2-/- versus Wt mice (in all vigilance state). The reference is statistically similar for each genotype permitting the statistical comparison 
between them (see material and method). 
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sleep is also characteristic of NREM sleep in humans suffering of primary insomnia often attributed 
to increased cortical arousal [50]. 
Per2-/- mice has significant spectral differences in REM sleep. However, together with Per1,2-
/- mice had not important changes in the θ range. In rodent, these frequencies were generated within 
the hippocampal network [311]. Nevertheless in both Per2-/- and Per1,2-/- mice the peak in theta ac-
tivity was faster than in Wt mice (p<0.001, p=0.005 respectively by t-test). These delays were respon-
sible of the huge spike in the ratio graphic. 
h. Per2-/- and Per1,2-/- mice sleep less after a sleep deprivation  
To study the implication of Per genes in the sleep homeostasis, we investigated the response to 6h of 
sleep deprivation (from ZT0-6) both in terms of sleep intensity and duration. In this section, I ana-
lyzed the impact on time spent asleep. Both amount and distribution of NREM and REM sleep were 
differently affected by the SD according to the genotype (1-way ANOVA, factor ‘genotype’, p<0.05; 2-
way ANOVA, factors ‘genotype’ and ‘ZT’; interaction: p<0.001). The effects of SD on NREM and REM 
sleep in Per1-/- mice did not differ from the observed in Wt mice. In both genotypes both NREM and 
REM sleep increased from the end of SD and were predominant until the end of the recovery light 
period, then minimum level was reached followed by a second increase from the 3rd hour of the dark 
recovery period, to finally decrease again before the dark-light transition (Fig.38A,B). Moreover the 
NREM and REM sleep amount between Per1-/ - and Wt mice did not differ (table 8). To better appre-
ciate the recovery dynamics, I determined the hour-by-hour accumulation of the recovery-to-
baseline differences in sleep amount after the SD (Fig.38C,D). This analysis revealed that despite dif-
ferences in distribution of sleep in baseline and during recovery between Per1-/- Wt mice their re-
spective recovery patterns overlapped, indicating that lack of Per1 does not affect the homeostatic 
regulation of sleep duration. 
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Lack of Per2 did affect the recovery dynamics of time spent asleep. In the first 5h of recovery 
sleep Per2-/-  and Per1,2-/- mice accrued less NREM and REM sleep compared to corresponding hours 
in baseline or, in other words, during the recovery light period animals further increased their sleep 
debt. For instance at ZT11 Per2-/- mice accumulated an extra deficit of 22.4min±5.5 of NREM sleep 
compared to their own baseline and 35.9min±4.1 compared to Wt mice (Fig.38C). This was confirmed 
by smaller total amount of NREM and REM sleep both in Per2-/- and Per1,2-/- mice compared to Wt 
mice (p<0.001 ; table 8) during the light recovery period. From ZT11 onwards, Per2-/- and Per1,2-/- 
Figure 38  Effect of 6 hours of sleep deprivation (SD) on sleep in Per knock-out mice. A,B. Effects of SD on NREM sleep (A) and 
REM sleep (B) in Per1-/-, Per2-/-, Per1,2-/- and Wt mice. Each point is the mean value in minute ±SEM for 1h intervals. 2-way 
ANOVA, factors ‘genotype’ and ‘ZT’; interaction: p<0.001.  or : p<0.05 with Holm-Sidak as post-hoc test between knock-out 
and Wt mice. C,D. Accumulation of recovery-baseline differences in NREM sleep (C) and REM sleep (D) starting at ZT6 (the end 
of the SD) and calculated with 1h increments for 18h. Each point is the mean difference ±SEM. : p<0.05 by t-test between 
knock-out and Wt mice. Number of used mice: Per1-/- (blue, n=10), Per2-/- (red, n=9), Per1,2-/- (green, n=10) and Wt (dark grey, 
n=21). 
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mice gain extra NREM sleep but the recovery curves ran largely in parallel to that of Wt mice indicat-
ing that this initial extra loss was not compensated for thereafter. Moreover, both Per2-/- and Per1,2-/- 
mice expressed higher levels of NREM and REM sleep amount compared to Wt mice in the dark re-
covery period (p<0.001 ; table 8). Interestingly, REM sleep seemed to be compensated to a larger 
extend in Per2-/- mice specifically with significant difference reaching at ZT22-23. In absolute terms 
Per2-/- mice spent 1.8-fold more REM sleep in the recovery dark period as compared to Wt mice. This 
increase was so large that REM amount of all recovery period remained higher Per2-/- compared to 
Wt mice (p=0.01 ; table 8).  These results support the notion that Per2 is needed to adequately com-
pensate the loss of NREM sleep after SD.  
i. Homeostatic control of EEG delta power seems not affected by a lack of Per2 
Above I showed that mice lacking PER2 had impaired homeostatic regulation of NREM sleep dura-
tion. Here, I analyzed the impact of the SD on another aspect of NREM sleep homeostasis; i.e., the 
sleep intensity.  I quantified the intensity or depth of NREM sleep by calculating EEG delta power. 
Most of the variance in the changes in EEG delta power can be explained by the sleep-wake distribu-
tion [48]. EEG delta power during NREM sleep is high after periods of extended waking and SD, and 
decreased during intervals where NREM sleep is prevalent [46]. In all four genotypes, EEG delta pow-
er decreased progressively from the beginning of the light period at ZT0 in baseline to the light-dark 
transition and then increased to reach the maximum level during the dark period (Fig.39). After the 
SD, EEG delta power reached the highest level and then decreased in an exponential manner. Despite 
the general similarity among genotypes, the time course of EEG delta power (2-way ANOVA, factors 
'genotype' and 'ZT'; interaction: p<0.001) as well as the EEG delta power quantified immediately dur-
Table 8  Summary table of sleep-wake 
state amounts during the recovery (in 
min) for the 6h light period, 12h dark 
period, and 18h for all genotypes. The 
mean of two days was used (SEM). 1-way 
ANOVA: factor ‘genotype‘ for Wake, 
NREM sleep and REM sleep: p<0.001.  
or : p<0.05 with Holm-Sidak as post-
hoc test between knock-out and Wt. 
Number of mice used: Per1-/- (n=10), 
Per2-/- (n=9), Per1,2-/- (n=10) and Wt 
(n=21). 
 
Per1
-/-
Per2
-/- 
Per1 ,2
-/- Wt
Wake [min] 110 (4) 195 (8)  162 (6)  114 (3)
NREM [min] 218 (5) 143 (7)  176 (5)  214 (3)
REM [min] 32 (2) 22 (3)  22 (2)  32 (1)
Wake [min] 476 (15) 374 (11)  368 (7)  461 (12)
NREM [min] 219 (14) 291 (9)  307 (8)  228 (10)
REM [min] 26 (2) 56 (4)  46 (3)  31 (2)
Wake [min] 586 (15) 567 (15) 530 (9)  575 (11)
NREM [min] 437 (15) 433 (13) 482 (9) 442 (10)
REM [min] 58 (4) 78 (6)  68 (4) 63 (2)
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ing the first 20min after the SD differed, among genotypes (1-way ANOVA, factor ‘genotype’, p= 
0.027). Small but significant changes (p<0.05 with Holm-Sidak as post-hoc, Fig.39) were observed in 
Per1-/- mice compared to Wt mice for the last two intervals the both dark periods. These statistical 
differences could be explained by difference sleep/wake distribution because Wt mice obtained 
more NREM sleep during the preceding 3h (i.e. the ‘nap’; Fig.38A).  
 
A previous study done with same Per1 knock-out mice on the same genetic background showed that 
after 6h of SD, EEG delta power of Per1-/- in the first hour of the recovery was lower than Wt mice 
(Fig.40) [203]. In opposite, another study under 129S4/SvJae background seemed to have an higher 
delta power in Per1-/- compared with Wt mice, however no statistic was done to confirm (Fig.40) 
Figure 39  Time course of EEG delta power during baseline and recovery sleep in Per 
knock-out mice. Mean time course of delta power (1-4Hz) in Per1-/- (blue, n=10), Per2-/- 
(red, n=9), Per1,2-/- (green, n=10) and Wt (dark grey, n=21) mice in baseline (ZT0-24, 
average of 2 baseline days), SD (between 24-30h) and in the recovery (from 30-48h). 
Values represent mean absolute values ±SEM calculated over 12-, 6-, 8- NREM sleep-
time percentiles in the baseline light period, both dark periods, and recovery light peri-
od, respectively. 2-way ANOVA, factors 'genotype' - 'ZT'; interaction: p< 0.001.  or : 
p<0.05 with Holm-Sidak as post-hoc test between knock-out and Wt mice. 
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[201]. Changes in delta power of Per1-/- mice were not observed after SD in the current experiment. 
Moreover, the EEG delta power during the first 20min after the SD did not differ from the Wt mice 
(p=0.4 with Holm-Sidak as post-hoc test). 
EEG delta power in both Per2-/- and Per1,2-/- mice was lower than Wt mice over most of the 
baseline dark period. Again this likely to be consequence of the difference in the sleep-wake distribu-
tion because mice lacking Per2 how sleep more during this period (Fig.38A). Per2 knock-out mice as 
well as the double knock-out mice responded as Wt mice in the first hours of the recovery following 
the SD, contrasting with a previous study showing a lower delta power for Per2m/m (Fig.40) [203]. Ad-
ditionally, EEG delta power quantified during the first 20min after the SD did not differ from both 
Per2-/- and Per1,2-/- mice as compared to the Wt mice (p=0.722 and p=0.052, respectively with Holm-
Sidak as post-hoc test). However, the higher delta power in Per2-/- mice at the end of the light recov-
Figure 40 Upper panel: Effects of 6-h sleep deprivation (SD) on slow-wave activity in NREM sleep (SWA in NREM sleep; mean EEG power 
density in the 0.75±4.0 Hz band) in the frontal (FRO) for the baseline (BL) and recovery (REC) for mPer1 mutants (n = 10), mPer2 mutants (n = 
12) and WT (n = 7). Mean 1-h values ± SEM. In the 6-h interval of recovery in the light period, rANOVA interaction between factors `condition' 
(BL, REC) and `1-h interval' (1-6) was P < 0.0001 in frontal derivations for all genotypes. Triangles below the curves indicate significant differ-
ences between conditions for the corresponding interval (P < 0.05, two-tailed paired t-test). ANOVA interaction between factors `genotype' 
(mPer1 mutants, mPer2 mutants, WT) and `1-h interval' (1-6) for the effect of sleep deprivation (difference REC-BL) was P < 0.05 for both 
derivations. Triangles in the lower panels indicate significant differences between mutant and WT mice in the frontal derivation (P < 0.05, 
Duncan test). Adapted from Kopp C. et al. (2002) [203] Upper panel: Electroencephalogram (EEG) delta power (0.1–3 Hz) during SWS in WT 
and mPer mice. Delta power during the entrained LD cycle (white dots) is double-plotted to illustrate the rise and fall of delta power during 
the dark and light periods, respectively. Black dots, Delta power after 6-h prolonged waking. In all of the genotypes, there was a significant 
increase in delta power after the 6-h prolonged waking compared with their respective entrained values. *P ˂ 0.05 vs.  white dots. Adapted 
from Shiromani P.J. et al. (2004) [201] 
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ery period was found in both the previous [203] and the present study and can be explained by the 
pronounced difference of 71min in NREM sleep in the recovery light period as compared to Wt mice 
(table 8). These results suggest that the homeostatic sleep intensity was not affected by PER2. 
j. Missing a central clock gene, Per2-/- react in the same way to a sleep depri-
vation at molecular level in the cerebral cortex  
Above I have presented and discussed the effects of the lack of Per genes on the behavioral and elec-
trophysiological aspects of sleep homeostasis. Here I focus on the molecular aspects of sleep homeo-
stasis in mice lacking Per2 by quantifying steady state mRNA levels in the cerebral cortex of the clock 
genes Per1, Per2, and Cry1 as well as a widely used clock controlled gene Dbp. The mRNA levels of 
these four genes are known to be activated by the BMAL1::CLOCK/NPAS2 and inhibited by CRY::PER 
[158]. Moreover Per1, Per2 and Dbp are known to be altered by sleep loss [26, 250-252]. I also quan-
tified Homer1a expression which reliable reflects the sleep homeostat at a molecular level [45, 48]. 
Expression levels were quantified at ZT6 in animals that were kept awake in the 6 preceding hours 
and in animals that were left undisturbed and could sleep ad lib (Fig.41).  
Figure 41  Effect of 6 hsleep deprivation (SD) on mRNA level in the cortex of Per2-/- and Wt mice. Relative expression of Cry1, Dbp, Per1, Per2, 
Homer1a and the house-keeping genes Eef1a, Gapdh and Rsp9 in the cerebral cortex of Per2-/- (in red) and Wt (in grey) mice measured by qPCR 
at ZT6 in control condition (C, open bars) or after 6h of SD at ZT6 (hatched bars), n=5 for each group expect for Wt SD that n=4. 2-way ANOVA, 
factors ‘genotype’ and ‘SD’. There was a genotype effect for Cry1 (p<0.01) and Dbp (p<0.001). SD revealed a significantly increase of Cry1, Per1, 
Per2 and Homer1a expression, and a decrease for Dbp (p<0.01 with Tukey as post-hoc test).  There was no significant difference for the house-
keeping genes. 
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Wt mice showed the expected response to the SD: Per1, Per2 and Homer1a increased, while 
Dbp decreased [48, 192]. The effects of SD on Cry1 were none or modest according to the literature 
[48, 195], however we found a statistically increase. The relative change after SD did not differ with 
genotype (no interaction with 2-way ANOVA, factors ‘genotype’ and ‘SD/C). SD had the same effect 
on Per2-/- mice; i.e., an increase for Cry1 (p<0.01 with Tukey as post-hoc test), Per1 (p<0.001) and 
Per2 (p<0.001); and a decrease for Dbp (p<0.008). As expected, Per2 was not detected in Per2-/- mice, 
while Homer1a (p<0.01) increased independently of the genotypes after the SD. So, both the elec-
trophysiological (EEG delta power) and the molecular correlates of sleep homeostasis seem not to 
depend on PER2. These data represent the time-point collected immediately after SD, however may-
be long-term effects could be revealed such as NREM sleep time homeostasis showed before.    
A genotype effect between Wt and Per2-/- mice for Cry1 and Dbp, (respectively p<0.01 and 
p<0.001 with 2-way ANOVA, factors ‘genotype’ and ‘SD/C’) was observed. The general level expres-
sion was higher independently of the condition for these genes in Per2-/- mice compared to Wt mice. 
These higher levels in gene expression could be due to the absence of PER2 which acts as a suppres-
sor of BMAL1::CLOCK/NPAS2 induced transcription. Alternatively, the analyses presented above 
show that under LD12:12 conditions clock gene expressions were advanced by circa 2h (Fig.32). 
However that would predict higher levels for Per1 too, which we did not observe here as well as in 
the previous results at ZT6 in the figure 32.  This is perhaps due to the reduction in the amplitude of 
Per1 transcript oscillation in mice lacking functional PER2 [197, 199].  
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In parallel to this experience, I tested if food had an impact on the RNA expression in the cer-
ebral cortex because during sleep deprivation animals might eat more and feeding is known to 
change the timing of clock gene expression at least in the liver and  also in the brain [103]. To analyze 
this effect I sleep deprived mice with and without access to food that I compared them to their non-
sleep deprived control mice (Fig.42). 
 
Food availability did not modify the effect of SD (with 2-way ANOVA, factors ‘genotype’ and 
‘Food availability’, no interaction); Cry1, Per1, Per2 and Homer1a increase (p˂0.05, p˂0.01, p˂0.001, 
p˂0.02, respectively) and Dbp decreased (p˂0.01) after the SD in both conditions. Thus food seems to 
do not play a role in the effects of sleep loss on clock gene expression.  
  
Figure 42  Effect of 6 hours of sleep deprivation (SD) on mRNA level in the cortex of Wt mice with or without access to food. Relative expres-
sion of Cry1, Dbp, Per1, Per2, Homer1a and the house-keeping genes Eef1a, Gapdh and Rsp9 in the cerebral cortex of and Wt mice with food ad 
libitum (in grey) or without food (in yellow) measured by qPCR at ZT6 in control condition (C, in blank) or after 6h of SD at ZT6 (in hatched), n=5 
for Food C, n=3 for No Food C and n=4 for both Food and No Food SD. 2-way ANOVA, factors ‘Food/No Food’ and ‘SD/C’. There was no food 
effect between the conditions, however there is a SD effect for Cry1 (p<0.05 with Tukey as post-hoc test), Dbp (p<0.01), Per1 (p<0.01), Per2 
(p<0.001), and Homer1a (p<0.02). There was not significantly effect on the control genes. 
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4. Conclusions and perspectives 
In this section of my doctoral work we first performed a in depth characterization of circadian rhyth-
micity at the behavioral level using locomotor activity recordings and the molecular level quantifying 
clock gene expression in the cerebral cortex in Per2-/- mice, and Per1-/- mice, as well as their double 
knock-out offspring (Per1,2-/-) and littermate wild-type (Wt) mice. The second and main aim of this 
project was to analyze the effects of these two Period genes on the homeostatic regulation of sleep 
at the behavioral (sleep and waking), electrophysiological (EEG) and molecular levels. I will discuss 
the results according these two main aims; i.e., circadian characterization and sleep regulation. 
a. Circadian characterization 
Under constant dark (DD) condition we showed that Per1-/- mice had a somewhat shorter period 
compared to Wt, while 94% Per2-/- and all Per1,2-/- mice became immediately arrhythmic. While in 
previous reports Per2-/- mice remained initially rhythmic under DD but then lost rhythms in locomo-
tor activity we here, surprisingly observed the opposite; Per2-/- female mice rhythmicity could be re-
instated by an event not yet fully understood both with respect to the triggering event and to the sex 
specificity of this event. These results suggested that PER2 was able in large part to substitute the 
lack of PER1 with minor changes, while PER1 can substitute PER2 only under very specify condition. 
This instability in the clock machinery, place Per2-/- mice at the border of arrhythmicity depending on 
conditions and sex. We also showed that under LD12:12 conditions, earlier onset were noted in Per2-
/- mice at behavioral (i.e., wake onset), physiological (i.e., corticosterone levels) and molecular levels 
(i.e., clock gene and Homer1a expression). We demonstrated that this earlier onset is probably not 
reflecting a true circadian entrainment but, instead, results from a light-driven rhythm of short peri-
od that is reset each day and linked to light onset.  
Per2 construct comparison 
Our findings demonstrate that our full null-Per2 knock-out (Per2-/-; i.e., Per2tm1Ccl) mice had a stronger 
circadian phenotype as previous Per2 mutant (Per2tm1Brd and Per2tm1Drw) mice studies [197, 199]. In-
deed we observed an immediate arrhythmicity when put in DD, than Per2tm1Brd mice on a 
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129S7/SvEvBrd x C57BL6 mixed background from 2-18 days to lose its circadian rhythm [199], while 
Per2tm1Drw on a C57BL/6J background had a circadian rhythm with a period similar to Wt mice [312]. 
Moreover the triple Per1,2,3tm1Drw knock-out mice on a C57BL/6J background possessed also and ear-
ly activity onset of about 2h under standard LD12:12, as well as an early activity onset of about 5h 
before the dark onset in LD18:6 and were immediately arrhythmic under DD [313]. This phenotype 
was strikingly similar to our Per2-/- mice. Given the fact that the Per2tm1Drw and Per1,2,3tm1Drw lines 
were backcrossed to the same genetic background than ours, we can conclude that it is a difference 
in the Per2 construction. Per2tm1Drw mice are a widely used appearing in 26 studies, and the last pub-
lished example dates from June 2013 [314]. However, Per2tm1Drw mice have the least severe pheno-
type compared to both Per2tm1Ccl and Per2tm1Brd mice, and might express a truncated PER2 lacking on-
ly 107 residues (corresponding to a fragment of the PAS domain). Therefore, Per2tm1Drw mice cannot 
be considered as a true knock-out, and the statements on PER2’s function reported in the literature 
using this strain are likely not accurate. Concerning the phenotype differences between Per2tm1Brd 
and our mice could be explained by both differences in the construct and genetic background.  
Early onset at behavioral, molecular and physiological level in Per2-/- mice 
Another obvious and reproducible feature unique to the Per2-/- genotype concerned their entrain-
ment under LD12:12 conditions. The onset of both waking and activity was earlier than in the other 3 
genotypes and occurred 2.0h and 1.4h prior to dark onset, respectively. We revealed using EEG anal-
ysis that wakefulness onset for Per2-/- mice occurred at ZT9.9±0.2 under LD12:12, while activity onset 
43min later. It’s possible that this difference in onsets is due to a partial masking effect of the light. 
Other genotypes did not show a statistical difference between wakefulness and activity onset. Per2-/- 
mice waking state seems to be more pronounced and differently timed that the locomotor activity 
and this difference could be even more important when relying on running wheels, because mice 
could be awake and active (such as feeding, drowsing, grooming) without using wheels. Thus activity 
onset does not imply that subject was not awake before, and circadian researchers that usually asso-
ciated wake with activity had to take into account. It is important to note that waking is more accu-
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rate measure reflecting SCN effects on behavior, while locomotor activity is just one behavior ex-
pressed during waking. 
We also revealed that gene expression of Bmal1, Npas2, Per1, Cry1, Cry2, Dbp and Homer1a 
as well as plasma corticosterone levels in Per2-/- mice were advanced by 2h. We showed that if Per2-/- 
data curves were delayed by 2h, surprisingly almost RNA curves and corticosterone fitted statistically 
with those obtained in the Wt mice. In addition, it seemed that the changes in Per1, Cry1 and corti-
costerone in Per2-/- mice were lower in amplitude compared to Wt. To confirm this assumption, a 
complete 24h time-course should be performed. Nevertheless, a smaller amplitude of the Per1 oscil-
lation was also observed in Per2tm1Brd mice on a 129S7/SvEvBrd x C57BL6 background [199], and both 
Per1 and Cry1 as well as PER1 and CRY1 oscillation were attenuated in Per2tm1Drw in 129S4/SvJae 
background [197]. However in these studies, both genes and proteins expression were not delayed in 
SCN. Conversely, another study showed that Per1 was advanced by about 3-6h in the SCN of 
Per2tm1Brd mice on a 129S7/SvEvBrd x C57BL6 mixed background [315]. An interesting follow-up ex-
periment would be to quantify core clock gene expression in SCN of our Per2-/- mice to know if Per2 is 
involved in phase advancing at the SCN level too. This raises the possibility to study the link at the 
molecular level between masterclock and peripheral clock.  
A method to verify if light-driven oscillations are regulated through the SCN would be to put 
Per2-/- mice under DD, and then put them back in LD. Clock gene expression in both SCN and periph-
eral tissues as cerebral cortex could be quantified in a time-course manner, expecting that clock gene 
expression will be flat before the light onset. Such experience could confirm the role of Per1 in the 
light-induction and tell us more about where and which others genes are first induced. 
Entrainment or masking effect 
The apparent rhythmicity observed in our Per2-/- mice at both behavioral and molecular levels under 
LD12:12, raises the issue whether to use “entrainment” or “masking effect”. Masking refers to dis-
ruption in the expression of overt rhythms caused by an external agent such as light without a direct-
ly effect on the period underlying the circadian pacemaker. For instance, a nocturnal animal avoids 
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moving under light, then if lights-off were to be delayed, the activity onset of this animal will be de-
layed too [101]. On the other hand, a short period of darkness during the light period will induce 
wakefulness [316]. These are thought to be direct effects of light that are not thought to be mediat-
ed by the circadian clock. In our case, this masking effect seem not to be applicable, in fact, there is 
no need to assume the locomotor behavior was driven by factors other than the clock mechanism. 
After all, we showed that other clock gene expression in Per2-/- mice continues to change in a circadi-
an-like manner. Moreover, they became active despite the light. However, the entrainment term 
(synchronization of a self-sustaining oscillation by a forcing Zeitgeber oscillation) also seems inappro-
priate because behavioral rhythmicity was totally abolished in Per2-/- mice under DD. Then the more 
appropriate term is “light-driven”. It was shown that light exposure is able to induce expression of 
Per1 and Per2 (but not Per3) in the SCN [214, 215, 317], then probably trigger the molecular rhyth-
micity. Our experiment showed that Per1,2-/- mice seems not to be light-driven, because they just 
follow the light dark cycle and all of them became directly arrhythmic under DD suggesting the ab-
sence of functional molecular rhythm. Given the fact that Per1 is directly induced in the SCN after a 
light pulse of 5-15min [128], and that Per1 induction in the SCN is required for light-induced phase 
shifting in mice [127], we thought that light-driven rhythm is mediated through Per1. To summarize, 
it seems that Per1 is sufficient to initiate the molecular oscillation via light induction in our Per2-/- 
mice, but Per2 is needed to maintain rhythmicity over more cycle.  
Cry1,2-/- mice share several phenotypes with our Per2-/- mice. They possessed an early onset 
at about ZT9 under LD12:12 [318] and are behaviorally and molecularly arrhythmic when kept under 
DD [164, 196]. To my knowledge Vitaterna and colleagues were the first to propose the concept of a 
light-driven rhythm [196]. Given the fact that both Per2 and Cry1,2 genes act at the same level as 
negative regulator of the clock machinery at the molecular level, the similar circadian phenotype be-
tween them are striking. Additionally, they noted that Cry1,2 genes differentially influenced Per1 and 
Per2 transcription and suggested that then these two genes have non-redundant functions [196]. 
Surprisingly, Cry1,2-/- mice on Per2-/- and Per1,2-/- animals had diametrically opposed sleep  pheno-
129 
 
types; Cry1,2-/- mice had altered  EEG delta power  and  increased  consolidation  of  NREM sleep 
[191].   
Entrainment under LD11:11 
We showed that Per2-/- mice are incapable of generating self-sustained rhythms under LD12:12. We 
then raised the question whether Per2-/- mice might be able to stably entrain to a short 22h day 
schedule (11h light, 11h dark; LD11:11) better matching the period observed in one male (21.1h), 
seven females (21.9h±0.2), and the short period reported in the literature [199]. An ongoing experi-
ment using running wheel showed that Per2-/- mice (n=13) adapted perfectly to the new schedule 
with an activity onset set at ZT12.15±0.0, i.e., 10min after the dark onset, while four Wt mice had a 
large variability in activity onset (ZT13.02±1.33) and two free-ran under these conditions. More sur-
prising, Per2-/- mice remained rhythmic when released into DD, while majority of these mice (n=5/6) 
became subsequently arrhythmic under DD following LD12:12 as in the main experiment. This sug-
gests that an entrainment corresponding to the period 22h could have a lasting impact on the stabil-
ity of the Per2-/- mice molecular clock, whereas a T-cycle with too long period has a destabilizing ef-
fect. A following experiment to confirm this T-cycle influence on the clock machinery would be to 
compare clock gene expression under LD12:12 and LD11:11 and also when release under DD. 
Red dim light, a potential factor of the rhythmicity reinstatement in Per2-/- female  
In contrast to males, Per2-/- females rhythmicity can be triggered under DD but the key trigger is un-
known. A first possibility is the short exposure (max. 5min) to red dim light associated with opening 
the recording cabinets during DD for health status verification although mice are considered ‘blind’ 
to red light. Several publications have shown that dim red light can impact locomotor activity 
rhythms in mice adapted to DD conditions [101, 319]. Moreover, it was shown that arrhythmic 
Per2tm1Brd mice in 129S7/SvEvBrd x C57BL6 mixed background under DD could have similar rhythmici-
ty reinstatement using 6h white light pulse [199]. Taken together, that let us suppose that dim red 
light could be the triggering factor of this circadian reinstatement in our Per2-/- female mice. It is well 
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known that there are differences between male and female concerning the vigilance state (e.g. high-
er locomotor activity in the females, different regulation of REM sleep time and NREM sleep need) 
[194]. However to be able to sustain circadian rhythm in DD, females have something more than 
male, perhaps it is due to an effective color vision in females as in human [320] or more probably due 
to the estrus cycle phase and its specific hormones in females. However, primary female sex hor-
mone estrogen was able to delay the phase and increased the amplitude of Per1 in liver and kidney 
only but not in SCN and in the cerebral cortex [210]. Maybe the estrogen effect on the reinstatement 
of the circadian rhythmicity did not pass through Per induction, but by other way such as Cry. In fact, 
it was show that in rats that estrogen was able to modify Cry2 expression (but not Cry1) in the SCN 
[321]. 
Rhythmicity reinstatement under DD 
By chance we found that an event could trigger establishment of rhythmicity that was associated 
with checking the mice while kept under DD. The key trigger could be one of many; e.g., fresh food, 
noise, odor, dim red light. In some ways this triggering of rhythmicity is reminiscent of serum shock 
cultured cells which induced and synchronized rhythms in gene expression [322]. We are currently 
systematically investigating the effects of a dim red light pulse (625-30nm, 5min). We choose 5min, 
because it was the maximum time required in the previous experiment to verify the health status 
under DD using red dim light. Because mice do not have red cones like human, it is assumed that 
they are not able to respond to the red light input [323]. Moreover, several studies analyzed in depth 
the spectral sensitivity of the photoreceptors in mice and predicted no or minimal response to red 
light [324-326]. For these reason red dim light is widely used during DD to permit to easily check the 
mice, without disturbing them. Conversely, an impact of red light on rodent’s circadian rhythmicity 
was shown in the 1980’s. For instance, circadian running activity and luteinizing hormone secretion 
were shifted by a 2h red light pulse (> 650 nm) in rats under DD [327]. More recently, it was shown 
that constant dim red light (with a light-emitting diode (LED) at 652 nm) lengthens circadian period 
compared to constant darkness [319]. Thus although mice are not thought to see in the red wave-
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length range, when adapted to for a long time to DD, they seem to be able to detect it.  It is still un-
clear what cell type is responsible for responding to dim red light.  
In a previous experiment using arrhythmic Per2tm1Brd mice in 129S7/SvEvBrd x C57BL6 mixed 
background under DD, it was found similar rhythmicity reinstatement using 6h white light pulse 
[199]. The fact that only 5min of an “invisible” light has the same effect is very surprising. We hy-
pothesize that after the red dim pulse Per2-/- female mice will free-run with a short period of about 
22h, while males will remain arrhythmic. Preliminary results indicate that our hypothesis is partially 
correct; following a 5min red light pulse, three arrhythmic female Per2-/- mice regained rhythmicity 
with a short period (21.5h±0.2), while two Per2-/- mice were not affected. However, contrary to what 
we hypothesized, exposure to red light had the same effect on Per2-/- males. Rhythmicity was estab-
lished in three arrhythmic male mice with a period similar to the female (21.6h±0.1), while two Per2-
/- mice were not affected. While more experiments need to be performed. 
Sex difference effect on circadian rhythmicity strengths 
Despite the fact that a lot of phenotypes (such as activity onset under LD, arrhythmicity under DD, 
period length as far as could be determined, etc.) were shared between Per2-/- female and male 
mice, it seems that rhythmicity could be reinstate specifically in female suggesting a more robust cir-
cadian rhythm in females compared to males. This sex-effect deserves further investigation. The ob-
vious physiological differences found between males and females are of course sexual hormones. 
Estrogens are a family of female sex hormones with an exceptionally wide spectrum of effects. To 
better study the effect of these hormone on mice, ovariectomy has commonly been performed to 
suppress the rapidly cycling hormone production from the estrous cycle and could be replaced by 
17β-estradiol exogenously administrated [328]. Estrogen hormone could have also an impact on cir-
cadian rhythm through Per or Cry genes as it was shown that 17β-estradiol treatment in ovariecto-
mized female rats was able to advance the peak of Per2 expression in the SCN and to delay the phase 
and increased the amplitude of Per1 specifically in liver and kidney, suggesting that estrogen effect 
on Per genes was tissue specific [210]. It has also been shown that 17β-estradiol modified Cry2 ex-
132 
 
pression, but not Cry1 in SCN of ovariectomized female rats [321]. An interesting project would be to 
investigate if the sex differences in the circadian reinstatement behavior found in our Per2-/- female 
were still present after ovariectomy and if 17β-estradiol administration could rescue the phenotype 
in female and could make more robust circadian rhythms in Per2-/- male. 
b. Sleep regulation analysis 
 Lack of Per2 affected several aspects of sleep both under baseline and during recovery from a 6h 
sleep deprivation. In baseline the most salient feature was the increased NREM sleep fragmentation. 
In addition, and consistent with our main hypotheses concerning a role of Per2 in sleep homeostasis, 
we observed a profound deficit in the compensatory response in NREM sleep duration during the 
first 5h of recovery from SD during which Per2-/- mice expressed less sleep than during baseline. 
However, other aspects of sleep homeostasis such as EEG delta power its molecular correlate 
Homer1a were not altered. 
Baseline 
Quantification and consolidation analysis of NREM and REM sleep during baseline revealed that PER1 
is not needed to maintain a normal sleep distribution and sleep integrity. On the other hand PER2 is 
required, because in both Per2-/- and Per1,2-/- mice NREM sleep is more fragmented, and Per1,2-/- 
mice expressed more NREM sleep. This alteration in the sleep integrity was also found in other clock 
gene mutant mice such as Bmal1-/- [190] and Clockm/m mice [193]. While double Cry1,2-/- knock-out 
mice had more consolidated sleep, more NREM sleep and longer NREM sleep episodes than Wt mice 
[191]. This suggests that several clock genes are involved in a specific manner in sleep consolidation. 
It was previously shown that animals rendered arrhythmic by lesioning the SCN had more fragment-
ed sleep [22]. An intact circadian system is probably required to consolidate sleep. Moreover a hu-
man study shown that sleep at the wrong circadian phase decreased its quality [21]. From an evolu-
tionary view, enabling sleep-wake consolidation represents then an adaptive advantage provided by 
the circadian system [329]. However more investigations were needed to understand this relation-
ship.  
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What role could clock gene have in sleep homeostasis 
Several studies demonstrated that clock genes play a role in sleep homeostasis [26]. Two previous 
studies assessed in mice lacking Per1  and⁄or Per2 gene concluded that knock-out mice did not show 
a homeostatic phenotype [201, 203]. Kopp and colleagues found a lower EEG delta power rebound in 
Per1 and Per2 single mutant mice  6h SD, but they proposed that EEG differences between mutants 
and Wt mice reflects behavioral differences during the extended waking episode rather than changes 
in the homeostatic sleep process [203]. Although not commented on by Shiromani and collaborators, 
Per1,2 double-mutant mice EEG delta power seemed enhanced to a greater extent after sleep depri-
vation compared to Wt mice [201]. These results suggest an eventual functional implication of Period 
genes in sleep homeostasis. Because of the disparate results we here re-assessed this question using 
a null-mutant Per2 mouse line. We quantified 3 different aspects of sleep homeostasis sleep dura-
tion, sleep intensity, and at the molecular level by clock gene quantification. 
We observed the amount of NREM and REM sleep in the recovery are similar between Per1-/- 
and Wt mice, while both Per2-/- and Per1,2-/- mice had a distinct phenotype. In the first 5h of recovery 
sleep these mice slept less than during baseline and thus further increase their sleep loss. Their actu-
al recovery started in the last hour of the light period (ZT11) but the extra sleep obtained during the 
following dark did not make up for this later onset of recovery sleep indicating that this initial extra 
loss was not compensated for. Thus PER2 is necessary to adequately compensate for the loss of 
NREM sleep suggesting that PER2 at some level is needed to sense sleep need or to translate in-
creased sleep need into the appropriate behavior; i.e., sleep. Interestingly, although initially also for 
REM sleep extra loss was accrued Per2-/- mice subsequently compensated to a larger extend with sig-
nificant difference reaching at ZT22-23. Higher REM sleep amount during baseline and its REM sleep 
over compensation during recovery was only found in Per2-/- mice, suggesting a particular link be-
tween REM sleep regulation and PER2. Given the fact that double knock-out and Per1-/- mice didn’t 
show this phenotype, we can speculate that it is not a direct effect of PER2 but, instead, an effect of 
the shorter non-functional clock machinery present in Per2-/- mice under LD12:12. To verify, this hy-
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pothesis, sleep-wake distribution could be analyzed under LD11:11 conditions, where Per2-/- mice 
seemed to be correctly entrained. 
We observed that expression of Cry1, Per1, Dbp and Homer1a genes in both Per2-/- and Wt 
mice respond in the same way to a sleep deprivation suggesting that the absence of PER2 did not 
modify the circadian machinery at the molecular level in response to higher sleep pressure. Moreo-
ver, quantification of the sleep-wake dependent dynamics of EEG delta power revealed that lack of 
Period gene had no influence on homeostatic sleep intensity. The time course of EEG delta power 
during baseline and recovery periods seemed to reliably follow the sleep-wake distribution within 
each genotype. Moreover, EEG delta power levels reached immediately after the end of the SD did 
not vary among genotypes. This let us conclude that EEG delta power dynamic is not altered by the 
lack of Per1, and/or Per2.  
 Another way to confirm that observed EEG delta power in our knock-out mice did not result 
in a more rapid or slow build-up of homeostatic sleep need during wakefulness compared to Wt 
mice, would be to perform a simulation analyze, a mathematical method that quantifies the relation-
ship between the changes observed in delta power and the sleep-wake distribution for each geno-
type [46]. This method permits to separate the effects of sleep-wake patterns, which varied between 
genotypes, from the effects of different dynamics of EEG delta power [46]. Thereafter we could com-
pare the simulated EEG delta power dataset versus the empirical EEG delta power dataset.  
Many other clock mutant mice had impairment in the EEG delta power dynamics, such as 
Bmal1-/- mice which EEG delta power just after 6h SD was lower than the Wt mice[190], or Npas2-/- 
mice which dynamic of delta power increased slower than Wt mice [194] or Cry1,2-/- mice in which 
the the need for sleep increased at a faster rate than Wt mice [191]. In contrast, despite the fact that 
EEG delta power of the Clockm/m mice was lower that Wt mice in baseline, this mutant mice respond-
ed similarly to SD suggesting that homeostatic regulation of sleep intensity was not affected [193]. 
Contrasting with the almost of these sleep studies, our data revealed that lack of either PER1 and 
PER2 did not affect the dynamics of EEG delta power. 
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Usually sleep deprivation was performed between ZT0-6 in Wt mice corresponding to 1st half 
of the man sleep period, which SD have the larger impact on the sleep homeostasis. Perhaps this 
starting time-point from SD is not optimal for mice with early activity onset such as Per2-/- mice. Thus 
an experience would be to initiate SD when delta power is at its maximum under baseline for Per2-/- 
mice at about ZT15. 
Although both Per1 and Per2 did not modulate the sleep-wake distribution dynamics of EEG 
delta power, we demonstrated that PER2 is involved in REM sleep regulation, NREM sleep consolida-
tion and in the ability to adequately compensate a lack of both REM and NREM sleep. Then PER2, in 
contrast to PER1, seems to be implicated in these aspects of sleep homeostasis. This report shows 
that a modification on clock gene alters the sleep homeostasis specifically in term of duration, such 
as Clockm/m and Dbp-/- mice [193, 248]. Other clock mutant studies showed modification in term of 
sleep intensity or both. Although clock genes have a non-circadian role in sleep homeostasis, the sto-
ry appears to be more complicated. All aspects of sleep homeostasis are not equally affected by an 
altered clock gene. Moreover these effects cannot be categorized for instance by mutation in clock 
gene of the positive (e.g. Bmal1, Npas2) or negative regulator (e.g. Cry, Per) of the circadian machin-
ery. Both Cry1,2-/- and Per1,2-/- mice had similar circadian phenotype (see above), but with a specific 
altered sleep homeostasis.  
c. Others remarks 
Food effect 
Food availability is thought to be a strong Zeitgeber in rodents. When food is offered ad libitum, mice 
and rats feed usually at night. However when food is restricted to a short period during light, they 
will adapt to the new condition developing an anticipatory locomotor activity before the food availa-
bility even in the light period. This food anticipatory phenomenon is effective even in mice with SCN 
lesions, demonstrating that it not depend on the SCN [330]. It was shown in C57BL/6 mice that food 
restriction confined to light period during several weeks altered Bmal1, Clock and Per2 gene expres-
sion in the liver but had no effect in the hypothalamus [103, 331]. Same alteration was found in kid-
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ney, heart, pancreas and cortex, but not in SCN [332, 333]. In short food intake at specific time could 
modify core clock gene oscillation in tissue specific manner [331, 334]. Then we raised the question if 
modification of gene expression after 6h of sleep deprivation is a direct effect of this sleep loss or a 
result of food availability, i.e., during SD mice could eat more compared to the sleeping control mice. 
Here we showed that food availability during SD had no impact on the changes in Per1, Per2, Cry1 
and Dbp gene expression in the cerebral cortex. These results did not call into question our sleep 
deprivation protocol and suggest maybe that it is not food intake that synchronizes circadian rhythm 
but hunger. 
Background effect 
A very general important point to highlight is the genetic background that had an influence on both 
sleep and circadian behavior. It was shown that genetic background in mice has a strong impact on 
the NREM sleep need. It was shown that both the dynamics of NREM sleep intensity (delta power) 
and NREM sleep duration are regulated with a large strain differences in mice [46]. The genetic back-
ground has an impact on the circadian phenotype too. For instance, as it was previously reported, 
Per1-/- mice in 129S7/SvEvBrd background had a shorter period (22.6h ±0.2) [26] than in C57BL6/J 
background (23.4h ±0.1) shown in the present study. Another example is the Per2tm1Drw on a 
129S4/SvJae background that initially displayed a short period (23.0h±0.3) and became arrhythmic 
under DD condition [197]. This strong phenotype completely disappear when backcrossed onto a 
C57BL6/J background, these mice remained rhythmic with a normal period (data not shown) 
throughout DD [200]. That demonstrates that the genetic background could have a more important 
impact on the circadian phenotype and could modify the penetrance of a clock gene mutation. For 
these reasons, I would like to warn the reader to take particular attention to genetic background be-
fore to compare results between different studies, an important point often overlooked in the litera-
ture. 
C57BL6/J is a widely used particular inbred strain that do not produce melatonin hormone 
[335, 336]. Melatonin is produced in the pineal gland with high day/night amplitude can be consid-
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ered as a neuroendocrine hand of the clock. In fact, melatonin may provide a feedback loop to the 
circadian clock in the SCN and may serve the synchronization of peripheral oscillators. In the SCN, 
melatonin interacts with PACAP, a neuropeptide of the retinohypothalamic tract and suppresses indi-
rectly the transcription factor CREB that activate Per transcription [336]. Mice with melatonin such as 
C3H/HeJ could affect a knock-out, and perhaps change the phenotype. A relevant example is the hy-
pomorphic mutant Clockm/m mice that a longer period in a C57BL6/J background [193], while this 
phenotype completely disappeared in a C3H/HeJ background [337]. Then an intriguing project imply-
ing very long period of backcrossing would be to put our Per2-/- mutation on a C3H/HeJ background 
to study if melatonin could rescue our phenotype and improve the knowledge between this hormone 
the Per genes regulation. Another easier idea would be to directly administrate melatonin at about 
ZT24 (maximum plasma concentration [335]) to our mice. 
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VIII. Concluding remarks 
Sleep is regulated by a homeostatic process that is activated by the loss of sleep and by a circadian 
process that determines the time-of-day when sleep occurs. These two processes are functionally 
and anatomically separated. However, this work underlines the idea that clock genes, which gener-
ate the circadian rhythm, are also involved in sleep homeostasis. My research is of both fundamental 
and clinically relevant, as many disorders are sleep associated. 
In first part of my doctoral work, we presented the first and thus far only study that asses the 
changes in DNA-binding pattern of clock genes following sleep-deprivation. DNA-binding of NPAS2 
and BMAL1 to Per2 and Dbp E-box and E’-box elements was decreased after sleep deprivation sug-
gesting that the sleep-wake state contributes to the circadian changes in DNA-binding and clock gene 
expression. However, the precise dynamic relationship between DNA-binding and mRNA expression, 
especially for Per2, remains elusive. Our results also suggest that part of the reported circadian 
changes in DNA-binding of core clock components in tissues peripheral to the suprachiasmatic nuclei 
could, in fact, be sleep-wake driven. In the second part of my doctoral work, we demonstrated that 
PER2 is involved in REM sleep regulation, NREM sleep consolidation and in the ability to adequately 
compensate a lack of both REM and NREM sleep after sleep deprivation. This last finding strongly 
suggests that sleep homeostasis, in term of duration, was in part regulated by PER2, while PER1 
seems not to be involved. However, it was shown that at the molecular level PER1 could partially re-
place PER2, because even in the absence of PER2 all other clock genes were expressed in a circadian 
fashion. Given the fact that behavioral rhythmicity was totally abolished in Per2-/- mice from the first 
day under DD, we proposed that Per2-/- rythms under LD12:12 conditions are light-driven in a fashion 
different from masking. 
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Sleep and circadian rhythms are closely interconnected. Their subtle interaction allows us to 
stay awake and alert, despite the increase of sleep need accumulated throughout the day. Minor 
changes in only one of these two processes are enough to significantly decrease performance and 
clinically disrupt the quality of sleep. Disrupted of insufficient sleep those are wide‐spread in our hec-
tic modern society represent a serious public health problem. Chronic disturbances in sleep can have 
profound adverse physiological effects. For instance, epidemiological and experimental evidence re-
veals that poor sleep hygiene increases the risk for metabolic disorders such as type-2 diabetes and 
obesity [338]. Experimental studies also demonstrates that only 6 consecutive nights of 5h sleep are 
enough to increase levels of free fatty acids, beta-cell dysfunction, and insulin sensitivity. Moreover, 
the circadian system is tightly associated with metabolism at the molecular, cellular and system lev-
els [339]. Mice with mutated or lack of some core clock genes such as Bmal1 and Clock were respon-
sible of metabolic syndrome with obesity, hyperglycemia, and hypoinsulinemia, while lack of Per2 
promote inter alia lymphomas [120], hyperinsulinemia [340] , altered glucose homeostasis [341] and 
suppression of glucocorticoid rhythm [342]. It important to note that etiology of both chronic sleep 
loss and disrupted circadian rhythmicity might be through clock genes. 
Strikingly, patients suffering of FASPS (human familial advanced sleep phase syndrome) have 
been found to have a mutation in PER2 [141] or in the kinase responsible for PER2 phosphorylation 
[144]. This syndrome is characterized by a very short circadian period with early sleep and early 
morning awakening time [140]. These patients have blood melatonin level and the body core tem-
perature rhythm phase advanced by about 3-4 hours. Our work helps understanding this disease by 
strengthening the implication of Per2 in the sleep-wake distribution and in sleep regulation. Our re-
sults provide new knowledge on this gene which will help to design treatments for FASPS. Moreover, 
the use of Per knock-out mice as model, allow to better understand their genes implication in many 
metabolic and physiological pathway as well in behavior.  
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